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ABSTRACT OF DISSERTATION 
 
 
 
 
ROLE OF CALCIUM AND NITRIC OXIDE SYNTHASE (NOS) IN BRAIN 
MITOCHONDRIAL DYSFUNCTION 
 
Mitochondria are essential for promoting cell survival and growth through 
aerobic metabolism and energy production. Mitochondrial function is typically 
analyzed using mitochondria freshly isolated from tissues and cells because they 
yield tightly coupled mitochondria, whereas those from frozen tissue can consist 
of broken mitochondria and membrane fragments. A method, utilizing a well-
characterized cryoprotectant such as dimethyl sulfoxide (DMSO), is described. 
Such mitochondria show preserved structure and function that presents us with a 
possible strategy to considerably expand the time-frame and the range of 
biochemical, molecular and metabolic studies that can be performed without the 
constraints of mitochondrial longevity ex vivo. 
Mitochondrial dysfunction is implicated in Alzheimer’s disease (AD) mainly 
through oxidative stress and altered metabolism. Mitochondria are isolated from 
post-mortem brain samples from selective regions of AD and control patients 
and, utilizing the cryopreservation strategy, analyzed for respiration and oxidative 
damage. While we did not observe increases in free radicals, we did observe 
decreased respiration and increases in oxidative damage markers in AD patients, 
suggesting a role for oxidative stress in mitochondrial dysfunction.   
While in the mitochondria, calcium (Ca2+) increases free radical generation 
by processes not completely understood. A new isoform of nitric oxide synthase 
(mtNOS) has been isolated and localized to mitochondria; though its existence 
and physiological role is debated. Nitric oxide synthase (NOS), when activated by 
Ca2+, produces nitric oxide (NO•) that can interact with ROS producing various 
reactive nitrogen species (RNS). These highly reactive radical species can 
damage DNA, proteins and lipids, ultimately resulting in cell death via apoptosis 
or necrosis. 
The current research is aimed at understanding the role of Ca2+ and NOS 
in oxidative stress leading to mitochondrial dysfunction. We observed a 
significant reduction in mitochondrial respiration with increasing doses of calcium. 
We also observed NOS enzyme activity and detected NOS protein in the purified 
mitochondrial fraction. Lastly, we were also able to show that Ca2+ increased the 
levels of free radicals and changes in oxidative damage markers. These results 
suggest the presence of NOS in mitochondria that could play a role in Ca2+ 
induced mitochondrial dysfunction and potentially leading to cell death as 
relevant to aging and neurodegenerative diseases. 
 
KEYWORDS:  Brain Mitochondria, Cryopreservation, Alzheimer’s disease (AD), 
Calcium, Nitric Oxide Synthase and Oxidative Stress 
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Chapter One 
 
Mitochondria, Calcium, Nitric Oxide Synthase, 
Oxidative Stress, Cell Death and Aging 
 
  
Mitochondria act as a biological switch in determining a cell’s fate, in that 
they provide the necessary energy for the cell and in cases of noxious stimuli 
cause cell death by necrosis and/or apoptosis. The physiological function of 
mitochondria is to produce adenosine triphosphate (ATP), energy currency of the 
cell, through Kreb’s cycle and electron transport chain (ETC). This ATP is utilized 
for various biological reactions inside the cell. Mitochondria are also involved in 
calcium (Ca2+) homeostasis. However, as a consequence of ATP production, 
mitochondria also produce reactive oxygen species (ROS) as a by-product, 
mainly in the form of superoxide. The mitochondria are also equipped by anti-
oxidant molecules and enzymes, and repair mechanisms. However, during 
pathophysiological conditions such as aging, neurodegeneration and 
neurotrauma, the balance between ROS and anti-oxidants is tipped causing 
oxidative stress and Ca2+ dysregulation. This leads to mitochondrial dysfunction, 
triggering a signaling cascade resulting ultimately in death of the cell (Pedersen 
1999; Duchen 2000; Kroemer and Reed 2000; Newmeyer and Ferguson-Miller 
2003; Smaili et al. 2003; Wallace 2005).  
 
Mitochondria 
 
Margulis, in one of the early theories of mitochondrial evolution in 1970, 
proposed that mitochondria originated from α-Proteobacteria that formed an 
endosymbiotic relationship with nucleocytoplasm of Archeon about 1.5 – 2.0 
billion years ago (Gray et al. 1999; Lang et al. 1999; Gray et al. 2001; Searcy 
2003; Dyall et al. 2004). However, studies of protists (unicellular eukaryotes) 
indicate that mitochondria originated at the same time as the eukaryotic nucleus 
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and not as a separate and subsequent event. In either case, genes necessary for 
amino acid biosynthesis, nucleoside biosynthesis, anaerobic glycolysis, cofactor 
biosynthesis, fatty acid and phospholipid metabolism, energy and intermediary 
metabolism, cell envelope synthesis, and cell division as well as most 
informational genes (genes directing replication, transcription, and translation) 
were typically transferred to host nuclear de-oxy ribo nucleic acid (DNA), thereby 
rendering a simple mitochondrial DNA (Gray et al. 1999; Wallace 2005). 
Kolliker, in 1850, was among the first to describe characteristically 
arranged granules in the sarcoplasm of striated muscle, separated them from cell 
structure and noted they possess a membrane. They were termed “sarcosomes” 
by Retziius and “bioplasts” by Altman in 1890 and “mitochondria” (Greek; mitos 
meaning a thread and chondros meaning grain) by Benda in 1898. They were 
also known by various other terms such as blepharoblasts, chondriokonts, 
chondriomites, chondrioplasts, chondriosomes, chondriospheres, fila, interstitial 
bodies, mitogel, parabasal bodies, plasmasomes, spheroplasts, and vermicules, 
among others. Kingsbury and Warburg in 1912 studied mitochondria and 
demonstrated that they were involved with respiration, while Lewis and Lewis in 
1914 found mitochondria to undergo changes in their size, shape and location. In 
the 1920s and 1930s, Szent-Gyorgyi (awarded the Nobel Prize in 
Physiology/Medicine in 1937) discovered the catalytic effect of the four-carbon 
dicarboxylic acids on respiration and Krebs (Nobel Prize in Physiology/Medicine 
in 1953) postulated the citric acid cycle as the primary cellular mechanism for the 
oxidation of carbohydrates, thus bringing mitochondria into the limelight as 
“powerhouses of the cell”.  
Lohmann in 1931 discovered ATP, but its true significance in cellular 
energy requirements came about with the demonstration of Warburg in 1937–
1938 of the formation of ATP coupled to enzymatic oxidation of glyceraldehyde 
phophate (and won the Nobel Prize in Physiology/Medicine in 1931) and the 
work of Meyerhof (Nobel Prize in Physiology/Medicine in 1922) on the formation 
of ATP from phosphopyruvate. During the same period, Kalckar demonstrated 
that oxidative phosphorylation was coupled to respiration. In 1940, Claude 
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investigated the structure, behavior, and chemical composition of mitochondria 
and microsomes isolated by differential centrifugation of liver homogenates (and 
won the Nobel Prize in Physiology and Medicine in 1974). During the period from 
1943–1947, Leloir and Munoz, Lehninger and Kennedy, and Schneider and 
Potter conducted studies on oxidation of fatty acids in the liver, and established 
that mitochondria are indeed the sites of fatty acid oxidation, citric acid cycle and 
synthesis of ATP by oxidative phosphorylation (Nisoli et al. 2004). 
Biogenesis of mitochondria has its roots in three theories: a) de novo 
synthesis of mitochondria from precursors present in the cytoplasm; b) formation 
from other membranous structures in the cell and c) growth and division of pre-
existing mitochondria. Biogenesis of mitochondria can be initiated during mitosis 
or various external and internal stimuli such as inhibitors of oxidative 
phosphorylation, Ca2+ fluxes, thyroid hormone and low temperature.  
Mitochondria are also capable of undergoing frequent fusion and fission cycles, 
modulated by the mitofusins (Mfn) and dynamin-related proteins (Drp) 
respectively, thus displaying plasticity in their size, shape, number (or mass 
volume) and distribution. This ensures adequate availability of mitochondria to 
meet the energy requirements and limits the number of defective or damaged 
mitochondria. Mitochondrial biogenesis is brought about by transcriptional 
regulation. Peroxisome proliferator-activated receptor-γ coactivator 1α (PGC-1α) 
and PGC-1β induce the expression of nuclear respiratory factors (NRF-1 and 
NRF-2), which in turn upregulate the expression of genes coding for both nuclear 
subunits of the respiratory chain and proteins involved in mitochondrial DNA 
transcription and replication. There is growing evidence of involvement of Ca2+ 
and nitric oxide acting as cellular sensors of energy expenditure and activating 
the mitochondrial biogenesis pathways (Nisoli et al. 2004; Nisoli et al. 2005). 
 The first high resolution images and structure of mitochondria were 
described by Sjostrand and Palade in 1952 and 1953 respectively. Mitochondria 
consist of an outer (OMM) and inner membranes (IMM) separated by the inter-
membrane space (IMS). The inner membrane is impermeable to most molecules 
and consists of numerous invaginations called cristae, coined by Palade (who 
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later won the Nobel Prize in Physiology/Medicine in 1974), that house 
components of the ETC (Complexes I, II, III, IV) and ATP Synthase (Complex V). 
The inner membrane also encloses the matrix containing mitochondrial DNA 
(mtDNA), ribonucleic acid (RNA), ribosomes and several enzymes. In 
mammalian cells, each organelle contains several identical copies of mtDNA, 
whose structure and gene organization is highly conserved among mammals, 
each containing 37 genes that code for 2 ribosomal RNAs (rRNA), 22 transfer 
RNAs (tRNA) and 13 polypeptides (Taanman 1999; Szewczyk and Wojtczak 
2002; Gibson 2005).  
Another unique feature of mtDNA is its maternal inheritance in mammals. 
mtDNA is transferred through germline alone, when the sperm mitochondria are 
transferred to the oocytes during fertilization. All the mtDNA-coded polypeptides 
are subunits of the enzyme complexes of the ETC. The rest of the proteins are 
transcribed in the nucleus and imported into the mitochondria by an elaborate 
machinery of translocases located on the membranes of the mitochondria (Dyall 
et al. 2004; Wallace 2005). The outer membrane contains TOM (translocase of 
the outer membrane) complex for translocation and SAM (sorting and assembly 
machinery) complex for assembly of outer membrane proteins. The inner 
membrane contains TIM23 (translocase of the inner membrane) that mediates 
the import of mitochondrial matrix proteins with a typical N-terminal targeting 
sequence (positively charged on one side and hydrophobic on the other side and 
gets cleaved upon import), and the TIM22 complex mediates the import of inner 
membrane proteins (Koehler 2004). 
One of the reasons for oxidative damage in mitochondria is increased 
susceptibility of mtDNA, owing to its proximity to ROS generation sites, absence 
of introns and lack of protective histones. This invariably leads to a very high 
mutation rate among mtDNA leading to a mixed intracellular population of 
mtDNAs, termed as heteroplasmy. Furthermore, in post-mitotic tissues, mtDNAs 
harboring deleterious mutations have been found to be preferentially, clonally 
amplified within cells. As the percentage of mutant mtDNAs increases, the 
mitochondrial energetic output declines, ROS production is elevated, and the 
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propensity for apoptosis increases. As cells are progressively lost through 
apoptosis, tissue function declines causing aging and/or movement disorders, 
dementias, cardio-vascular diseases and diabetes (Wallace 2005). 
Mitochondria generate upto 95% of cellular ATP via oxidative 
phosphorylation carried out by the ETC. The ETC located on the IM of 
mitochondria comprises of Complexes I through IV and mobile electron carriers, 
coenzyme Q and cytochrome c. They are arranged in a series such that the 
electrons, donated by reducing equivalents from Kreb’s cycle like nicotanamide 
adenine dinucleotide (NADH) or flavin adenine dinucleotides (FADH2), flow down 
a voltage gradient, ultimately reducing oxygen to water at the level of Complex 
IV. In 1961, Mitchell proposed a mechanism for the coupling of electron transfer 
to ATP synthesis, based on an indirect interaction between oxidizing and 
phosphorylating enzymes. He suggested that the flow of electrons through the 
enzymes of the respiratory chain causes positively charged hydrogen ions, or 
protons, from the mitochondrial matrix being pumped by Complexes I, III and IV 
to the IMS of mitochondria. As a result, an electrochemical proton gradient is 
created across the membrane. The gradient consists of two components: a 
difference in hydrogen ion concentration (pH gradient) and a difference in 
membrane potential (∆ψ) of around 150mV; forming the 'protonmotive force'. The 
synthesis of ATP is driven by a reverse flow of protons down the gradient through 
ATP synthase (Complex V) resulting in generation of ATP from ADP (adenosine 
diphosphate) and inorganic phosphate (Pi). Mitchell's proposal has been called 
the 'chemiosmotic theory', which won him a Nobel Prize in Chemistry in 1978, 
giving rise to the field of ‘bioenergetics’ (Pedersen 1999; Nicholls and Ward 
2000; Nicholls and Ferguson 2002; Newmeyer and Ferguson-Miller 2003; 
Wallace 2005). 
Each of the components of the ETC undergoes a cycle of oxidation and 
reduction reactions resulting in energy changes. NADH donates electrons to 
NADH-ubiquinone oxidoreductase (Complex I), which transfers them to 
coenzyme Q (ubiquinone), accompanied by pumping of protons from matrix into 
the IMS. Complex I can be inhibited by rotenone and piericidin A. On the other 
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hand, FADH2 bypasses complex I and donates electrons to Succinate-
ubiquinone oxidoreductase (Complex II) instead, that can then transfer them to 
ubiquinone. Complex II can be inhibited by malonate and nitroproprionic acid (3-
NP) (Nicholls and Ferguson 2002).  
Coenzyme Q transfers electrons to cytochrome b component of 
Ubiquinone-cytochrome c oxidoreductase (Complex III or cytochrome c 
reductase or simply bc1 complex), which then reduces cytochrome c1 
component. This leads to further pumping of protons into the IMS. Complex III 
can be inhibited by Antimycin A, myxothiazol and stigmatellin (Nicholls and 
Ferguson 2002).  
The electrons are carried from cytochrome c1 of Complex III to 
cytochrome c oxidase (Complex IV or cytochrome a,a3) by Cytochrome c located 
in the IMS, causing pumping of more protons into the IMS. Only cytochrome c 
oxidase is capable of overcoming the large kinetic barrier of simultaneous 
addition of four electrons to a molecule of oxygen that is then reduced to water 
(H2O).  Cyanide can inhibit Complex IV (Nicholls and Ferguson 2002).  
F0-F1-ATPase or ATP synthase (Complex V) synthesizes ATP from ADP 
and Pi. This is achieved through reversing the ATPase in favor of synthase by 
consuming the energy of the proton gradient when protons flow back into the 
matrix from the IMS. This pioneering work on ATP synthase earned Boyer and 
Walker the Nobel Prize in Chemistry in 1997.ATP can then be transported out of 
the mitochondria by the ADP/ATP antiporter, adenine nucleotide translocase 
(ANT). Thus, flow of electrons down the voltage gradient is coupled to the proton 
gradient and subsequent phosphorylation of ADP to ATP (Nicholls and Ferguson 
2002).  
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Figure 1.1: Illustration of the mitochondrial Electron Transport Chain (ETC). 
Electrons from NADH or FADH2 FADH are passed through the ETC in the 
following order – a) NADH-ubiquinone oxidoreductase (Complex I) or Succinate-
ubiquinone oxidoreductase (Complex II) b) coenzyme Q (ubiquinone) c) 
Ubiquinone-cytochrome c oxidoreductase (Complex III or cytochrome c 
reductase) d) Cytochrome c e) Cytochrome c oxidase (Complex IV or 
cytochrome a,a3) and donated to oxygen reducing it to water. Protons are 
pumped from mitochondrial matrix to the inter-membrane space, that flow back 
through F0-F1-ATPase or ATP synthase (Complex V) resulting in generation of 
ATP. 
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Calcium 
 
 The story of calcium (Ca2+) began around 1883 with the publication of a 
paper by Sydney Ringer, who observed that Ca2+ is needed for maintaining heart 
contraction in the saline medium, now known as Ringer’s solution. It was not until 
the 1930’s that anyone paid much attention to this molecule. However, in 1940s, 
Heilbrunn proposed that Ca2+ by diffusion was one of the activators for 
intracellular processes, especially muscle contraction, that was also observed by 
Kamada and Kinoshita. In 1942, Bailey discovered that the ATPase function of 
myosin was activated by Ca2+ but not by magnesium (Mg2+) and concluded that 
liberation of Ca2+ in the vicinity of ATPase was responsbible for muscle 
contraction. Sandow (1950) proposed that Ca2+ released from cortical or 
membrane regions of the muscle fibers activated actomyosin ATPase, a process 
he named “excitation-contraction coupling”. Miledi’s (1973) studies reporting 
release of neurotransmitters from presynaptic terminals, Kanno’s group (1973) 
reporting exocytosis in mast cells, Timourian’s group (1972) showing formation of 
cleavage furrow in oocytes, and Rose and Lowenstein’s (1975) observations on 
the distribution of Ca2+ in the cytoplasm raised its status from just a structural 
element to one of the most important molecules required for biological activity 
(Carafoli et al. 2001; Carafoli 2002). 
Calcium homeostasis is critical for cell survival and hence Ca2+ levels are 
maintained in the cytoplasm at a resting level of about 100nM, and can rise upto 
1µM upon activation, as opposed to a concentration of approximately 1.2mM 
extracellularly (Berridge et al. 2000). It exhibits a wide-ranging spatial and 
temporal dynamics resulting in an extensive, but highly regulated, Ca2+ signaling 
network (Carafoli et al. 2001). At any given time, intracellular Ca2+ levels are 
maintained by a balance of ‘on’ reactions enabling Ca2+ to enter the cell and ‘off’ 
reactions resulting in its extrusion from the intracellular space, and the variations 
of on/off reactions generate Ca2+ transients. The ‘on’ reactions are activated 
primarily upon flow of Ca2+, down its concentration gradient, from extracellular 
space, upon membrane depolarization via voltage-operated channels (VOC that 
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include L-, P/Q-, N-, R- and T-type channels) or agonist binding (glutamate, ATP, 
acetylcholine) via receptor-operated channels (ROC; ex: N-methyl-D-aspartate 
(NMDA) receptors) or store-operated channels (SOC) on the plasma membrane 
(PM). This initiates a signaling cascade engaging G-protein linked receptors, 
receptor tyrosine kinases (TyrK) and Phospholipase C (PLC). In a calcium-
induced manner, Ca2+ can be released from internal stores such as endoplasmic 
reticulum (ER) predominantly via Ca2+-sensitive inositol 1,4,5-trisphosphate 
receptors (InsP3R) or ryanodine receptors (RyR) (Michelangeli et al. 2005).   
Intracellular Ca2+ can activate Ca2+-dependent enzymes such as protein 
kinase C (PKC), protein kinase A (PKA) and protein phophatases 1 and 2a (PP1 
and PP2a), and through their phosphorylation/dephosphorylation functions can in 
turn modulate InsP3R and RyR activity on the ER. At the same time, most of the 
intracellular Ca2+ is sequestered and buffered by calbindin and calretinin in the 
cytosol, thereby fine-tuning the amplitude and duration of Ca2+ transients. 
Calcium can be buffered by the low affinity and high capacity calnexin and 
calreticulin inside the ER lumen, where it is required for chaperone-mediated 
protein folding. The Ca2+-binding ratio (Ks) is defined as the ratio of amount of 
bound Ca2+ compared to Ca2+ that is free in the cytosol and varies greatly among 
different cell types. Calcium can also bind to sensor proteins such as calmodulin 
(CaM) and troponin C (TnC) or effector proteins  like synaptotagmin, annexins, 
adenylyl cyclases, NOS, calpains among others and trigger a multitude of 
signaling cascades (Berridge et al. 2000; Berridge et al. 2003; Nicholls 2005). 
Calcium can also induce transcription by activating various transcription factors 
such as   nuclear factor-kappaB (NF-κB), nuclear factor of activated T cells (NF-
AT), cyclic-AMP response element binding protein (CREB) through NF-kappaB 
inhibitory protein (IκB), calcineurin and Ca2+/Calmodulin-dependent calmodulin 
kinase II (CaMKII) respectively. 
 The ‘off’ reactions, on the other hand, include cytosolic calcium uptake by 
sarco(endo)plasmic reticulum Ca2+-ATPases (SERCA), secretory-pathway Ca2+-
ATPases (SPCA) on golgi and mitochondrial calcium uniporter (MCU), while 
calcium extrusion is achieved by Na+/ Ca2+ exchangers (NCX) on mitochondria 
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and plasma membrane (PM) and plasma membrane Ca2+-ATPases (PMCA) 
(Berridge et al. 2000; Berridge et al. 2003; Michelangeli et al. 2005; Saris and 
Carafoli 2005). The Ca2+ transients trigger off signaling cascades that can last 
from micro-seconds to a few hours and are responsible for synaptic exocytosis in 
learning/memory, muscle contraction, metabolism, transcription, fertilization, cell 
cycle, cell differentiation and development (Berridge et al. 2000; Berridge et al. 
2003). 
Mitochondria are one of the important organelles for intracellular calcium 
homeostasis and are equipped with a highly regulated Ca2+ transport system.  
They sequester Ca2+  rapidly during the development of Ca2+  signal and then 
release it back slowly during the recovery phase, thus shaping both the 
amplitude and the spatio-temporal patterns of Ca2+  signals. Slater and Cleland 
(1953) first observed that isolated mitochondria could take up large amounts of 
Ca2+ even at 0°C. Chance (1955) noticed that Ca2+ stimulated State 4 respiration 
in isolated mitochondria and concluded that Ca2+ was being ‘consumed’ during 
uncoupling phase. This was followed by the finding, in 1959 by Saris, that 
addition of Ca2+ to isolated mitochondria acidified the external medium, leading 
the author to conclude that proton (H+) and Ca2+ gradients were produced due to 
uptake of Ca2+ by mitochondria. Eventually, in 1961-62, Vasington and Murphy 
measured directly the uptake of Ca2+ by isolated kidney mitochondria coupled to 
oxidative phosphorylation, and extended the observation by showing that the 
uptake required respiration and inorganic phosphate. De Luca and Engstrom 
(1961) had shown that the process of energized Ca2+ uptake was an alternative 
to ADP phosphorylation in the usage of respiratory chain energy. Lehninger’s 
group (1963) pointed out that inorganic phosphate was accumulated together 
with Ca2+ and a carrier-mediated process was proposed for the uptake of Ca2+ by 
Lehninger and Carafoli in 1969. A second pathway separate from that catalyzed 
by the Ca2+ uniporter has been described recently, a “rapid” mitochondrial (RaM) 
Ca2+ uptake pathway by Gunter’s group in 1998, which is transiently activated by 
high [Ca2+].  
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Figure 1.2: Illustration of mitochondrial ion transport. Ion transport in 
mitochondria is strictly enforced by a set of tranporters and pumps. Calcium 
(Ca2+) enters the mitochondria through a Ca2+ uniporter, at the expense of 
mitochondrial membrane potential (∆ψ). Calcium leaves the mitochondria 
through a sodium-linked (Na+) antiporter, bringing Na+ into the mitochondria. 
Sodium, on the other hand, leaves mitochondria through the Na+-H+ (sodium-
proton) pump. Lastly, protons are pumped into the inter-membrane space (IMS) 
through Complexes I, III and IV and flow back into the matrix through Complex V 
or ATP-Synthase.  
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Figure 1.2: Illustration of mitochondrial ion transport. 
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The excess cytosolic calcium is sequestered into mitochondria via an 
electrogenic Ca2+ uniporter  that is driven by ∆ψ and has a low sensitivity for Ca2+ 
(Nicholls and Chalmers 2004). This requires the mitochondria to be in close 
proximity to calcium-releasing channels of ER (Sorrentino and Rizzuto 2001; 
Hajnoczky et al. 2003) or PM. Work by Benton’s group in 1970’s showed an all 
important physiological function for Ca2+ is that it regulates the citric acid cycle by 
activating pyruvate dehydrogenase, NAD+-dependent isocitrate dehydrogenase, 
α-ketoglutarate dehydrogenase complex (KGDHC) as well as ATP synthase, 
causing increases in respiration and ATP production (Gunter et al. 2004), in the 
0.1 to 1µM concentration range. Calcium inside the matrix tends to form Ca2+-
phosphate compound that is readily dissociable, which keeps the free matrix 
Ca2+ at low levels (Nicholls and Chalmers 2004).  
 The Na+-linked efflux pathway was first identified in heart mitochondria by 
Carafoli’s group in 1974 and was subsequently shown to be the primary Ca2+ 
efflux mechanism of most mitochondria. In 1979, Carafoli proposed the 
‘mitochondrial Ca2+ cycle’ - the continued operation of the uptake and release 
limbs of the transport process results in a futile cycle, in which respiratory energy 
is dissipated. This efflux occurs till the extra-mitochondrial concentration is 
around 1µM known as the ‘set-point’. 
Calcium is taken up by mitochondria if the concentration is above the set-
point and released if below (Nicholls and Chalmers 2004; Nicholls 2005). In 
addition to Ca2+ efflux via specific transporters, the inner mitochondrial 
membrane may under certain conditions undergo permeability changes, 
observed by Beatrice’s group in 1980, leading to the loss of membrane potential 
and to the leakage of small ions, induced by high Ca2+ concentrations. It has 
been suggested that they are mediated by a high conductance unselective 
channel, named permeability transition pore (PTP) and the proposal that 
mitochondria could protect the cytosol against the damage induced by excessive 
Ca2+. Thus, mitochondria play a key role in Ca2+ homeostasis. However, calcium 
dysregulation has been shown to be involved in mitochondria-mediated cell 
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death (Nicholls and Ward 2000; Yu et al. 2001; Hajnoczky et al. 2003; Orrenius 
et al. 2003; Nicholls 2005).  
 
Nitric oxide synthase (NOS) and Nitric oxide (NO) 
 
 The significance of nitric oxide synthase (NOS) and its product nitric oxide  
or nitrogen monoxide (NO•) is exemplified by awarding of the Nobel Prize in 
Physiology/Medicine to Furchgott, Ignarro and Murad in 1998 and recognizing 
Moncada as the most highly cited UK biomedical scientist in 1999 (Alderton et al. 
2001). Furchgott, in 1980, made the observation that vascular smooth muscle 
relaxation was dependent on a diffusible substance released by the surrounding 
endothelium and called it the endothelium-dependent relaxation factor (EDRF) 
with a short half-life that can be destroyed by superoxide (O2•-). 
Nitrovasodilators, such as glyceryl trinitrate and sodium nitroprusside, could 
cause vascular smooth muscle relaxation, by stimulation of guanylyl cyclase and 
increase in cyclic guanosine monophosphate (cGMP), shown by Murad, and 
could be inhibited by haemoglobin. Ignarro and Moncada independently 
confirmed, in 1987, that NO• was indeed the EDRF. Moncada’s group also 
showed that NO synthesis in endothelial cells requires the amino acid L-Arginine. 
The first NOS protein was isolated and purified by Bredt and Snyder in 1990 
(Vallance 2001; Stuart-Smith 2002; Clementi 2003).   
Nitric oxide synthase (NOS) enzyme is one of the most highly conserved 
proteins across species and plays a critical role in the normal physiology of the 
body via its major product nitric oxide (NO•). Three distinct NOS isoforms have 
been identified namely – neuronal NOS (nNOS or NOS-1), inducible NOS (iNOS 
or NOS-2) and endothelial NOS (eNOS or NOS-3). The human nNOS gene has 
been localized to chromosome 12 and its protein product is 161kDa, with multiple 
splice variants, found mainly in the cytosol of neuronal, skeletal and cardiac 
muscle cells, neutrophils, pancreatic islets. eNOS gene has been localized to 
chromosome 7 with a protein product of 133kDa and, owing to its myristate and 
palmitate groups at its N-terminus, is present bound to plasma membrane of 
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endothelial cells, smooth muscle and neurons. Both nNOS and eNOS are 
constitutively present and activated by binding of Ca2+ and calmodulin (CaM). On 
the other hand, iNOS gene is present on chromosome 17 coding for a protein 
product of 131kDa, and is predominantly found in the cytosol of macrophages, 
neurons, endothelial and other cell types. It is Ca2+-independent for its activation 
since it is tightly bound by CaM and mainly controlled at the level of gene 
transcription in response to challenges to the immune system (Forstermann et al. 
1995; Geller and Billiar 1998; Hobbs et al. 1999; Guix et al. 2005).   
The X-ray crystal structures of NOS domains were made available in 1998 
and 1999. The primary structure of NOS consists of an N-terminus oxygenase 
linked to a C-terminus reductase domain by Ca2+/CaM binding site and is found 
typically as a homodimer. The oxygenase domain contains binding sites for L-
Arginine, heme and (6R)-5,6,7,8-tetrahydro-L-biopterin (BH4). Nicotinamide 
adenine dinucleotide phosphate (NADPH), flavin adenine dinucleotide (Fadeel 
and Orrenius) and flavin mononucleotide (FMN) have their binding sites in the 
reductase domain at the C-terminus. In presence of Ca2+/CaM bound to the 
NOS, electrons from NADPH are donated to the reductase domain of the 
enzyme and proceed via FAD and FMN redox carriers to the oxygenase domain. 
They interact with the haem iron and BH4 at the active site of the oxygenase 
domain to catalyze the reaction of oxygen with L-arginine, generating L-citrulline 
and NO• as products (Forstermann et al. 1995; Bryk and Wolff 1999; Hobbs et al. 
1999; Groves and Wang 2000; Alderton et al. 2001; Guix et al. 2005). NOS can 
be post-translationally regulated by various mechanisms such as dimerization, 
sub-cellular localization, phosphorylation, availability of substrates and cofactors, 
feedback inhibition and proteolytic degradation (Forstermann et al. 1995; 
Alderton et al. 2001).  
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Figure 1.3: Illustration of various Nitric Oxide Synthase (NOS) isoforms. 
Three well-known isoforms of Nitric Oxide Synthase (NOS) are depicted below. 
Each of the isoform contains a distinct oxygenase and reductase domains with 
various sites for binding of substrates and cofactors. In addition, neuronal NOS 
(nNOS or NOS-1) contains a PDZ domain and endothelial NOS (eNOS or NOS-
2) contains myristic and palmitate groups near their N-terminus, both of which 
are absent in inducible NOS (iNOS or NOS-3). 
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Figure 1.3: Illustration of various Nitric Oxide Synthase (NOS) isoforms. 
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Figure 1.4: Illustration of Nitric Oxide Synthase (NOS) enzyme reaction. 
Electrons are donated by NADPH to FAD in the reductase domain of one 
monomer. They are passed onto FMN and then to haem iron (Fe) bound to the 
oxygenase domain of the other monomer in the homo-dimer required for activity. 
In presence of cofactors (Ca2+/CaM, BH4), the electrons are then donated to the 
NOS substrate L-Arginine (L-Arg) to react with O2 forming L-Citrulline (L-Cit) and 
nitric oxide (NO•).  
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Figure 1.4: Illustration of Nitric Oxide Synthase (NOS) enzyme reaction. 
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In neuronal synapses, nNOS typically interacts, through its unique N-
terminal PSD-95 discs large/ZO-1 homology (PDZ) domain, with the PDZ domain 
of post-synaptic density protein 95 (PSD-95) that in turn binds to NMDA 
receptors and regulates the entry of Ca2+ into the cell. Glutamate-induced Ca2+ 
entry into the cell results in a Ca2+/CaM complex that then translocates to the PM 
and binds to nNOS, where the binding is enhanced by heat-shock protein 90 
(Hsp90). Calcineurin dephosphorylates and activates nNOS, which then 
translocates to the cytosol where it produces NO•. Nitric oxide (NO•) activates 
guanylyl cyclase resulting in production of cyclic guanosine monophosphate 
(cGMP) that in turn activates various signaling pathways while PKA or PKC can 
inactivate nNOS by phosphorylation. Alternately, nNOS activity is proposed to be 
inhibited by protein inhibitor of NOS (PIN) which dissociates the dimerized form 
of NOS while others have proposed that PIN only affects translocation of nNOS 
(Alderton et al. 2001; Kone et al. 2003).   
Endothelial NOS (eNOS) is myristoylated and palmitoylated and trafficked 
to caveolae (micro-domains of plasma membrane invaginations) of endothelial 
cells. It is inserted into the caveolae membranes and exists in an inactive state 
when bound to caveolin-1. Activation of endothelial acetylcholine receptors in 
turn activates phospholipase C (PLC) that catalyzes the production of inositol 
1,4,5-trisphosphate (IP3) and diacylglycerol (DAG) from phosphatidylinositol 4,5-
bisphosphate (PIP2). The IP3-induced increase in intracellular Ca2+ activates 
calmodulin binding to eNOS, which then dissociates from caveolin and 
translocates to the cytoplasm. Heat-shock protein 90 (Hsp90) in this case is 
shown to act as an allosteric activator of eNOS, and together with CaM and 
caveolin form a dynamic ternary complex. Phosphorylation by protein kinase B 
(Akt) activates eNOS while phosphorylation by protein kinase A (PKA) inactivates 
the enzyme and is sequestered away from caveolae with diminished activity by 
eNOS-interacting protein (NOSIP) and eNOS traffic inducer protein (NOSTRIN). 
Finally, a fall in Ca2+ levels dissociates CaM from eNOS, and the inactive form 
relocates to the membrane caveolae. Both nNOS and eNOS activities also seem 
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to be regulated by certain G-protein coupled receptors such as Bradykinin B2 
receptor by binding and inhibiting them (Alderton et al. 2001; Kone et al. 2003).  
Upon cytokine interferon-γ (IFN-γ) binding and activation of IFN-γ 
receptors, the signal is passed onto the Janus kinase (JAK) family and signal 
transducers and activators of transcription (STAT) proteins. Receptor occupation 
and dimerization induces the phosphorylation of associated STATs. Activated 
STATs dimerize and translocate to the nucleus where they increase expression 
of the transcription factor, IFN-γ regulatory factor 1 (IRF-1), that in turn binds to 
specific DNA elements in the iNOS gene promoter region to increase iNOS gene 
expression. Its activity is found to be increased by Rac1 and Rac2 of Rho-like 
GTPases family. On the other hand, iNOS protein is regulated by 3 inhibitory 
proteins namely a) NOS-associated protein 110 (NAP-110) b) kalirin and c) 
caveolin. While the former two proteins inhibit iNOS activity by preventing its 
dimerization, caveolin binds to iNOS and tags it for proteolysis (Kone et al. 2003).  
Lastly, nNOS and iNOS are targeted for degradation mostly by calpains or the 
ubiquitin-proteasome pathway, the choice of pathway and mechanisms needing 
further elucidation (Osawa et al. 2003). 
Nitric oxide (NO•) was declared “The Molecule of the Year” by Science 
magazine in 1992. Nitric oxide acts a local hormone owing to its solubility in lipid 
and water, being a diatomic free radical and having short half-life of a few 
seconds in biological fluids. This allows NO• to diffuse across membranes (with a 
diffusion coefficient 1.4 times that of oxygen at 37°C) and act as a messenger 
within a radius of hundred microns. In vivo, the concentration of NO• can range 
from 5nM to 4µM and is buffered and transported by oxyhaemoglobin in red 
blood cells and NO• mediates its effects by acting on compounds containing 
transition metals, such as iron-sulphur (Fe-S) clusters. Most of these are 
transcription factors, while it also reacts with four haem-containing enzymes 
namely heme-oxygenase 1 (HO-1), cytochrome c oxidase (COX-IV), catalase 
and soluble guanylyl cyclase (sGC) (Hanafy et al. 2001; Ridnour et al. 2004).   
Aconitase and hypoxia-inducible factor 1 (HIF-1) are among the NOS-
regulated transcription factors. Aconitase serves two roles in the cell; it can 
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function as a soluble enzyme in the Krebs cycle and as an iron homeostatic 
sensor. When iron is plentiful, a tetranuclear iron-sulfur center (4Fe-4S) 
aconitase is active as an enzyme in the Krebs cycle, which functions as an 
isomerase regulating the equilibrium between citrate and isocitrate. However, 
when the serum iron is depleted, there is no longer sufficient iron to form the 
tetranuclear iron-sulfur center. Aconitase in the absence of its 4Fe-4S center is 
called an iron-regulatory protein (IRP). To maintain iron homeostasis, the IRP 
binds to iron-responsive elements (IREs) and stabilize transferrin receptor 
mRNA, while they inhibit translation of ferritin mRNA. Ferritin is the major iron 
storage protein found in bone marrow. Increasing transferrin receptor and 
decreasing ferritin will increase serum iron. Nitric oxide synthase (NOS) also 
mediates regulation of the angiogenic transcription factor HIF-1. HIF-1 is a 
heterodimeric complex comprising of HIF-1a and ARNT (aryl-hydrocarbon 
receptor nuclear translocator)]. Under hypoxic conditions or NO• donation, HIF-1 
binds to its response element and stimulates transcription of vascular endothelial 
growth factor (VEGF), insulin-like growth factor II (IGF-II) and erythropoietin 
(Hanafy et al. 2001; Droge 2002; Ridnour et al. 2004).  
Heme-oxygenase 1 (HO-1) catalyzes the degradation of the heme moiety 
into biliverdin, carbon monoxide, and iron. HO-1 mRNA is destabilized by NO•, 
and since NOS is a heme requiring enzyme, a negative feedback loop is formed. 
Therefore, the cell has a system to keep NO• levels from becoming toxic. 
Cytochrome c oxidase (COX) is the final component of the electron transport 
chain where oxygen is reduced to water. Since NO• reacts on a similar time scale 
as oxygen diffusion, it acts as a competitive inhibitor to oxygen binding and thus 
reversibly inhibits COX. Catalase, a ferric-containing heme moiety, is involved in 
the reduction of hydrogen peroxide to oxygen and water. NO• binding to the ferric 
ion results in inhibition of catalase activity (Hanafy et al. 2001; Droge 2002; 
Ridnour et al. 2004).  
Most of NO• effects are mediated by soluble guanylyl cyclase (sGC). 
Soluble guanylyl cyclase is a heterodimer composed of α- and β subunits. Upon 
binding of NO•, sGC catalyzes the conversion of 1 mole of guanosine 5’-
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triphosphate to 1 mole of 3’,5’-cyclic guanosine monophosphate and 1 mole of 
pyrophosphate. Cyclic GMP mediates its effects through 4 targets: cGMP-
dependent protein kinase (PKG), cyclic nucleotide-gated channels (CNG), cAMP-
dependent protein kinase and phosphodiesterase (Hanafy et al. 2001; Droge 
2002; Ridnour et al. 2004). 
Thus, NOS-derived NO•, at physiological levels, is credited with a role in 
angiogenesis, peristalsis, micturition, muscle contraction, wound healing, cardiac 
development, reproduction, learning/memory and apoptosis. Neuronal NOS 
derived NO• in the central nervous system (CNS) is shown to be involved in 
neurotransmission and neuronal plasticity; while in the peripheral nervous system 
(PNS), NO• from nitrergic nerves is involved in pain perception and mediates 
smooth muscle relaxation affecting gastro-intestinal motility and penile erection. 
In the skeletal muscle, nNOS derived NO• is suggested to be involved in 
regulation of myotube development, innervation and contractility (Bryk and Wolff 
1999; Guix et al. 2005). nNOS knockout mice exhibit aggressiveness, pyloric 
sphincter stenosis, resistance to ischemia and stroke (Mashimo and Goyal 1999; 
Vallance 2001; Mungrue et al. 2003).  
 Endothelial NOS derived NO• is shown to maintain blood pressure and 
flow in the vasculature by smooth muscle relaxation through its action on soluble 
guanylyl cyclase, as well as inhibiting platelet aggregation. Nitric oxide from both 
eNOS and nNOS is suspected to be acting as a retrograde messenger involved 
in long-term potentiation (LTP) in brain hippocampus. Majority of eNOS knockout 
mice die shortly after birth due to cardiovascular abnormalities. Lack of NO• 
causes hypertension and enhances the formation of atherosclerotic lesions in the 
vessel walls of eNOS knockout mice, while overproduction of NO• itself can 
cause profound vascular relaxation resulting in acute drop in blood pressure 
(Bryk and Wolff 1999; Mashimo and Goyal 1999; Vallance 2001; Mungrue et al. 
2003; Guix et al. 2005).  
Inducible NOS (iNOS), on the other hand is transciptionally upregulated in 
macrophages, hepatocytes, astrocytes and other cell types by various agents 
such as lipopolysaccharide (LPS), cytokines and other microbial products. 
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Should such a situation arise, iNOS produces large amounts of NO• and its 
derivatives that are toxic to tumors and invading pathogens as well as promotes 
would healing and angiogenesis (Bryk and Wolff 1999; Guix et al. 2005). 
However, iNOS knockout mice show increased susceptibility to bacterial and viral 
pathogens, tumors and resistance to sepsis-induced hypotension (Mashimo and 
Goyal 1999; Vallance 2001; Mungrue et al. 2003).  
Taken together, there is redundancy in the source and actions of NO• in 
normal physiology which also accounts for compensatory mechanisms in the 
event of deficiencies in one or more the NOS isoforms. Finally, NO• is also 
shown to result in formation of reactive nitrogen species (RNS) such as nitroxyl 
(NO-) radicals or peroxynitrite (ONOO-), causing nitrosylation/nitration of key 
proteins thereby contributing to oxidative/nitrosative/nitrative stress and 
subsequent cell death (Nicotera and Melino 2004) implicated in several 
pathologies (Groves 1999; Hobbs et al. 1999; Szabo 2003; Guix et al. 2005). 
 
ROS/RNS and Oxidative Stress 
 
The properties of what constituted air for life has intrigued humans since 
recorded history as noted in a Sumerian creation myth stating: “for the sake of 
the good things in their pure sheep-folds, Man was given breath.”  Da Vinci, in 
the late 15th century, observed that air incapable of combustion was also 
incapable of supporting life, which he called the ‘vivifying spirit’. Mayow, in 1673, 
stated that “an aerial something essential to life, whatever it may be, passes in to 
the masses of blood”. In the 18th century, Priestley, Lavoisier and Scheele 
discovered oxygen and its multi-faceted properties. The ‘Oxygen Paradox’ 
emerged as oxygen or dioxygen, apart from sustaining aerobic life, also 
possesses a dark side of its own by being toxic to such organisms. Plants and 
animals survive only for a few days at oxygen concentrations greater than its 
atmospheric level of 20.9%. Joseph Priestley, in 1775, elegantly put that “we 
might live out too fast, and the animal powers be too soon exhausted, in this pure 
kind of air. A moralist, at least, may say that the air which nature has provided for 
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us is as good as we deserve,” (Fridovich 1998; Davies 2000; Freeman 2000; 
McCord 2000). 
Fenton’s work, in 1890’s, on iron/peroxide chemistry and the recognition 
that reactive oxygen species (ROS) could introduce reactive diols and carbonyl 
groups into biomolecules, spawned a whole new field known as Fenton 
chemistry. Haber, from 1931-34, was responsible for discovery of hydroxyl 
radical (OH.) and the metal catalyzed peroxide decomposition reaction known as 
the Haber-Weiss reaction. Based on quantum mechanics theory, Pauling (Nobel 
Prize in Chemistry in 1954 and Nobel Peace Prize in 1962) predicted the 
existence of superoxide (O2•-) as early as 1933. However, it was only in 1954 
that the first significant scientific contribution towards the ‘oxygen paradox’ was 
made in the form of a seminal paper by Gershman and Gilbert. They proposed 
that the lethal effects of ionizing radiation might be ascribed to oxygen free 
radicals that gave birth to the burgeoning field of free radical biology. In the same 
year, Commoner presented the first proof that free radicals exist in biological 
organisms and are either proteinaceous or associated with biopolymers (see 
reviews by Freeman 2000; Gutteridge and Halliwell 2000; Hensley and Floyd 
2002).  
In the period 1951-56, Chance worked on the ability of catalase to reduce 
hydrogen peroxide (H2O2) and showed that it can be produced by respiring 
mitochondria. Based on these observations, Harman in 1956 proposed the 
classical hypothesis known as the “Free Radical Theory of Aging (FRTA)”, which 
has just turned 50.  FRTA states that aging is a result of a) progressive 
deterioration of physiological function due to free radical reactions initiated in 
mitochondria at an increasing rate with age and b) the life-span is determined by 
the rate of free radical damage to the mitochondria, thus giving rise to the 
“Mitochondrial Theory of Aging (MTA)”. The anti-oxidant enzyme copper,zinc-
associated superoxide dismutase (Cu,Zn-SOD), discovered by McCord and 
Fridovich in 1969,  followed by Halliwell’s report  in 1973, marked the dawn of 
anti-oxidant biology. These studies firmly established that oxygen can biologically 
be reduced to a diffusible free radical superoxide that can further generate the 
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toxic and highly reactive hydroxyl radicals, and that all aerobic organisms survive 
in such harsh environment owing to their arsenal of antioxidant defenses. Later in 
1973, Babior’s group showed the first physiological role of free radicals in host 
defense as well as their pathological role in inflammation (Beckman and Ames 
1998; Fridovich 1998; Freeman 2000; Gutteridge and Halliwell 2000; Hensley 
and Floyd 2002; Harman 2003; Harman and Harman 2003). 
Environmental sources of free radicals are ozone (O3), γ-radiation, ultra-
violet (UV) radiation, car exhaust, cigarette smoke, industrial contaminants, 
narcotic drugs, anesthetizing gases, xenobiotics (pesticides, herbicides), 
chemicals such as alcohol, mustard gas and lastly human diet itself. Major 
sources of endogenous free radicals in mammals include the respiratory chain, 
monoamine oxidase, xanthine oxidase, NADPH oxidase, myeloperoxidase, 
cycloxygenases, cytochrome P-450 system, nitric oxide synthases (NOS) and 
non-enzymatic reactions of oxygen (Droge 2002; Kohen and Nyska 2002; 
Andreyev et al. 2005).  
The reactive molecules can be further divided into radicals and non-radical 
species. Radicals are atoms or molecules containing an unpaired electron, such 
as nitric oxide radical (NO•), superoxide radical (O2•-), hydroxyl radical (•OH), 
peroxyl (ROO•) and alkoxyl radicals (RO•), making them highly reactive. There 
are also other reactive non-radical species such as peroxynitrite (ONOO-), 
hypochlorous acid (HOCl), hydrogen peroxide (H2O2), organic peroxides, 
aldehydes and ozone (O3). Their reactivity renders them with short half-lives that 
can range from nano-seconds to minutes. Hydroxyl radical (•OH) is the most 
reactive (10-9 sec) and therefore attacks any macro-molecules in the immediate 
vicinity, while nitric oxide (NO•) due to its relatively longer half-life (1-10 sec) can 
cross membranes and cause damage at a site distant from its origin, whereas 
the fate of H2O2 and O2•- is only limited by the presence of their decomposition 
enzymes. This makes them unique molecular signaling switches that can 
mediate reversible coupled oxidation-reduction reactions of factors involved in 
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gene and enzyme regulation (Bergendi et al. 1999; McCord 2000; Kohen and 
Nyska 2002).  
Several components of mitochondria are known to be involved in the 
generation of free radicals as byproducts, mainly in the form of superoxide 
(around 2% of available oxygen or dioxygen). Oxygen in its ground state contains 
two unpaired electrons with the same spin and hence exists as a relatively 
unreactive diradical, which upon partial reduction results in the more reactive 
superoxide. Normally, the superoxide is converted into hydrogen peroxide (H2O2) 
and oxygen by manganese-superoxide dismutase (Mn-SOD). However, 
superoxide can convert Fe3+ to Fe2+ known as the Haber-Weiss reaction. Fe2+ in 
turn can react with H2O2 to give Fe3+ and the highly reactive OH• radicals, known 
as the Fenton reaction. H2O2 is usually decomposed by catalase or glutathione 
peroxidase (GPx) into water (Fridovich 1998; Pedersen 1999; McCord 2000; 
Kohen and Nyska 2002; Andreyev et al. 2005; Scandalios 2005). Nitric oxide 
(NO•), produced by NOS, can react with superoxide in a diffusion controlled 
reaction to produce peroxynitrite (ONOO-) (Beckman and Koppenol 1996; Radi et 
al. 2001). This can further react with carbon dioxide (CO2), another gaseous 
messenger, forming nitrosoperoxo carbonate (ONOOCO2-) that decomposes into 
nitrogen dioxide (•NO2) and carbonate (CO3•-). Instead, ONOO- can also gain a 
proton forming peroxynitrous acid (ONOOH). This in turn can decompose into 
nitrogen dioxide and hydroxyl radicals which are highly unstable and hence 
possess a greater potential to cause damage (Bolanos et al. 1997; Bergendi et 
al. 1999; Radi et al. 2001; Kohen and Nyska 2002). 
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Figure 1.5: Illustration of the interplay between Reactive Oxygen Species 
(ROS) and Reactive Nitrogen Species (RNS). About 2% of molecular oxygen 
undergoes partial reduction in the mitochondrial electron transport chain resulting 
in the more reactive superoxide (O2•-). Normally, the superoxide is converted into 
hydrogen peroxide (H2O2) and oxygen by manganese-superoxide dismutase 
(Mn-SOD). However, superoxide can convert Fe3+ to Fe2+ known as the Haber-
Weiss reaction. Fe2+ in turn can react with H2O2 to give Fe3+ and the highly 
reactive •OH radicals, known as the Fenton reaction. H2O2 is usually 
decomposed by catalase or glutathione peroxidase (GPx) into water. Nitric oxide 
(NO•), produced by NOS, can react with superoxide in a diffusion controlled 
reaction to produce peroxynitrite (ONOO-). This can further react with carbon 
dioxide (CO2) forming nitrosoperoxo carbonate (ONOOCO2-) that decomposes 
into nitrogen dioxide (•NO2) and carbonate (CO3•-). Instead, ONOO- can also 
gain a proton forming peroxynitrous acid (ONOOH). This in turn can decompose 
into nitrogen dioxide and hydroxyl radicals both of which are highly unstable and 
can cause greater damage. 
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Figure 1.5: Illustration of the interplay between Reactive Oxygen Species 
(ROS) and Reactive Nitrogen Species (RNS). 
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Owing to the discovery of NO• and its physiological role, a paradigm shift 
happened in the field of free radical biology. Free radicals were now looked, 
under new light, as being regulated physiological signaling molecules rather than 
damage-causing stochastic entities. This is evident in the roles free radicals play 
in regulating gene expression, cell replication, differentiation, host-defense (via 
oxidative burst), cell adhesion, and apoptosis by acting as second messengers in 
signal transduction pathways. Low levels of oxidants in fact are known to induce 
cells to proliferate, moderate oxidative environment is shown to induce transient 
growth arrest, upregulation of anti-oxidant enzymes and stress response 
proteins, to adapt to the present and cope with future encounters with oxidants 
(Davies 2000; Droge 2002; Kohen and Nyska 2002; Scandalios 2005).  
A classic case of redox signaling is the oxidative burst by immune cells. 
Activated macrophages and neutrophils can produce large amounts of O2•- and 
HOCl, upon activation of NADPH oxidase and myeloperoxidase respectively, 
induced by lipopolysaccharide (LPS) and pro-inflammatory cytokines such as 
interferon-γ (IFN-γ), interleukin-8 (IL-8) and interleukin-1β (IL-1β). Activation of 
NADPH oxidase is controlled by G proteins belonging to rac family. The massive 
production of antimicrobial and tumoricidal ROS in an inflammatory environment 
is called the “oxidative burst” and plays an important role as a first line of defense 
against environmental pathogens (Droge 2002; Babior 2004).  
 Hydrogen peroxide (H2O2) has been shown to oxidatively modify and 
inhibit protein tyrosine phosphatases, thus increasing net activity of protein 
tyrosine kinases and thereby altering activities of epidermal growth factor (EGF), 
insulin receptor kinase (IRK). Hydrogen peroxide (H2O2), among others, is also 
shown to activate protein kinase C (PKC), Src family protein tyrosine kinase, 
mitogen-activated protein kinases (MAPK) members such as extracellular signal-
regulated kinase 1 (ERK-1) and ERK-2, c-Jun NH2-terminal kinase (JNK) and 
p38, transcription of activator protein 1 (AP-1) consisting of c-Jun and c-Fos. 
Finally, ROS can also activate NF-κB, the first transcription factor responding 
directly to oxidative stress, by promoting degradation of its partner I-κB by the 
proteasome. ROS can also alter the binding sites on DNA, of transcription factors 
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such as NF-κB and AP-1, thereby affecting the expression of specific genes. The 
redox signaling is further modulated by the redox state of glutathione inside the 
cell. However, in vivo, cells function normally in a reducing environment and their 
function is invariably altered when the environment is increasingly oxidized, 
leading to oxidative stress (Davies 2000; Droge 2002; Kohen and Nyska 2002; 
Scandalios 2005).  
With the advent of aerobic life, an arsenal of antioxidants and antioxidant 
enzymes evolved to protect the cells from oxidative stress and damage. 
Antioxidants are defined as substances that are able, at relatively low 
concentrations, to compete with other oxidizable substrates and, thus 
significantly delay or inhibit the oxidation of these substrates. Mammalian cells 
exist in vivo at 2-4% oxygen tension known as tissue normoxia, compared to 
21% in the surrounding environment, creating an oxygen tension gradient. 
Therefore, multiple layers of defenses will be put forth as per the need, to 
maintain redox homeostasis and minimize free radical–induced damage, that 
include low-molecular-weight antioxidants (LMWA) such as ascorbate, 
tocopherols, glutathione, melatonin, histidine dipeptides, β-carotene, ubiquinone 
and uric acid (produced by xanthine dehydrogenase). Ascorbate (Vitamin C), a 
water-soluble antioxidant, is available to humans only through diet. It mediates its 
antioxidant effects by donating two electrons to ROS, such as O2•-, •OH, ROO•, 
HOCl and ONOOH, and removing them. Tocopherols (Vitamin E) stabilize 
cellular membranes by donating hydrogens lost by fatty acid radicals, thus acting 
as chain-breaking antioxidants. A similar mechanism is utilized by melatonin, 
hormone synthesized by the pineal gland. Glutathione (GSH), a reduced 
tripeptide (glutamic acid-cysteine-glycine) present in milli-molar concentrations 
inside the cell, is involved as a cofactor for peroxidase donating electrons for 
decomposition of H2O2 as well as a chelator of Cu+ preventing the Haber-Weiss 
reaction. When oxidized, GSH is converted to GSSG formed by joining of two 
GSH molecules by a disulfide bridge. It can directly interact with superoxide 
radical (O2•-), hydroxyl radical (•OH), peroxyl (ROO•), alkoxyl radicals (RO•) and 
hypochlorous acid (HOCl) forming a glutathione radical that can be regenerated 
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to its reduced form.  Histidine dipeptides, synthesized in the brain and skeletal 
muscles, can also directly exert a similar action as GSH.  Uric acid, in the form of 
urate, can react with •OH, ROO• as well as ONOO- to prevent protein nitration 
(Kohen and Nyska 2002; Scandalios 2005).  
Endogenous anti-oxidant enzymes include peroxidases (e.g., peroxisomal 
catalase and cytosolic glutathione peroxidase), DT diaphorase or quinone 
reductase, superoxide dismutases (cytosolic Cu,Zn-SOD, extracellular EC-SOD 
and mitochondrial Mn-SOD), cytosolic Fe-binding ferritin and plasma Cu-binding 
cerruloplasmin. Apart from above, there are damage repair systems that can be 
divided into direct and indirect repair (Davies 2000; Kohen and Nyska 2002; 
Andreyev et al. 2005). However, the antioxidant defenses are not adequate and 
when in excess, free radicals can react with macromolecules, such as proteins, 
lipid membranes and DNA, in a self-perpetuating manner thereby disrupting the 
redox homeostasis. The extent of damage is based on their reactivities and half-
lives, apart from their intracellular source and the surrounding anti-oxidant 
environment (Bergendi et al. 1999; Kohen and Nyska 2002; Scandalios 2005).  
Lipid peroxidation occurs upon oxidative modification of membrane 
phospholipids. It occurs in 3 stages- a) chain initiation b) chain propagation and 
c) chain termination. Initiation occurs by the abstraction of a hydrogen atom (from 
carbon of a methylene group) in an unsaturated fatty acyl chain. Following 
hydrogen abstraction, the remaining fatty acid radical retains 1 electron and is 
stabilized by rearrangement of the molecular structure to form a conjugated 
diene. In an aerobic environment, oxygen will add to the fatty acid at the carbon 
centered lipid radical (L•) to give rise to a lipid peroxyl radical (LOO•). Once 
initiated, LOO• can further propagate the peroxidation chain reaction by 
abstracting a hydrogen atom from other vicinal unsaturated fatty acids. The 
resulting lipid hydroperoxide (LOOH) can easily decompose into several reactive 
species including: lipid alkoxyl radicals (LO•), aldehydes such as 
malondialdehyde (MDA) and 4-hydroxynonenal (4-HNE), alkanes, lipid epoxides, 
and alcohols. Chain termination occurs upon interaction of LOO• with another 
radical or an antioxidant. Peroxidized membranes become rigid, lose selective 
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permeability, and under extreme conditions lose their structural and functional 
integrity. Lipid peroxidation is also thought to lead to formation of DNA adducts 
as well as inhibition of enzyme function. Oxidized lipid layers are subject to the 
actions of phospholipase A2, which prevents the propagation reactions by 
removing the membrane hydroperoxides, or glutathione peroxidase, which acts 
by reducing fatty acid hydroperoxides to their corresponding hydroxyl fatty acids 
(Davies 2000; Kohen and Nyska 2002). 
Protein oxidation refers to oxidative modification of a protein, usually in the 
form of highly reactive carbonyl groups (aldehydes and ketones). Cysteine (Cys) 
and methionine (Met), owing to their susceptible sulfur atoms, are two amino 
acids that are most prone to oxidative attacks. Oxidation of Cys leads to intra-
molecular disulfide bonds, inter-molecular disulfides (with glutathione etc). 
Methionine (Met), on the other hand, undergoes oxidation to give Met sulfoxide. 
Both Cys and Met can undergo oxidation directly by γ–radiation through the 
highly reactive hydroxyl (•OH) radicals, discovered by Stadtman’s group. 
Alternatively, their oxidation can be catalyzed by protein-bound transition metals 
iron (Fe2+) and copper (Cu+) as shown by Levine’s group or by ONOO-, O2•-, •OH 
and HOCl. Lysine (Lys), histidine (His) and Cys are susceptible to form lipid-
peroxidation adducts. Disulfide reductase and methionine sulfoxide reductase 
directly mediate re-reduction of oxidized sulfhydryl groups on proteins. 3-
nitrotyrosine (3-NT) is considered to be a specific marker of ONOO- mediated 
oxidation. Other amino acids subject to oxidation include arginine (Arg), proline 
(Pro), threonine (Thr) and tryptophan (Trp), resulting in aldehydes or ketones. 
Oxidative modification of key residues in proteins could result in loss or gain of 
function of enzymes or structural proteins (Shacter 2000; Stadtman and Levine 
2003).  
Intracellular proteolysis can be carried out by mitochondrial proteases, 
lysosomal proteases, calcium-activated calpains, or the ubiquitin-proteasome 
system found in the cytosol, nucleus and ER of cells. Most of the oxidized 
proteins are selectively degraded by the proteasome, which is involved in the 
normal turn-over of, regulatory proteins involved in cell cycle, cell surface 
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receptors and ion channels, as well as antigen presentation and processing. An 
enzyme cascade consisting of ubiquitin ligases tag the proteins on their lysine 
residues to be degraded with poly-ubiquitin molecules, except when the proteins 
are oxidatively modified, and process them to the proteasome. The removal of 
the ubiquitin molecules before degradation requires ATP. (This work on ubiquitin-
mediated proteolysis, by Ciechanover, Hershko and Rose, was awarded with the 
Nobel Prize in Chemistry in 2004). Oxidized proteins, as opposed to native 
proteins, are recognized by their hydrophobic surface patches, formed by partial 
unfolding and exposure of hydrophobic amino acid residues due to oxidation. 
Mitochondria contain three ATP-dependent proteases namely Lon, Clp-like and 
AAA. Lon protease is shown to be responsible for degradation of oxidatively 
modified proteins in the mitochondrial matrix. It is also shown to bind mtDNA and 
act as a chaperone protein. However, during oxidative stress, there may be an 
overload on the proteasome system for degradation as well as the proteasome 
itself might be oxidatively modified and damaged, leading to formation of 
insoluble and stable aggregates of misfolded/damaged proteins, such as 
lipofuscin, both inside the cell and extracellularly (Davies 2000; Grune et al. 
2003; Stadtman and Levine 2003; Grune et al. 2004; Ciechanover 2006; Friguet 
2006).  
De-oxyribo nucleic acid (DNA) in the nucleus contains the genetic code 
necessary for cell survival, growth and cell division, in other words life.  However, 
DNA is rather susceptible to free-radical mediated damage, even more so the 
case with mitochondrial DNA (mtDNA) due to its close proximity to sites of ROS 
generation and the lack of protective histones. Damage occurs in the form of 
modification of DNA bases, single- and double-strand breaks, loss of purines and 
DNA-protein cross-linkage. Most of the damage to DNA such as 8-hydroxy-2-
deoxyguanosine (8-OHdG), 8-hydroxyadenine, thymine peroxide and thymine 
glycol is caused by •OH radicals (Kohen and Nyska 2002). Modified DNA can be 
repaired by DNA glycosylases, endonucleases, polymerases and ligases. 
However, if insufficient, oxidized DNA results in mutations leading to transcription 
and translation of mutated proteins that in turn may have lost function or gained 
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an undesirable one. Such mutations in DNA can also be passed onto the 
progeny through the germ-line. The resulting oxidative stress has been 
implicated in cancer, diabetes, cardiovascular diseases, chronic inflammation, 
aging and neurodegenerative disorders (Dykens 1994; Bolanos et al. 1997; 
Droge 2002; Kohen and Nyska 2002; Wallace 2005). 
 
Cell Death 
 
The importance of programmed cell death during development by 
Brenner, Horvitz and Sulston was recognized and accorded a Nobel Prize in 
Physiology/Medicine in 2002. Cell death signals invariably converge on 
mitochondria which then commit the cell to apoptosis and/or necrosis to maintain 
tissue homeostasis (Brown et al. 1999; Kroemer and Reed 2000; Lemasters 
2005). It should be noted that, although apoptosis and necrosis are considered in 
an oversimplified manner to be distinct forms of cell death, there is evidence for 
their coexistence. Both forms of cell death are characterized by mitochondrial 
permeability transition, defined as the loss of trans-membrane potential across 
the mitochondrial inner membrane. The MPT pore itself is described as voltage-
dependent, cyclosporine-sensitive, high conductance channel involving the inner 
mitochondrial membrane. One of the strongest inducers of MPT is Ca2+ that can 
be competitively inhibited by Mg2+, manganese (Mn2+) and Pi. Matrix pH below 
and above 7.4 also induces MPT. MPT also causes loss of pyridine nucleotides 
needed for respiration and membrane depolarization leads to inhibition of ATP 
synthesis. The route of cell death is dependent upon severity of the insult and 
intracellular levels of ATP, wherein apoptosis requires ATP and necrosis occurs 
upon depletion of cellular ATP (Leist et al. 1999; Nicotera and Melino 2004; 
Bernardi et al. 2006; Zong and Thompson 2006), with exceptions (Chiarugi 
2005).  
Apoptosis, coined by Kerr and colleagues in 1972 and synonymously used 
with “programmed cell death” and “cell suicide”, is derived from Greek and 
stands for “falling off”, referring to an orchestrated physiological process of 
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removing individual components with minimal damage to the organism (Kerr 
2002). All eukaryotic cells are equipped with genetic machinery, of varying 
similarities conserved evolutionarily, for undergoing apoptosis. Apoptosis is 
necessary for gametogenesis, embryogenesis and hematopoiesis, cardiac, 
immune and neuronal development as well normal adult tissue turnover, owing to 
the property of apoptotic cells not causing inflammation or tissue scarring. This 
not only ensures stable cell populations but is also important for host survival 
during invasions by pathogens (Kerr et al. 1972; Ranger et al. 2001; McHugh and 
Turina 2006).  On the other hand, inhibition of apoptosis can cause a wide variety 
of pathological conditions such as cancer and auto-immunity whereas chronic 
activation of apoptosis is implicated in aging (Pollack et al. 2002; Ziegler and 
Groscurth 2004; Lemasters 2005) and neurodegeneration (Ranger et al. 2001; 
Ameisen 2002; Fadeel and Orrenius 2005).   
Apoptosis is an ATP-dependent process and typically characterized by 
chromatin condensation and inter-nucleosomal DNA degradation termed as 
pyknosis, cell shrinkage, formation of numerous small surface blebs, 
externalization of phosphatidyl serine (PS) on the plasma membrane, resulting in 
condensed apoptotic bodies tagged for phagocytosis (Ziegler and Groscurth 
2004; Lemasters 2005). Depending on the source of signal, cells can undergo 
apoptosis either by the extrinsic pathway, for normal tissue homeostasis, or 
alternately the intrinsic pathway initiated by mitochondria due to cues from the 
nucleus or other noxious stimuli (Fadeel and Orrenius 2005).  
Both the extrinsic and intrinsic pathways involve caspase activation. 
Caspases are constitutively expressed in mammals as inactive zymogens and 
proteolytically activated to form active tetramers. They are cysteine proteases 
with preference to substrate cleavage after aspartate residues. They can be 
divided into initiator (2, 8, 9, 10 and 12), effector (3, 6 and 7) and inflammation (1, 
5 and 11) caspases. The initiator caspases contain share conserved motifs 
known as caspase recruitment domain (CARD), death effector domain (DED) 
and the catalytic domain, while the effector caspases possess a short pro-
domain. The initiator caspases are activated by an autocatalytic mechanism 
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whereas they are required for activation of the effector caspases. Effector 
caspases are able to directly cleave their substrates that include proteins 
involved in scaffolding of the cytoplasm and nucleus, signal transduction and 
transcription-regulatory proteins, cell cycle components, DNA replication and 
repair proteins, and apoptosis inhibitors to form a positive feedback loop (Ranger 
et al. 2001; Nicotera and Melino 2004; Artal-Sanz and Tavernarakis 2005; Fadeel 
and Orrenius 2005).  
The extrinsic pathway (death-receptor signaling) is triggered upon binding 
of ligands to their receptors such as Fas-ligand/Fas, TNFα/TNFR1, their 
association with adapter proteins (FADD and TRADD respectively) forming a 
death-inducing signaling complex (DISC) and subsequent activation of initiator 
caspases such as caspase-8. It in turn can proteolytically activate execution 
caspases - caspase-3.  In some cells, caspase-8 further cleaves pro-apoptotic 
Bid, resulting in its translocation to mitochondria and subsequent cytochrome c 
release in order to generate sufficient caspase-3 activity (Ranger et al. 2001; 
Nicotera and Melino 2004; Fadeel and Orrenius 2005).  
On the other hand, nuclear DNA damage, kinase inhibition, trophic factor 
deprivation, UV and calcium/oxidative stress act as triggers of the intrinsic 
pathway of apoptosis. This causes, the pro-apoptotic proteins of Bcl2 family, Bak 
and Bax to translocate from cytosol to mitochondria and interact with anti-
apoptotic BclxL & Bcl2 and induce mitochondrial membrane permeability 
transition (MPT). This results in the formation of a MPT pore (MPTP), causing 
membrane depolarization and inhibition of respiration. Some reports suggest that 
the loss in membrane potential causes more ions to flow into the matrix followed 
by influx of water. This leads to swelling of the matrix and rupture of 
mitochondrial outer membrane. Other reports indicate that the pro-apoptotic 
proteins are released through the formation of a pore, comprising of Bax and 
other proteins such as peripheral benzodiazepine receptor (PBR), hexokinase 
(HK), and creatine kinase (CK), the exact composition and mechanisms of which 
are still unclear (Crompton 2003; Hajnoczky et al. 2003; Kim et al. 2003; 
Armstrong 2006; Bernardi et al. 2006). This results in release of cytochrome c, 
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second mitocondria-derived activator of caspases/ direct IAP-binding protein with 
low pI (Smac/Diablo), procaspases-2,3,8 and 9, apoptotic protease-activating 
factor 1 (Apaf-1), apoptosis-inducing factor  (AIF), Endonuclease G (Endo G) and 
possibly  high temperature requirement protein A2 (HtrA2/Omi) (Ranger et al. 
2001; Parone et al. 2002; Armstrong 2006).   
Apaf-1 binds with cytochrome c, in the presence of ATP, and recruits 
procaspase-9, forming a complex called the “apoptosome”. The now activated 
caspase-9 activates caspase-3. JNK, a kinase, also utilizes ATP for activation of 
pro-apoptotic proteins such as Bid and Bad, while inactivating anti-apoptotic 
proteins such as Bcl-2. Smac/Diablo, for its part, binds with the regulatory 
inhibitors of apoptosis proteins (IAP), resulting in disinhibition of both the initiator 
and effector caspases. On the other hand, in a caspase-independent manner, 
AIF and Endo G translocate from cytosol to nucleus and induce chromatin 
condensation and inter-nucleosomal DNA fragmentation respectively (Ranger et 
al. 2001; Lemasters 2005; Armstrong 2006). 
In contrast to apoptosis, necrosis is not programmed and occurs when 
cellular ATP is depleted, and is usually initiated by Ca2+ and ROS. Necrosis is 
characterized by electron-lucent vacuolation of cytoplasm, mitochondrial 
swelling, dilatation of ER and loss of PM integrity and subsequent rupture. MPT, 
in the case of necrosis, involves permeability of the inner mitochondrial 
membrane, resulting in a regulated high-conductance pore formed by voltage-
dependent anion channel (VDAC) from the outer membrane, adenine nucleotide 
translocator (ANT) from the inner membrane, cyclophilin D (CypD) from the 
matrix, or a more unregulated pore formed due to disulfide bridges among 
proteins of the inner mitochondrial membrane, the mechanisms of which are yet 
unclear. This leads to release of various matrix components into the cytosol that 
can be degraded by the proteolytic machinery in the cytosol. Some of them 
include the calcium-activated calpain proteases that can be divided into µ-calpain 
(calpain I) and m-calpain (calpain II), based on their micro and millimolar 
requirements of Ca2+ for activation. They exist as heterodimers consisting of a 
large catalytic sub-unit and a smaller regulatory sub-unit and when activated 
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bring about degradation of cytoskeletal proteins. Lack of ATP reverses some of 
the PM pumps resulting in influx of ions and water into the cell resulting in its 
swelling and extrusion of its contents into the extracellular space thereby eliciting 
an inflammatory response (Leist et al. 1999; Crompton 2003; Kim et al. 2003; 
Nicotera and Melino 2004; Artal-Sanz and Tavernarakis 2005; Wallace 2005; 
Armstrong 2006; Bernardi et al. 2006; Zong and Thompson 2006).  
When the defective or damaged mitochondria reach a certain threshold 
they are tagged for degradation by autophagy, more specifically called 
mitophagy. This is preceded by loss of mitochondrial membrane potential and 
release of cytochrome c and other pro-apoptotic proteins and usually followed by 
cell death. Mitophagy occurs in autophagolysosomes (autolysosomes) formed by 
fusion of lysosomes (the work is credited to de Duve who won the Nobel Prize in 
Physiology/Medicine in 1974) and autophagic vacuoles containing the 
mitochondria. Autolysosmes contain a variety of catabolic hydrolases 
(phosphatases, nucleases, glycosidases, proteases, peptidases, sulphatases 
and lipases) that operate at an acidic pH (4-5) and can digest the lysosomal 
contents for reuse.  Lysosomal cathepsin proteases can be divided into aspartyl 
(cathepsin-D) and cysteine (cathepsin-B, H and L), and can cause non-specific 
cleavage of proteins in lysosmes and sometimes in the cytosol. They can also 
activate pro-apoptotic Bid leading to mitochondrial membrane permeabilization 
and release of cytochrome c (Artal-Sanz and Tavernarakis 2005; Kroemer and 
Jaattela 2005; Lemasters 2005).  However, it is unclear at present if mitophagy is 
protective by providing energy generated from catabolic degradation of damaged 
mitochondria or if it hastens cell death by removing the major sources of energy 
from the cell (Klionsky and Emr 2000; Tolkovsky et al. 2002; Rodriguez-Enriquez 
et al. 2004; Golstein and Kroemer 2005; Kundu and Thompson 2005). Finally, 
there appears to be cross-talk between caspases, calpains and cathepsins 
leading to a continuum between apoptotic and necrotic forms of cell death. 
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Aging: A Full Circle
 
 Life of an organism is a function of its resistance to entropy i.e., the 
tendency of complex systems to move towards disorder and decay over time. 
Hence, life requires and utilizes energy, obtained from the available metabolic 
resources, to sustain a delicate balance among the competing processes namely 
growth, maintenance/repair and reproduction (Kirkwood and Austad 2000; 
Kirkwood 2005; Holliday 2006). Aging can be defined as an irreversible alteration 
in the intrinsic homeostasis of an organism, affected by its genetic make-up, 
environmental stresses and other stochastic events, leading to a) diminishing 
physiological capacity, b) decreased adaptability, c) a decline in fertility, d) 
increased vulnerability to disease and e) an exponential increase in mortality 
after maturation. Aging particularly increases the risk of occurrence of diseases, 
such as cancer, diabetes, cardio-vascular conditions as well as 
neurodegenerative conditions such as Alzheimer’s disease (AD), Parkinson’s 
disease (PD) and dementia, resulting ultimately in death (Troen 2003; Kirkwood 
2005; Wallace 2005).  
Longevity of a population can be measured by two different parameters – 
a) average life expectancy (ALE) and b) maximum lifespan (MLS). Life 
expectancy is the average/median age at which 50% of the population survives 
whereas maximum lifespan is the age of the longest-living member of that 
population. Improved nutrition, better sanitation and advances in health care 
have removed the humans from the pressures of natural selection and 
dramatically increased the ALE of humans over the past century, whereas the 
MLS in humans stands at 122 years indicating an underlying genetic component. 
This is particularly important in the context of United States where life expectancy 
at birth has increased from being less than 50 years to more than 76 years. It is 
projected that by the year 2030 the number of individuals aged 65 years and 
older will be around 70 million and those aged 85 years and older is estimated to 
be around 19 million by the year 2050. The ethical, medical and economic 
ramifications of such an aging population can already be felt by the society today. 
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The focus of human aging research is not so much on reversing aging but 
geared towards gaining insights of the underlying mechanisms to modulate aging 
and thereby ensuring a higher quality of life in the later years (Harman 2003; 
Troen 2003). 
Aging is not typically observed in natural populations as they do not 
survive extrinsic hazards such as starvation, predators, disease and other natural 
calamities. The main purpose of such organisms is to reach adulthood and be 
able to reproduce and generate progeny. The same animals when placed in 
protected environment with adequate resources are likely to live longer and 
exhibit an aging phenotype. While longevity refers to the time-frame of the 
organism, aging refers to the deleterious process occurring during that time. 
There exists an inverse relation between reproduction and longevity i.e. 
organisms with larger progeny have reduced life spans and vice versa. This is 
dependent on the allocation of limited resources to reproduction as opposed to 
somatic maintenance, as stated by the complementary ‘mutation accumulation’, 
‘antagonistic pleiotrophy’ and the ‘disposable soma’ theories of aging that 
attempt to explain why aging occurs evolutionarily (Kirkwood and Austad 2000; 
Kirkwood 2005; Holliday 2006). 
Owing to the evolutionary counter-intuitiveness and inherent complexity, a 
unifying theory is precluded from successfully elucidating the phenomenon of 
aging. Therefore, various theories have been put forth to explain how aging 
occurs that can be broadly divided into programmed (ex: longevity genes) and 
stochastic (ex: oxidative stress). While such mechanistic theories are not 
mutually exclusive and attempt to gain attention in the competing ‘cause vs. 
effect’ discussions, the ‘Mitochondrial Theory of Aging (MTA)’ offers to explain 
both the stochastic and genetic components associated with aging (Harman 
2003; Troen 2003; Kirkwood 2005; Wallace 2005). 
 Aging of the brain is characterized by mild cognitive impairment (MCI) and 
impairment of sensory and motor functions that has the potential to develop into 
neurodegenerative diseases such as Alzheimer’s (AD) and Parkinson’s (PD). 
The decline or loss of cognitive function with aging is not due to universal loss of 
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neuronal cells per se, as previously thought, but primarily due to loss of synaptic 
function in distinct cell populations. Selective regions in the cortex and 
hippocampus are more susceptible to synaptic reduction, dendritic degeneration 
and/or neuronal cell loss thereby affecting learning and memory (Uylings and de 
Brabander 2002).  
The brain is a unique organ in that it  consists of mostly post-mitotic cells, 
has a heterogeneous composition of cell types (neurons, astrocytes, glia etc), 
has distinct structural (cortex, hippocampus, striatum etc) regions and functional 
(motor vs. sensory vs. memory) areas. It has low levels of stored glycogen, 
almost exclusively utilizes glucose as its energy source and consumes about 
20% of total body oxygen even though it constitutes only 2% of the body weight. 
In addition, it contains high amounts of unsaturated fatty acids along with high 
iron content and found to be low in antioxidant defenses. All the above reasons 
make the brain a prime target for oxidative stress that is believed to increase with 
aging. In fact, increased protein oxidation, lipid peroxidation and DNA 
modifications, all markers of oxidative damage, were observed with aging that 
correlate well with cognitive dysfunction. There is also a strong negative 
correlation between energy metabolism and lifespan in mammals, lending 
credibility to the free radical theory of aging (Levine and Stadtman 2001; Floyd 
and Hensley 2002; Dufour and Larsson 2004; Poon et al. 2004; Stadtman 2006). 
Various groups have presented divergent reports on the distribution, 
expression, activity of different NOS isoforms in the brain and resultant protein 
modifications. Contradictory reports have emerged regarding the role of NO• and 
the extent of RNS mediated damage with aging measured by levels of 3-NT in 
different regions of the brain. However, there are no reports to date 
characterizing mtNOS as a function of age in the brain. None of these studies 
addressed the source of 3-NT measured and could plausibly account for the 
discrepancies (Bolanos et al. 1997; Drew and Leeuwenburgh 2002; Calabrese et 
al. 2006). 
According to the Ca2+ hypothesis of brain aging, there is dysregulation of 
calcium homeostasis in the brain with aging that has a detrimental cascade effect 
 43
 
on Ca2+-dependent processes thereby impairing brain synaptic function. This is 
evident from the increased vulnerability to excitotoxicity with age, increased 
numbers and activity of Ca2+-dependent channels, decreased capacity to recover 
after stimulation (although intracellular Ca2+ levels at rest do not change with 
age), increased Ca2+ influx into mitochondria or finally due to enhanced 
mitochondrial permeability transition pore (MPTP) activation with aging. Such 
Ca2+ dysregulation may lead to the undesirable consequence of impaired 
memory and cognition (Brown et al. 2004; Toescu and Verkhratsky 2004; Toescu 
et al. 2004; Kelly et al. 2006). 
Mitochondria occupy the center stage in aging and neurodegeneration 
owing to their capacity for- a) providing cellular ATP, b) buffering calcium, c) 
being a major source and target of ROS/RNS and finally d) being initiators of cell 
death pathways (Beal 2005). Therefore, mitochondria provide the converging 
point to successfully combine the ‘calcium dyshomeostasis hypothesis’ (Toescu 
et al. 2004) with the ‘free radical theory’ (Miquel 2002; Wei and Lee 2002; 
Harman 2003; Wallace 2005; Lenaz et al. 2006) of brain aging into a synergistic 
Mitochondrial Theory of Aging (MTA). The MTA postulates that mitochondrial 
dysfunction, due to a stochastic and exponential rise in mtDNA mutations leading 
to defective ETC complexes causing a reduction in ATP generation/levels and 
increased oxidative stress leading to irreversible alterations in mitochondrial 
structure and function, is central to the decline in function observed with aging 
(Miquel 2002; Wei and Lee 2002; Harman 2003; Wallace 2005; Lenaz et al. 
2006).  
 It has been documented that, with age, brain accumulates mtDNA 
deletions, rearrangements and point mutations resulting in a mixed population of 
around 1% of total mtDNA. Since mtDNA codes for 13 of the subunits of the ETC 
complexes I, III, IV and V, any mutations in their coding regions will result in 
synthesis of defective respiratory complexes decreasing their efficiency to carry 
out respiration. One of the fallouts of this is the increased leakage of electrons 
from the ETC, generating more free radicals. These are in turn shown to cause 
oxidative modifications of mtDNA as well as other mitochondrial proteins (ex: 
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ANT) and enzymes (ex: MnSOD) reducing or inhibiting their activities. Brain 
mitochondrial membranes have a higher concentration of polyunsaturated lipids 
and age-related decrease in amounts of cardiolipin which makes them more 
susceptible to free radical damage and thereby alters their fluidity, protein-lipid 
interactions and ultimately their structure. Taken together, there is a positive 
correlation between oxidative damage to mitochondrial components and decline 
in ATP generation and levels. Moreover, decreases in mitochondrial membrane 
potential, oxygen consumption and respiratory control ratio (RCR) were also 
observed with age resulting in a bioenergetic failure of mitochondria. In addition, 
aged mitochondria were also more susceptible to Ca2+ and free radical induced 
MPT (Bolanos et al. 1997; Toescu et al. 2000; Wei and Lee 2002; Brown et al. 
2004; Dufour and Larsson 2004; Liu and Ames 2005; Wallace 2005). 
 Cell death resulting from mitochondrial dysfunction is not readily evident 
with normal aging in the brain (Pollack et al. 2002). One of the reasons for this 
difference could be the intra-cellular trafficking and location (soma vs. synapses) 
of mitochondria, conditions in their surrounding milieu and their functional status 
within the neuron (Chang and Reynolds 2006). The cognitive decline with aging 
is explained by the changes in neuronal structure and loss of neuronal function, 
resulting from mitochondrial dysfunction, rather than neuronal cell death. 
However, cell death was indeed observed in other tissues with aging and more 
pronouncedly in age-related neurodegeneration (Uylings and de Brabander 
2002; Sastre et al. 2003; Sullivan 2005; Sullivan and Brown 2005; Mattson 
2006).  
  
Summary 
  
Mitochondria occupy a unique position inside the cell, in the sense they 
are the non-nuclear master regulators of cell’s fate. Their primary and most vital 
function is to provide ATP energy for the normal physiology of the cell, with an 
unfortunate but an inevitable consequence being generation of free radicals. In 
addition, they also possess calcium-buffering capacity. The combination of Ca2+ 
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and free radicals, under certain conditions, could lead to oxidative stress. And 
finally, they also bring about the death of the cell in the form apoptosis/necrosis 
that could be beneficial as in development or detrimental as in the case of aging, 
neurodegeneration and other pathologies. 
Brain mitochondria in particular are more susceptible to oxidative stress 
that is greatly modulated by the cellular Ca2+ fluxes as implicated in aging and 
age-related neurodegeneration conditions such as Alzheimer’s (AD) and 
Parkinson’s (PD). However, the sources of ROS/RNS, how their levels are 
altered by calcium and how the resulting oxidative stress is responsible for 
mitochondrial dysfunction observed with aging are all questions begging further 
clarification. 
It is of critical importance to prevent or ameliorate mitochondrial oxidative 
stress and preserve mitochondrial bioenergetics in order to maintain cellular 
homeostasis. Thus, it becomes imperative to understand the underlying causes, 
mechanisms and consequences of mitochondrial oxidative stress.  Therefore, the 
purpose of this dissertation is to study if there is cross-talk between calcium 
and nitric oxide synthase that affects mitochondrial bioenergetics and 
contributes to oxidative stress in isolated rat brain mitochondria. 
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Figure 1.6: Summary of hypothesis. Flowchart of plausible sequence of events 
resulting in mitochondrial dysfunction implicated in aging and neurodegeneration. 
Excess cytosolic calcium (Ca2+) is taken up by mitochondria which can activate a 
number of enzymes in the mitochondria including Nitric oxide Synthase (NOS). 
This leads to production of nitric oxide (NO•) that can react with superoxide (O2•-)   
forming peroxynitrite (ONOO-). It inturn can cause oxidative damage to various 
mitochondrial components namely mtDNA, proteins and lipids. This will alter 
mitochondrial structure and function resulting in reduced energy generation 
and/or initiation of cell death cascades. Loss of cell function and cell numbers are 
implicated in aging and age-related neurodegenerative conditions such as 
Alzheimer’s disease (AD). 
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Figure 1.6: Summary of hypothesis. 
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Chapter Two 
 
Cryopreservation of Brain Mitochondria: A Novel Methodology for 
Functional Studies 
 
 
Introduction 
 
Mitochondria are essential for aerobic metabolism and ATP production in 
the cell [for reviews see (Szewczyk and Wojtczak 2002; Watts and Kline 2003)] 
and play a significant role in cell death as relevant to aging and 
neurodegenerative diseases (Lemasters et al. 1999; Newmeyer and Ferguson-
Miller 2003). Mitochondrial function is typically analyzed using mitochondria 
freshly isolated from tissues and cells because they yield tightly coupled 
mitochondria, whereas those from frozen tissue can consist of broken 
mitochondria and membrane fragments (Lee 1995). This prevents serial usage 
as well as long-term batch storage or ‘banking’ of isolated mitochondria for later 
use in functional studies (Kuznetsov et al. 2003). To overcome such limitations, 
research has been done to optimize methods to cryopreserve mitochondria 
without affecting the structural and functional integrity of isolated mitochondria. 
 There are various natural and synthetic compounds currently being used 
as cryoprotective additives (CPA) such as alcohols, saccharides, heterocyclic 
compounds, certain amino-acids and proteins, as well as complex substrates 
such as yeast extract and skimmed milk. Of the lot, glycerol and dimethyl 
sulfoxide (DMSO) are the most widely used CPA. DMSO in particular is 
considered to be an effective cryoprotectant since it is cell-permeable, universal 
and well-characterized (Hubalek 2003; Santos et al. 2003). While previous 
studies have demonstrated cryopreservation of isolated mitochondria using 
DMSO in liver and muscles of rabbits (Araki 1977; Araki 1977), mice (Fishbein 
and Griffin 1976), rats (Tsvetkov et al. 1985; Tsvetkov et al. 1985; De Loecker et 
al. 1991; Kuznetsov et al. 2003) and humans (Lee 1995; Kuznetsov et al. 2003), 
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relatively few studies have directly addressed the effects of cryopreservation on 
the mitochondria in rat brain (Lee 1995).  
In the present study, cortical mitochondria were isolated from adult 
Sprague-Dawley rats. DMSO (10% v/v) was added to the crude or percoll-
purified fraction and assessed for respiration or allowed to cool at a uniform rate 
of ~ 1ºC/min and stored at -80ºC for a week. The cryopreserved mitochondria 
were reanimated after a week and assessed for respiration while structural 
intactness was verified by electron microscopy. The samples used for respiration 
studies were also used to measure the levels of mitochondrial marker proteins 
namely COX or COX IV (inner membrane), Cytochrome c (inter-membrane 
space) and VDAC (outer membrane).  
We conclude that DMSO can be successfully used to cryoprotect rat 
cortical mitochondria which could be extended as a possible strategy for 
preservation of human brain mitochondria as well. This will considerably expand 
the range of biochemical, molecular and metabolic studies that can be performed 
on rat or human post-mortem tissues without the constraints of mitochondrial 
longevity ex vivo and allow the banking of samples for future comparative 
studies. 
 
Materials and Methods 
 
Reagents: 
Mannitol, sucrose, bovine serum albumin (BSA), ethylene glycol-bis(2-
aminoethylether)-N,N,N',N'-tetraacetic acid (EGTA), hydroxyethyl piperazine-1- 
ethanesulfonic acid potassium salt (HEPES), potassium phosphate monobasic 
anhydrous (KH2PO4), magnesium chloride (MgCl2), potassium chloride (KCl), 
malate, pyruvate, adenosine 5’-diphosphate (ADP), digitonin, succinate and 
dimethyl sulfoxide (DMSO) were purchased from Sigma-Aldrich (St. Louis, MO, 
USA). Oligomycin A and carbonyl cyanide 4-(trifluoromethoxy) phenylhydrazone 
(FCCP) were purchased from Biomol (Plymouth Meeting, PA). Bicinchoninic acid 
(BCA) protein assay kit was purchased from Pierce (Rockford, IL). 
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Isolation and Purification of Brain Mitochondria: 
All experimental protocols involving animals were approved by the 
University of Kentucky Animal Use and Care Committee. This protocol contains 
modifications of previously described procedures (Brown et al. 2004; Sullivan et 
al. 2004). All procedures were performed on ice throughout the protocol. 
Depending on the sample size, this protocol requires about 2.5 – 3hrs of total 
preparation time. Male Sprague-Dawley rats (~250g) were decapitated and the 
brains were rapidly removed. The cortices were dissected out and placed in an 
all-glass dounce homogenizer containing five times the volume of isolation buffer 
with 1mM EGTA (215 mM mannitol, 75mM sucrose, 0.1% BSA, 20mM HEPES, 
1mM EGTA and pH is adjusted to 7.2 with KOH).  The tissue was homogenized 
and mitochondria were isolated by differential centrifugation. Briefly, the 
homogenate was centrifuged at 1300 x g for 3 minutes in an eppendorf 
microcentrifuge at 4ºC and the supernatant was transferred to new tubes. The 
loose pellet was resuspended in isolation buffer with EGTA and was centrifuged 
again at 1300 x g for 3 minutes. The resulting supernatant was transferred to 
new microcentrifuge tubes and topped off with isolation buffer with EGTA and 
centrifuged at 13,000 x g for 10 minutes. The supernatant was discarded and the 
pellet was resuspended in 500 µL of isolation buffer with EGTA. A fraction of the 
sample was aliquoted for cryopreservation. To obtain maximal yield of total 
(synaptic and non-synaptic) mitochondria, synaptosomal membranes were 
disrupted by adding 0.01% Digitonin (from 10X stock) to the sample and 
incubated on ice for 10 min. To remove the digitonin, the sample was topped off 
with isolation buffer and centrifuged at 10000 x g for 10 min. The sample was 
further purified by percoll density gradient centrifugation. Stocks of 40%, 26% 
and 24% percoll were prepared fresh in isolation buffer with EGTA. 3.5 ml of 26% 
stock was carefully layered over 3.5 ml of 40% in 13 ml ultra-clear tubes. Equal 
volume of 24% percoll was added to the sample to get a 12% final concentration 
and loaded gently on top of the 26% layer. The sample was centrifuged in fixed 
angle type 50.2 Ti rotor at 32,000 x g for 10 min at 4ºC in Optima L-90K 
ultracentrifuge (Beckman Coulter). Fraction 3 containing total mitochondria 
 51
 
formed at the interphase of 40% and 26% layers was carefully removed and 
placed in fresh ultra-clear tubes. The tubes were topped off with isolation buffer 
and centrifuged in type 50.2 Ti fixed angle rotor at 16,700 x g for 10 min at 4ºC in 
Optima L-90K ultracentrifuge (Beckman Coulter). The supernatants were 
carefully removed and the loose pellets at the bottom were transferred to 
microcentrifuge tubes. The tubes were topped off with isolation buffer without 
EGTA (215mM mannitol, 75mM sucrose, 0.1% BSA, 20mM HEPES and pH is 
adjusted to 7.2 with KOH) and centrifuged at 13,000 x g for 10 min at 4ºC. The 
supernatants were carefully removed and the pellets were resuspended in 500 
µL of isolation buffer without EGTA. The tubes were topped off with isolation 
buffer without EGTA and centrifuged at 10,000 x g for 10 min at 4ºC. The 
supernatants were carefully removed and the pellets were resuspended in 500 
µL of isolation buffer without EGTA. The tubes were topped off with isolation 
buffer without EGTA and centrifuged at 10,000 x g for 5 min at 4ºC to yield a 
tighter pellet. The final mitochondrial pellet was resuspended in isolation buffer 
without EGTA to yield a concentration of ~ 10mg/ml. The protein concentration 
was determined using the BCA protein assay kit measuring absorbance at 562 
nm with a BioTek Synergy HT plate reader (Winooski, Vermont). 
 
Cryopreservation of Brain Mitochondria: 
Brain Mitochondria were preserved before or after percoll purification. 
Dimethyl sulfoxide (DMSO) was added to the mitochondria (10% v/v). The 
sample was then placed in Nalgene freezing container (catalog number: 5100-
0001) and allowed to cool to -80ºC at a uniform rate of ~ -1ºC/min. The sample 
can be stored at -80ºC for up to 6 months for later use. 
 
Reanimation of Brain Mitochondria: 
 To reanimate the mitochondria, frozen samples were briefly thawed on 
ice. The sample tubes were topped off with isolation buffer with EGTA and 
centrifuged at 13000 x g for 10 min at 4ºC. The pellets were resuspended in 
500ul isolation buffer with or without EGTA, topped off and centrifuged at 10000 
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x g for 10 min @ at 4ºC. The pellets were resuspended in appropriate volume. If 
needed, the sample can then percoll purified as described above for subsequent 
analysis. 
 
 Electron Microscopy: 
After the last 10,000 × g centrifugation, the mitochondrial pellets were 
fixed in 4% glutaraldehyde overnight at 4ºC before being embedded for electron 
microscopy. Next, the pellets were washed overnight at 4ºC in 0.1M sodium 
cacodylate buffer, followed by 1 hr secondary fixation at room temperature in 1% 
osmium tetroxide. Then, the mitochondrial pellets were rinsed with distilled water 
and dehydrated for 10 min each in 70%, 85%, 95%, twice in 100% ethanol and 
twice in propylene oxide. The pellets were placed in a 1:1 mixture of propylene 
oxide and Epon/Araldite resin and infiltrated overnight on a rotator. Next, 100% 
Epon/Araldite resin was added and rotated for 1hr at room temperature. Finally 
fresh resin was prepared and degassed using a vacuum chamber. The 
mitochondrial pellets were added to the flat molds, filled with fresh resin, and 
baked overnight at 60ºC. The 90 nm sections were cut using an RMC MT-7000 
ultramicrotome mounted on 150 mesh copper grids and stained with uranyl 
acetate and lead citrate. The sections were examined using a Zeiss 902 
transmission electron microscope.  
 
Respiration Studies:  
The respiratory activity of isolated mitochondria was measured using a 
Clark-type oxygen electrode (Hansatech Instruments, Norfolk, England) as 
previously described (Brown et al. 2004; Sullivan et al. 2004).  100-120 ug/mL of 
isolated mitochondria were suspended in a sealed, constantly stirred, and 
thermostatically-controlled chamber at 37ºC in respiration buffer (125mM KCl, 
2mM MgCl2, 2.5mM KH2PO4, 0.1% BSA, 20mM HEPES at pH 7.2). The rate of 
oxygen consumption was calculated based on the slope of the response of 
isolated mitochondria to oxidative substrates, 5mM pyruvate and 2.5mM malate; 
150µM ADP; 2µM oligomycin; 2µM FCCP; and finally 10mM succinate.  
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Enzyme-Linked Immunosorbent Assay (ELISA) for Cytochrome c:  
Cytochrome c levels were analyzed according to the quantitative sandwich 
enzyme immunoassay protocol from the manufacturer (Quantikine kit; RnD 
Systems, Minneapolis) with slight modifications. Briefly, samples used for 
respiration were centrifuged at 10,000 x g for 5 min at 4ºC. The pellets were 
diluted to 0.01-0.03ug/ul with isolation buffer without EGTA. Samples were added 
to wells pre-incubated with Cytochrome c conjugate alongside known 
concentrations of standards. The plate was incubated in the dark for 2hr at room 
temperature. The contents of the wells were washed to remove unbound protein; 
colorimetric solution was added and incubated for 30min. Lastly, stop solution 
was added which turns the enzyme reaction from blue to yellow. The 
concentration of Cytochrome c was determined from optical density readings at 
450nm (background was measured at 570nm) using Multiskan Plus (Thermo 
LabSystems) and expressed as ng/mg protein (% Fresh mitochondria). 
 
Western Blotting: 
Western blots for COX and VDAC were carried out as described 
previously (Brown et al. 2004). Briefly, samples used for respiration were 
centrifuged at 10,000 x g for 5 min at 4ºC. The resulting mitochondrial pellet was 
diluted to 1ug/ul in isolation buffer without EGTA and used for western blots.  
Sample buffer was added to the samples based on relative protein 
concentrations and boiled for 10min. Samples (5ug each) were separated by 
SDS-PAGE 12% Tris-bisacrylamide gels (NuPage), along with molecular weight 
markers (Multi-Marker, Invitrogen).  Following SDS-PAGE, polypeptides were 
transferred electrophoretically onto 0.2 µM nitrocellulose membranes. 
Membranes were incubated at room temperature for 1 hour in 5% non-fat milk in 
50 mM Tris-saline containing 0.05% Tween-20 at pH 7.5 (TTBS).  The blots were 
incubated overnight in the primary antibody in TTBS at room temperature.  The 
primary antibodies used in study included monoclonal cytochrome c oxidase 
subunit IV (COX IV) at 1:20,000 from Molecular Probes (Eugene, OR, USA); and 
polyclonal voltage-dependent anion channel (VDAC) at 1:10,000 from Affinity 
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Bioreagents (Golden, CO, USA). After overnight incubation in primary antibody, 
the membranes were rinsed three times in TTBS and incubated in secondary 
antibody for one hour in either HRP-conjugated goat anti-mouse IgG (1:6000) for 
COXIV, or HRP-conjugated goat anti-rabbit IgG (1:6000) for VDAC. The blots 
were rinsed thoroughly in TTBS and were developed using Pierce SuperSignal 
West Pico chemi-luminescent substrate and analyzed using Kodak Image-
Station. 
 
Statistical Analysis:  
All results are expressed as means ± standard deviations (SD). For 
statistical evaluation, One-way analysis of variance (ANOVA) was performed 
followed by Student-Newman-Keuls post-hoc test. Significance was set at p < 
0.05 for all analyses.  
 
Results 
 
Effect of Cryopreservation on Ultrastructure of Brain Mitochondria:  
To determine the effects of cryopreservation on the ultra-structure of brain 
mitochondria, electron microscopy was performed on fresh and cryopreserved 
mitochondria. DMSO preserves the structure of cryopreserved brain 
mitochondria. Both the freshly isolated mitochondria (Figure 1A) and the 
cryopreserved mitochondria (Figure 1B) had intact inner and outer membranes, 
as well as tight cristae.  
 
Effect of Cryopreservation on Brain Mitochondrial Bioenergetics:  
To determine the effects of cryopreservation on the respiratory control 
ratio of brain mitochondria, oxygen consumption measurements were carried out. 
Freshly isolated brain mitochondria with respiratory control ratio (RCR) of greater 
than 5 only, obtained by dividing State 3 (presence of ADP) over State 4 
respiration (absence of ADP), were used for subsequent experiments. Oxygen 
consumption measurements revealed that there were no significant differences in 
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the RCR between percoll-purified non-cryopreserved mitochondria with DMSO 
and crude- or purified-cryopreserved mitochondria with DMSO (Figure 2.2 and 
2.3). This indicates that the electron transport system (ETS) is well coupled to the 
oxidative phosphorylation even upon cryopreservation. The RCR of mitochondria 
cryopreserved with DMSO was significantly higher from mitochondria frozen 
without DMSO. 
To determine effects of cryopreservation on the respiratory activity of brain 
mitochondria, the respiratory values of each state were analyzed for fresh and 
cryopreserved mitochondria. We observed a significant reduction in activity in 
fresh mitochondria washed with DMSO compared to freshly isolated brain 
mitochondria in all the respiration states except States II and IV. The reduction in 
activity suggests a DMSO effect on the mitochondrial bioenergetics. This 
reduction in activity is further exacerbated in the crude and purified mitochondria 
cryopreserved with DMSO (Figure 2.4). However, the cryopreserved 
mitochondria had significantly higher activity in all states compared to the 
mitochondria frozen without DMSO (data not shown) indicating that DMSO, in 
spite of lowering the respiration by itself, does indeed preserve mitochondrial 
bioenergetics. 
 
Effect of Cryopreservation on Cytochrome c levels of Brain Mitochondria:  
To determine the reduction in respiratory activity upon cryopreservation, 
we used ELISA to analyze Cytochrome c levels of all groups. Mitochondria 
cryopreserved with DMSO retain significantly higher Cytochrome c levels 
compared to the mitochondria frozen without DMSO (Figure 2.5). However, all 
groups were significantly lower than the fresh non-cryopreserved brain 
mitochondria. Surprisingly, DMSO alone significantly reduced Cytochrome c 
content in the mitochondria. This loss of Cytochrome c could account for the 
observed reduction in the bioenergetics upon cryopreservation. 
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Effect of Cryopreservation on Membrane Markers of Brain Mitochondria: 
Finally, to determine the possibility of mitochondrial membrane rupture 
resulting in reduction in cytochrome c levels, we carried out western blots for 
mitochondrial membrane marker proteins namely COX (inner membrane) and 
VDAC (outer membrane). Western blots of brain mitochondria cryopreserved 
with or without DMSO (Figure 2.6) demonstrated no significant differences in 
immunoreactivity of markers COX IV or VDAC. These data support our EM 
findings and taken together indicate that the mitochondrial membranes remain 
intact following cryopreservation. 
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Figure 2.1:  Cryopreservation of brain mitochondria does not alter their 
ultra-structure.  Electron microscopy pictures of fresh and cryopreserved 
mitochondria. The top panel (A) is a photograph of freshly isolated brain 
mitochondria. The bottom panel (B) is a photograph of cryopreserved 
mitochondria isolated from the same preparation. The small arrows indicate 
intact outer mitochondrial membranes whereas the large arrows indicate well-
formed cristae in both the freshly isolated and cryopreserved mitochondria.  
(Scale bar =0.25 µm). 
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Figure 2.1:  Cryopreservation of brain mitochondria does not alter their 
ultra-structure. 
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Figure 2.2: Representative Oxymetric traces of fresh and cryopreserved 
mitochondria obtained using a Clark-type oxygen electrode. Baseline 
respiration is termed as State I containing 125mM KCl respiration buffer and 
mitochondria (25-30ug). State II is initiated by addition of 5mM Pyruvate and 
2.5mM Malate as substrates for Complex I of the electron transport chain (ETC). 
State III is initiated by activation of ATP Synthase (Complex V) with addition of 
ADP (150µM). State IV occurs when ATP Synthase is inhibited by addition of 
Oligomycin (2µM). FCCP (2µM) induces State V by uncoupling electron transport 
from oxidative phosphorylation followed by Succinate (10mM) to verify electron 
transport through Complex II. Freshly isolated brain mitochondria or those 
washed in DMSO responded very similar to crude- or purified-cryopreserved 
brain mitochondria whereas brain mitochondria that were frozen without 
cryopreservation demonstrated an obvious loss of bioenergetics.  
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Figure 2.2: Representative Oxymetric traces of fresh and cryopreserved 
mitochondria obtained using a Clark-type oxygen electrode. 
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Figure 2.3: Cryopreservation of brain mitochondria preserves respiratory 
control ratio (RCR). Respiratory control ratios (RCR) of mitochondria, measured 
as State III (presence of ADP) over State IV (presence of oligomycin), 
demonstrate that cryopreserved brain mitochondria are well-coupled.  However 
their RCRs were significantly lower than freshly isolated mitochondria, but no 
different than freshly isolated mitochondria washed with DMSO. The line 
represents the RCR of frozen, non-cryopreserved brain mitochondria. Data 
represent group means ± SD; n = 3 per group except for Fresh + DMSO + Wash 
(n = 2) and Frozen (n = 2). One-Way ANOVA; Student-Newman-Keuls post-hoc 
test; # indicates p < 0.05 compared to fresh mitochondria. 
 
Measurement DF F – value P – value Power 
RCR 3 8.016 0.0115 0.885 
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Figure 2.3: Cryopreservation of brain mitochondria preserves 
respiratory control ratio (RCR). 
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Figure 2.4: Cryopreservation of brain mitochondria preserves active 
bioenergetics. Although cryopreserved brain mitochondria remain well-coupled 
demonstrated by their RCR, they do demonstrate a significant loss of 
bioenergetics compared to freshly isolated mitochondria or DMSO washed 
mitochondria. However, this loss of electron transport system (ETS) function was 
also significant in DMSO washed mitochondria in States III A, III B, V and VI 
compared to freshly isolated mitochondria. Between the cryopreserved 
mitochondria, the loss in bioenergetics is markedly higher in the crude 
cryopreserved mitochondria compared to the purified mitochondria 
cryopreserved with DMSO. Data represent group means ± SD; n = 3 per group 
except for Fresh + DMSO + Wash (n = 2). One-Way ANOVA; Student-Newman-
Keuls post-hoc test; # indicates p < 0.05 compared to fresh mitochondria; * 
indicates p < 0.05 compared to DMSO washed fresh mitochondria. 
 
Measurement DF F – value P – value Power 
Pyr/Mal 3 14.722 0.0021 0.992 
ADP 1 3 13.658 0.0026 0.987 
ADP 2 3 19.374 0.0009 0.999 
Oligo 3 14.233 0.0023 0.990 
FCCP 3 22.955 0.0005 1.000 
Succ 3 18.626 0.0010 0.998 
 
 
 
 
 
 
 
 
 
 
 64
 
Figure 2.4: Cryopreservation of brain mitochondria preserves 
active bioenergetics. 
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Figure 2.5: Loss of Cytochrome c in mitochondria upon cryopreservation. 
Mitochondrial samples were collected after respiration studies and used to 
assess Cytochrome c levels using ELISA. It demonstrated a significant loss of 
Cytochrome c in both the fresh mitochondria washed with DMSO and crude- or 
purified-cryopreserved mitochondria compared to freshly isolated brain 
mitochondria. However, mitochondria frozen without DMSO have significantly 
lower amounts of Cytochrome c compared to crude- or purified-cryopreserved as 
well as fresh mitochondria and those washed with DMSO. Data represent group 
means ± SD; n = 3 per group except for Fresh + DMSO + Wash (n = 2) and 
Frozen (n = 2). One-Way ANOVA; Student-Newman-Keuls post-hoc test; # 
indicates p < 0.05 compared to fresh mitochondria; * indicates p < 0.05 
compared to DMSO washed fresh mitochondria; @ indicates p < 0.05 compared 
to purified-cryopreserved mitochondria. 
 
Measurement DF F – value P – value Power 
Cytochrome c 4 22.810 0.0002 1.000 
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Figure 2.5:  Loss of Cytochrome c in mitochondria upon cryopreservation. 
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Figure 2.6:  Outer and inner mitochondrial membrane marker protein 
levels are maintained upon cryopreservation. Aliquots of mitochondrial 
samples collected from respiration studies were used for Western blot analysis 
using a monoclonal antibody (1:20,000) against Cytochrome c oxidase (COX IV) 
and a polyclonal antibody against (1:10,000) against Voltage dependent anion 
channel (VDAC). Representative Western blots demonstrated no significant 
differences in COX IV (inner membrane marker) or VDAC (outer membrane 
marker) protein levels between fresh and cryopreserved brain mitochondria 
indicating that both membranes are intact. 
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Figure 2.6:  Outer and inner mitochondrial membrane marker protein 
levels are maintained upon cryopreservation. 
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Discussion 
 
In the present study, we show that DMSO (10% v/v) can be used for 
successful cryopreservation of brain mitochondria. Reanimated mitochondria 
exhibited preserved bioenergetics as well as intact structure. There was a 
reduction in Cytochrome c levels with the addition of DMSO alone which further 
decreased upon cryopreservation. This observation could help explain, the 
reduction in respiratory activity of cryopreserved mitochondria. It is not however 
due to rupture of mitochondrial membranes as evident both at the EM level and 
retention of mitochondrial membrane marker proteins upon cryopreservation. 
 DMSO has been initially reported to cryoprotect bull spermatozoa and 
human and bovine red blood cells (Lovelock and Bishop 1959) and used for 
cryopreservation of several other cell types. It is an oxidized thioether with a 
chemical formula of (CH3)2SO, thus making it water-soluble whereas its further 
oxidized form called as dimethyl sulfone does not exhibit any cryoprotective 
properties. Permeable CPAs like DMSO are highly hydrophilic and act by binding 
to intracellular water preventing excessive dehydration, reducing salt toxicity and 
thereby preventing formation of ice crystals inside the cell or in this case of 
isolated mitochondria. DMSO is also shown to possess hydroxyl radical 
scavenging capacity thus acting as an anti-oxidant (Santos et al. 2003). 
 One of the first reports of cryopreservation of mitochondria using DMSO 
appeared in the 1960’s. It has been shown that DMSO and glycerol prevented 
decreases in respiration and oxidative phosphorylation in frozen rat liver 
mitochondria (Greiff and Myers 1961; Greiff et al. 1961) which was later 
confirmed by various groups (Lusena 1965; Lusena and Dass 1966; Dickinson et 
al. 1967; Fishbein and Griffin 1976). DMSO was shown to be more convenient 
for usage owing to its less viscosity and rapid penetration compared to glycerol. 
Mitochondria isolated from rat liver homogenates that had been frozen for 
months retained their energy-linked functions, even though DMSO by itself 
lowered the respiratory control ratio (Fleischer 1979; Fuller et al. 1989; De 
Loecker et al. 1991; Kuznetsov et al. 2003). Cryopreservation was also 
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successfully applied to primary rat hippocampal neurons (Mattson and Kater 
1988), rat brain synaptosomes (Begley et al. 1998), rat cardiac and skeletal 
muscles and human biopsy samples (Kuznetsov et al. 2003). Begley et al. (1998) 
have shown that glucose and glutamate transport activities, mitochondrial 
transmembrane potential and electron transport systems maintained in 
cryopreserved synaptosomes were identical to freshly isolated synaptosomes 
and also can be successfully applied to human post-mortem brain tissues. These 
data indirectly provide evidence that mitochondria present in the neurons and 
synaptosomes were also preserved and functional. 
Taking these studies into account, we decided to test whether DMSO 
could act as an effective CPA when added to rat cortical mitochondria. Our 
results support that DMSO (10% v/v) can be successfully used to cryopreserve 
brain mitochondria. Our lab previously demonstrated that there are no significant 
differences in RCR or marker proteins (COX and VDAC) in mitochondria 
prepared either by nitrogen-cell disruption or digitonin (Brown, Sullivan et al. 
2004).  In this study, we employed 0.01% digitonin to rupture the 
synaptoneurosomes which were further separated by discontinuous percoll 
gradient centrifugation to yield total (synaptic and non-synaptic pools of) 
mitochondria. These mitochondria were robust and well-coupled as 
demonstrated by their RCR. The current findings also demonstrate that freezing 
mitochondria without DMSO destroys their structural integrity and functional 
viability. Infact, freeze-thaw procedure is routinely employed to disrupt 
mitochondria and obtain sub-mitochondrial fractions. However, significantly 
higher cytochrome c levels are maintained in mitochondria cryopreserved with 
addition of DMSO as evident by respiration measurements. This suggests that 
the freeze-thaw procedures do disrupt mitochondrial membranes and that DMSO 
prevents most but not all damage. Infact, we did not observe any significant loss 
of mitochondrial membrane marker proteins (COX and VDAC) which indicates 
that the membranes are not ruptured and are intact, that was also evident by 
electron microscopy.  
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Clayton’s group (2005) have shown that the release of cytochrome c is 
mediated, in part, by mitochondrial outer membrane components such as Bak 
and VDAC forming pores rather than by non-specific rupture or by Bax and 
VDAC (Brustovetsky et al. 2003). This further supports our data that cytochrome 
c release is due to increased leakiness of the mitochondrial outer membrane and 
not due to its rupture per se. One possible explanation for this observation is that 
cytochrome c is a low molecular weight (12kD) protein that is present in the inter-
membrane space loosely bound to the mitochondrial inner membrane. 
We observed a DMSO effect on the RCR and respiratory states between 
fresh non-cryopreserved mitochondria and the mitochondria that were incubated 
with 10% DMSO that was washed out immediately. This loss in activity could 
possibly be due to exchange of DMSO and water across the membranes and in 
the process causing leaking of cytochrome c as well. The loss of cytochrome c is 
further exacerbated upon cryopreservation. However, addition of DMSO retained 
significantly higher levels of cytochrome c in cryopreserved mitochondria 
compared to those frozen without DMSO indicating that it is indeed 
cryoprotective.  
Kuznetsov’s group (2003) have done a comparative analysis of the 
cryopreservative properties of glycerol and DMSO using mitochondria from 
permeabilized human skeletal muscles and concluded that DMSO was clearly 
more effective than glycerol with a better preservation obtained at concentrations 
between 20 to 50% with an optimal around 30%. They also observed that 
cryopreserved mitochondria demonstrated functional integrity, normal ATP 
production and energy transfer as well as structural intactness of outer 
mitochondrial membranes. This is in contrast to our findings that 10% DMSO 
causes a reduction of mitochondrial bioenergetics in part due to loss of 
cytochrome c. 
We observed no obvious differences in the ultra-structures between the 
crude cryopreserved mitochondria and the percoll-purified cryopreserved 
mitochondria. Both the crude mitochondria cryopreserved with DMSO and the 
percoll-purified mitochondria cryopreserved with DMSO showed similar RCR 
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(>5). This suggests that the stage of cryopreservation of mitochondria (crude or 
purified) is not critical. Furthermore, we observed similar levels of cytochrome c 
and membrane marker proteins (COX and VDAC) in both the groups 
(Unpublished Data). This would give an opportunity to bank the crude 
mitochondria and reanimate and purify them at a later time for functional studies. 
 In summary, we report here for the first time, a practical and novel method 
for cryopreservation of brain mitochondria.  The use of this methodology to retain 
the functional viability of cryopreserved mitochondria allows the banking of CNS 
mitochondria for comparative studies or studies to be performed in 
geographically isolated laboratories. 
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Chapter Three 
 
Analysis of Mitochondrial Function in Post-mortem Brains of  
Alzheimer’s (AD) and Control Patients 
 
 
Introduction 
 
Alzheimer’s disease (AD) is a neurodegenerative condition marked by 
progressive loss of cognitive function and memory that currently affects 4 million 
Americans. Age is the major risk factor predisposing individuals over 65 years, in 
an exponential manner, to AD. Over 90-95% of AD incidences are sporadic while 
the rest are familial cases. Loss of synapses, deposition of extra-cellular plaques 
composed of β-Amyloid (Aβ) and intracellular accumulation of neurofibrillary 
tangles consisting mostly of tau protein polymers are hallmarks in both forms of 
AD pathology (Markesbery 1997; Mattson 2004; Harman 2006).  
AD associated dementia is invariably accompanied by reductions in 
cerebral metabolic rate for glucose and cerebral blood flow, as measured in vivo 
by positron emission tomography (PET) and functional magnetic resonance 
imaging (fMRI) (Farkas and Luiten 2001). They precede neuroanatomic evidence 
for the disease, such as increased expression of amyloid precursor protein 
(APP), cytoskeletal abnormalities, synaptic dysfunction and selective loss of 
neurons, and neuropsychological symptoms (Blass 2001). 
Frontal, parietal and temporal cortices and hippocampus are some of the 
brain regions more vulnerable to such damage, whereas primary sensory cortex 
and cerebellum are not affected in AD (Scheff and Price 2003). Although altered 
metal ion homeostasis, aberrant protein accumulation and inflammation are 
shown to be involved, mechanisms implicated in aging, namely calcium 
dysregulation (LaFerla 2002), oxidative damage such as increased DNA 
oxidation, protein oxidation or nitration and lipid peroxidation (Markesbery 1997; 
Floyd and Hensley 2002; Perry et al. 2002; Butterfield et al. 2006; Moreira et al. 
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2006), are naturally extended and, in combination with impaired proteasome 
activity (Keller et al. 2000; Sullivan et al. 2004) and cell death by apoptosis 
(Mattson 2006), are shown to play an increasingly important role in the 
pathophysiology of AD (Mattson 2004). 
  Mitochondrial dysfunction is considered to play a major role in the altered 
metabolism observed with AD (Beal 2005; Sullivan 2005; Sullivan and Brown 
2005; Parihar and Brewer 2007). This includes increased mtDNA mutations 
(Wallace 2005) and oxidation (Reddy and Beal 2005) and changes in mtDNA 
content (Hirai et al. 2001). Moreover, changes in the gene expression of ETC 
complexes (Manczak et al. 2004) were accompanied by decreases in activities of 
key mitochondrial enzymes (Gibson et al. 1998). Lastly, specific mitochondrial 
proteins are also shown to undergo oxidation and/or nitration (Sultana et al. 
2006; Sultana et al. 2006). 
Although several lines of evidence have implicated a role for mitochondrial 
dysfunction in AD none of the studies have directly assessed mitochondrial 
homeostasis. Studies that have assessed mitochondrial enzyme activities have 
been hindered by inconsistent results or called into question due to long (some 
greater than 24 hrs) postmortem intervals of the tissue (Sims 1996). The present 
study assessed region-specific alterations in mitochondrial homeostasis under 
tightly controlled conditions and a post-mortem interval (PMI) of less than 4 
hours.  We successfully employed the mitochondrial cryopreservation method 
described in Chapter 2 (Nukala et al. 2006). Synaptic and non-synaptic 
mitochondria were isolated from 3 regions of brain which are differentially 
affected in Alzheimer’s disease. Mitochondria were used to measure respiration, 
ROS/RNS generation and oxidative damage.  
Our preliminary data shows that there is a decrease in the Respiratory 
Control Ratios (RCR) in synaptic mitochondria isolated from AD patients 
compared with Control group. The respiration measured as maximum Complex I 
activity also decreased across all the regions in AD patients compared to 
Controls. While we did not notice changes in the ROS/RNS levels across the 
regions or between AD and Controls, we observed an increase in the levels of 
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protein carbonyls in all regions and across groups of AD patients. Taken together 
these data do suggest a role for oxidative stress and mitochondrial dysfunction in 
AD pathology. 
 
Materials and Methods 
 
Reagents: 
Mannitol, sucrose, bovine serum albumin (BSA), ethylene glycol-bis(2-
aminoethylether)-N,N,N',N'-tetraacetic acid (EGTA), hydroxyethyl piperazine-1- 
ethanesulfonic acid potassium salt (HEPES), potassium phosphate monobasic 
anhydrous (KH2PO4), magnesium chloride (MgCl2), potassium chloride (KCl), 
malate, pyruvate, adenosine 5’-diphosphate (ADP), digitonin, succinate and 
dimethyl sulfoxide (DMSO) were purchased from Sigma-Aldrich (St. Louis, MO, 
USA). Oligomycin A and carbonyl cyanide 4-(trifluoromethoxy) phenylhydrazone 
(FCCP) were purchased from Biomol (Plymouth Meeting, PA). Dihydrodichloro 
fluorescein diacetate (H2DCF-DA) was obtained from Molecular Probes (Eugene, 
OR) and bicinchoninic acid (BCA) protein assay kit was purchased from Pierce 
(Rockford, IL). 
 
Brain Autopsy Samples from AD and Control Patients: 
The graduate student was on-call to collect brain tissue samples from 
Alzheimer’s patients (n=4; PMI ≈ 3.125hrs) and age-matched controls (n=2; PMI 
≈ 2.5hrs) enrolled and longitudinally followed by the Sanders-Brown Center on 
Aging Alzheimer’s Disease Research Center (ADRC). Dr. William Markesbery, 
Director of Neuropathology Core, led the Rapid Autopsy Team to perform short 
postmortem interval (PMI) autopsies using a standardized protocol on 
longitudinally followed patients with AD and other age-related dementing 
disorders and cognitively normal aged, longitudinally followed, control subjects.  
Dr. David Wekstein, Director of Education and Information Core, chief contact 
person along with Dr. James Geddes and Dr. Steve Scheff were available at the 
autopsies. 
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Table 3.1: Brain Autopsy Samples from AD and Control Patients 
 
Case # Group Sex (M/F) Age (yrs) PMI (hrs) 
1094 Control Male 70 3.0 
1097 Control Female 89 1.75 
1086 AD Female 90 2.75 
1090 AD Female 84 1.75 
1096 AD Male 84 4.5 
1101 AD Female 86 3.25 
 
 
Isolation and Purification of Brain Mitochondria: 
This protocol contains modifications of previously described procedures 
(Brown et al. 2004; Brown et al. 2006; Nukala et al. 2006). All procedures were 
performed on ice throughout the protocol. A 1-2 cm punch of tissue from frontal  
(F) cortex, middle temporal (MT) gyrus and sensory (S) cortex were collected at 
autopsy, minced and placed into a large manual glass dounce homogenizer 
containing 15 ml of ice-cold isolation buffer with EGTA and protease-inhibitor 
cocktail (215 mM mannitol, 75 mM sucrose, 0.1% BSA, 1 mM EGTA, 20 mM 
HEPES, pH adjusted to 7.2 with KOH). The tissue was homogenized and 
mitochondria were isolated by differential centrifugation. The homogenate is 
transferred to 50ml conical tubes (total volume of 35-40mls) and centrifuged at 
1300 x g for 5 min @ 4ºC using Eppendorf 5810-R table-top centrifuge. The 
resulting supernatant transferred to fresh tubes to a total volume of 35-40mls. 
The pellet is resuspended in the buffer again and centrifuged at 1300 x g for 5 
min @ 4ºC as above and the resulting supernatant transferred is to fresh tubes. 
The supernatants from these two spins are centrifuged at 13,000 x g for 10 min 
@ 4ºC. The supernatant was discarded and the resulting pellet was resuspended 
in 1-2mls of isolation buffer with EGTA. At this point, 10% (v/v) DMSO was added 
to the mitochondria, and were cryopreserved as described in chapter 1 (Nukala 
et al. 2006).  
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Upon reanimation, the samples were further purified by percoll density 
gradient centrifugation. Stocks of 40%, 26% and 24% percoll were prepared 
fresh in isolation buffer with EGTA. 3.5 ml of 26% stock was carefully layered 
over 3.5 ml of 40% in 13 ml ultra-clear tubes. Equal volume of 24% percoll was 
added to the sample to get a 12% final concentration and loaded gently on top of 
the 26% layer. The sample was centrifuged in fixed angle type 50.2 Ti rotor at 
32,000 x g for 10 min at 4ºC in Optima L-90K ultracentrifuge (Beckman Coulter). 
Non-synaptic mitochondria are collected as Fraction 3 formed at the interphase 
of 40% and 26% layers and was carefully removed and placed in fresh ultra-clear 
tubes. The synaptoneurosomes as Fraction 2 at the interphase of 26% and 24% 
are carefully removed. The synaptoneurosomal mitochondria are then released 
by use of a nitrogen cell bomb to avoid the conflicts of detergent based methods 
of synaptoneurosome rupture. The tubes were topped off with isolation buffer 
with EGTA and centrifuged in type 50.2 Ti fixed angle rotor at 16,700 x g for 10 
min at 4ºC in Optima L-90K ultracentrifuge (Beckman Coulter). The supernatants 
were carefully removed and the loose pellets at the bottom were transferred to 
microcentrifuge tubes. The tubes were topped off with isolation buffer without 
EGTA (215mM mannitol, 75mM sucrose, 0.1% BSA, 20mM HEPES and pH is 
adjusted to 7.2 with KOH) and centrifuged at 10,000 x g for 10 min at 4ºC. The 
final mitochondrial pellet was resuspended in isolation buffer without EGTA to 
yield a concentration of ~ 10mg/ml. This method yields synaptic and non-synaptic 
mitochondria from each region of interest. The protein concentration was 
determined using the BCA protein assay kit measuring absorbance at 562 nm 
with a BioTek Synergy HT plate reader (Winooski, Vermont).  
 
Respiration Studies:  
The respiratory activity of isolated mitochondria was measured using a 
Clark-type oxygen electrode (Hansatech Instruments, Norfolk, England) as 
previously described (Brown et al. 2004; Nukala et al. 2006).  Mitochondria were 
suspended in a sealed, constantly stirred, and thermostatically-controlled 
chamber at 37ºC in respiration buffer (215 mM Mannitol, 75 mM Sucrose, 2mM 
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MgCl2, 2.5mM KH2PO4, 0.1% BSA, 20mM HEPES at pH 7.2). The rate of oxygen 
consumption was calculated based on the slope of the response of isolated 
mitochondria to oxidative substrates, 5mM pyruvate and 2.5mM malate; 150µM 
ADP; 2µM oligomycin; 2µM FCCP; and finally 10mM succinate. 
 
Fluorescent Spectrometry to Measure Mitochondrial ROS/RNS Generation: 
Mitochondrial ROS/RNS production was measured using 10µM 
dihydrodichloro fluorescein diacetate (H2DCF-DA) obtained from Molecular 
Probes (Eugene, OR) with Ex: 485nm and Em: 530nm in presence of 25U/ml 
HRP in the Biotek Synergy HT plate reader as previously described (Brown et al. 
2006). Isolated mitochondria (100ug) were added to 100 µl of respiration buffer 
(see above) with 5 mM pyruvate and 2.5 mM malate as oxidative substrates and 
incubated at 37ºC. ROS production was calculated as the rate of dichloro 
fluorescein (DCF) fluorescence over 15min of incubation, expressed in arbitrary 
fluorescence units. 
 
Western Blotting: 
For determination of protein carbonyls, the OxyBlot Protein Oxidation 
Detection Kit (Chemicon) was used according to manufacturer’s specifications. 
Each sample (20ug) was loaded onto SDS-PAGE 12% gels and ran at 100volts 
for about 1.5hrs at room temperature following which they were 
electrophoretically transferred onto nitrocellulose membranes over 1hr at 4ºC. 
The membranes were blocked in 5% non-fat milk in TTBS for 1hr. The 
membranes were then incubated with polyclonal antibody against dinitrophenyl 
hydrazone (DNP) at 1:1000 overnight with agitation at 4ºC. The membranes were 
washed with TTBS three times and incubated with the secondary Goat-α-Rabbit 
antibody for 2hrs. The membranes were washed three times with TTBS and 
incubated with the ECL reagent (GE Healthcare) and the film was developed in a 
dark room. 
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Statistical Analysis:  
All results are expressed as means ± SD. For statistical evaluation, 
Student’s t-test was performed. Significance was set at p < 0.05 for all analyses. 
  
Results: 
 
Mitochondrial RCR in AD and Control Patients: 
 To assess the extent of mitochondrial dysfunction in Alzheimer’s disease 
(AD), we carried out respiration studies directly in synaptic mitochondria isolated 
from various regions of post-mortem brains from AD and control patients. The 
respiratory control ratio, described as State III/State IV and expressed as 
average of all the regions, is lower (~ 60%) in brain samples from AD patients  
(RCR = 2.69 ± 0.68) compared to Control group (RCR = 6.4 ± 2.97), approaching 
significance (p = 0.0551) (Figure 3.1).  
 
Mitochondrial Maximum Complex I Activity in AD and Control Patients: 
 We analyzed the maximum Complex I activity in synaptic mitochondria 
(defined as the respiration induced by FCCP in presence of Complex I 
substrates) and observed that it is lower in the entire three – mid-temporal (MT), 
frontal (F) and sensory (S) regions of AD patients compared to control patients. 
The differences were most prominent, approaching significance (p = 0.0669), 
between the frontal region (~ 75%) of AD and Control patients. The activity was 
lower by ~ 50% in MT and ~ 70% in S regions of AD compared to those of 
Control patients but not significant. 
 
Mitochondrial ROS/RNS Generation in AD and Control Patients: 
 We did not observe any changes in ROS/RNS levels in synaptic 
mitochondria from any of the regions between AD and Control patients. However, 
within AD, middle-temporal (MT) seems to have a higher ROS/RNS generation 
compared to frontal (F) and sensory (S) regions. 
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Mitochondrial Oxidative Damage in AD and Control Patients: 
 Finally, we measured levels of protein carbonyls, using western blots, as a 
measure of the extent of protein oxidation in both synaptic and non-synaptic 
mitochondria. The synaptic mitochondria show increased protein carbonyls in AD 
patients compared to synaptic mitochondria of Control group. Further, the non-
synaptic mitochondria of AD patients tend to show increased protein carbonyls 
across all regions compared to non-synaptic mitochondria of Control group. 
Lastly, we also observed increased protein carbonyls in non-synaptic 
mitochondria compared to synaptic mitochondria across all regions within AD 
and Controls. Overall, there is higher oxidative damage in mitochondria from AD 
patients compared to Control group. 
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Figure 3.1: Mitochondrial RCR decreased in AD patients. Mitochondrial 
respiration was carried out at 37ºC by incubating mitochondria in respiration 
buffer and oxygen consumption of mitochondria was measured in response to 
addition of various substrates and inhibitors. The respiratory control ratio (RCR), 
measured as State III (presence of ADP) over State IV (presence of Oligomycin) 
respiration, is lower, approaching significance (p = 0.0551) , in mitochondria from 
AD patients compared to Control group. Data represent group means ± SD; n = 4 
per AD group and n = 2 per Control group; Student’s t-test. 
 
Measurement DF t – value P – value 
RCR 4 - 2.682 0.0551 
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Figure 3.1: Mitochondrial RCR decreases in AD patients. 
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Figure 3.2: Mitochondrial maximum Complex I activity decreased in AD 
patients. The maximum Complex I activity, defined as the FCCP induced 
respiration in presence of Complex I substrates (pyruvate and malate) is lower in 
middle-temporal (MTs), frontal (Fs) and sensory (Ss) regions of synaptic 
mitochondria from AD compared to Control group. However, the differences are 
not significant in any of the regions assessed. Data represent group means ± SD; 
n = 4 per AD group and n = 2 per Control group; Student’s t-test. 
 
Measurement DF t – value P – value 
Mid-temporal (MT) 4 - 2.044 0.1105 
Frontal (F) 4 - 2.499 0.0669 
Sensory (S) 3 - 1.666 0.1944 
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Figure 3.2: Mitochondrial maximum Complex I activity decreased in  
AD patients. 
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Figure 3.3: No changes in mitochondrial ROS/RNS levels in AD and Control 
patients. Mitochondria were incubated in respiration buffer at 37ºC containing 5 
mM pyruvate and 2.5 mM malate as oxidative substrates and the reaction was 
carried out for 15min. There were no changes in DCF fluorescence (Ex: 485nm; 
Em: 530nm), as a measure of free radical production, in middle-temporal (MTs), 
frontal (Fs) and sensory (Ss) regions of synaptic mitochondria from AD compared 
to Control group. Data represent group means ± SD; n = 4 per AD group and n = 
2 per Control group; Student’s t-test. 
 
Measurement DF t – value P – value 
Mid-temporal (MT) 4 0.635 0.5602 
Frontal (F) 3 - - 
Sensory (S) 3 - 1.173 0.3255 
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Figure 3.3: No changes in mitochondrial ROS/RNS levels in AD and Control 
patients. 
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Figure 3.4: Mitochondrial oxidative damage is higher in AD patients. A 
OxyBlot Protein Oxidation Detection Kit was used in combination with western 
blots. The levels of protein carbonyls were probed using an antibody against 
DNP moieties (1:1000) of oxidized proteins. They were found to be higher in both 
synaptic and non-synaptic mitochondria across all regions of AD patients 
compared to Controls. Moreover, the protein carbonyls were higher in non-
synaptic [Mid-Temporal (MT), Frontal (F) and Sensory (S)] mitochondria 
compared to synaptic [Mid-Temporal (MTs), Frontal (Fs) and Sensory (Ss)] 
mitochondria across all regions within AD and Controls. n = 4 per AD group and 
n = 2 per Control group. 
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Figure 3.4: Mitochondrial oxidative damage is higher in AD patients. 
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Discussion: 
 
In the present study, we carried out experiments directly on mitochondria 
isolated from various regions of post-mortem brains and show mitochondrial 
dysfunction in AD patients compared to age-matched Control group. We were 
able to successfully use cryopreserved mitochondria as described in Chapter 1. 
We observed lower respiratory control ratio (RCR) as well as decreases in the 
maximum Complex I activity in synaptic mitochondria from middle-temporal (MT), 
frontal (F) and sensory (S) regions of AD brains. While we did not observe any 
changes in mitochondrial ROS/RNS levels in any of the groups, we were able to 
detect increased oxidative damage in AD mitochondria compared to Controls. 
Most of the studies involving mitochondria in AD were performed on 
mitochondria isolated from biopsy samples or post-mortem brains (Sims 1996). 
This resulted in data where no changes were observed with biopsy tissue or data 
with highly variable results due to the differences in the post-mortem intervals 
(PMI). We had the distinct advantage of having the graduate student available on 
an on-call basis to obtain brain samples from the University of Kentucky 
Alzheimer’s Disease Research Center (ADRC) with a post-mortem interval of 
under 4hours. This eliminates some of the variability observed and helps achieve 
more consistent data (Hynd et al. 2003). 
Mitochondria can be cryopreserved using dimethyl sulfoxide (DMSO) and 
can be retrieved with preserved structure and function (Nukala et al. 2006). We 
employed this technique to cryopreserve mitochondria obtained from post-
mortem samples from AD and Control brains. We were able to rapidly isolate 
mitochondria after collecting the brain samples within a couple of hours from the 
time of death. This is the first such study that enables laboratories to bank 
valuable post-mortem samples as well as conduct functional studies directly on 
mitochondria from such tissues. 
Mitochondrial dysfunction and the resulting altered metabolism is 
implicated in both aging and Alzheimer’s disease (Beal 2005; Sullivan and Brown 
2005; Parihar and Brewer 2007). There are increased mitochondrial DNA 
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(mtDNA) mutations in AD brains, in the form of point mutations (Lin et al. 2002) 
or rearrangements preferentially in the transcription and replication regulatory 
elements of mtDNA, with the inevitable consequence of defective ETC 
complexes (Wallace 2005). This is also evident from altered mRNA expression in 
NADH dehydrogenase and ATP Synthase, down-regulation of expression of 
Complex I and up-regulation of Complex III and IV subunits (Manczak et al. 
2004). Moreover, mtDNA had higher oxidized bases in the frontal, parietal and 
temporal lobes of AD brains and was 10-fold higher than nuclear DNA (nDNA) in 
the same tissues (Hirai et al. 2001; Wang et al. 2005). Lastly, significant 
decreases of mitochondria in selective neuronal cell populations were observed 
with AD. This was accompanied by increased mtDNA and protein content mainly 
in autophagic vacuoles and the cytoplasm (Hirai et al. 2001). 
In addition, reductions in key enzymatic activities were observed in 
mitochondria of AD patients (Gibson et al. 1998). Specifically, pyruvate 
dehydrogenase complex (PDHC), α-ketoglutarate dehydrogenase complex 
(KGDHC) and cytochrome c oxidase (COX) show decreased activity in the 
regions affected in AD. PDHC catalyzes the conversion of pyruvate from 
glycolysis to acetyl-CoA that enters the Kreb’s cycle. Interestingly, pyruvate 
dehydrogenase (PDHC) and α-ketoglutarate dehydrogenase complex (KGDHC) 
are two of the three mitochondrial dehydrogenases that are activated by calcium 
(Gunter et al. 2004). KGDHC converts α-ketoglutarate to succinyl-CoA within 
Kreb’s cycle. Alternately, KGDHC can also convert α-ketoglutarate to glutamic 
acid involved with glutamate metabolism. COX, on the other hand, is the last 
electron acceptor and donator in the ETC where, oxygen is reduced to water. 
Inhibition or decrease in activity of any the above enzymes would limit the 
substrate availability to the ETC and therefore reduce ATP generation (Blass 
2000). 
Based on above observations, we assessed mitochondrial respiration 
directly by measuring mitochondrial oxygen consumption in synaptic 
mitochondria. We observed a decrease in the respiratory control ratio (RCR) in 
AD patients of about ~ 45% of the age-matched control group (Figure 3.1). This 
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supports a previous report by Sims. et al., where they have observed a similar 
decrease in RCR (~ 60% of controls) in brain homogenates from regions affected 
in AD patients (Sims et al. 1987). In the same study, they did not observe 
changes in the maximal respiratory rate (in presence of an uncoupling agent) 
between AD and control subjects. In contrast, our data shows a marked 
decrease in the maximal respiration activity (induced by Complex I substrate) in 
presence of FCCP (Figure 3.2) in mitochondria of AD subjects. The discrepancy 
could possibly be due to the source of the mitochondria i.e. brain homogenates in 
the former versus purified mitochondria in the present study (Sims 1996). 
Moreover, the decreases were observed in all the three regions assessed, with 
most pronounced decreases in the frontal cortex.  
β-Amyloid (Aβ) is one of the mechanisms shown to increase oxidative 
stress in the mitochondria (Canevari et al. 2004; Caspersen et al. 2005; Reddy 
2006). In fact, both Aβ and its precursor protein APP are shown to be capable of 
entering mitochondria. Aβ can interact with pyruvate dehydrogenase complex 
(PDHC) and also inhibit Complexes III and IV of the ETC thus inhibiting 
mitochondrial respiration. It is also shown to lower mitochondrial membrane 
potential and ATP levels and increase free radicals. These free radicals in turn 
can activate secretases that can cleave APP into Aβ. Furthermore, Aβ is also 
shown to cause release of cytochrome c and caspase activation in functional 
mitochondria. Another source of mitochondrial superoxide, besides the ETC, is 
the KGDHC (Markesbery 1997; Perry et al. 2002; Starkov et al. 2004; Moreira et 
al. 2006) that also interacts with Aβ. All the above reasons make mitochondria a 
prime breeding ground for oxidative stress and damage leading to their 
dysfunction as seen with AD. 
We therefore carried out experiments to measure the free radical 
generation in synaptic mitochondria from AD and control subjects. We did not 
detect any differences in ROS/RNS levels in any of the regions from either group 
(Figure 3.3). This could be due to the fact that these studies were carried out in 
post-mortem tissues and might have missed out on the window to detect such 
changes. Moreover, such tissues might have altered antioxidant enzyme 
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activities or increased scavenging activity for which there are no consistent 
reports. Alternately, Aβ-induced free radical generation may not be a major 
pathway for the observed oxidative stress. Therefore, a more reliable indicator 
would be to measure the markers of oxidative damage as seen with numerous 
published studies (Markesbery 1997; Perry et al. 2002; Moreira et al. 2006). We 
measured changes in protein carbonyls as a marker for protein oxidation, 
although it detects protein-lipid peroxidation adducts as well (Sultana et al. 2006). 
They were higher in both synaptic and non-synaptic mitochondria across all 
regions of AD patients compared to Controls. Moreover, the protein carbonyls 
were higher in non-synaptic mitochondria compared to synaptic mitochondria 
across all regions within AD and Controls. These differences could be due to the 
variable properties of neuronal (synaptic) and non-neuronal mitochondria (Park 
et al. 2001; Brown et al. 2004; Vergun and Reynolds 2005; Brown et al. 2006; 
Chang and Reynolds 2006).  
In fact our lab (Brown et al. 2004; Brown et al. 2006) and others (Park et 
al. 2001; Vergun and Reynolds 2005) have shown that the different sets of 
mitochondria respond differently in undergoing mitochondrial membrane 
permeability transition (MPT) to similar calcium loads. In addition, Butterfield’s 
group, using redox proteomics, has shown that key mitochondrial proteins such 
as VDAC and ATP Synthase α-chain undergo protein oxidation as well as 
nitration (Sultana et al. 2006; Sultana et al. 2006). Lastly, It is well known that 
cytochrome c oxidase (COX) is reversibly inhibited by nitric oxide at low 
concentrations and irreversibly at higher concentrations through peroxynitrite 
(Brown and Borutaite 2002; Moncada and Bolanos 2006). This is possibly 
induced through a calcium-activated nitric oxide synthase (mtNOS) localized to 
the mitochondria (Giulivi et al. 2006; Cooper and Giulivi 2007). Based on 
previous literature on calcium dysregulation, increases in free radicals and our 
own data showing decreases in mitochondrial respiration and higher oxidative 
damage, the existence of and role for a mitochondrial nitric oxide synthase 
(mtNOS) requires further elucidation and therefore explored in the next chapter. 
Copyright © Vidya Nag Nukala 2007 
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Chapter Four 
 
Relationship Between Calcium and Nitric Oxide Synthase in Brain 
Mitochondrial Dysfunction 
 
 
Introduction 
 
Various reports can be found in recent literature on the existence of nitric 
oxide synthase enzyme (mtNOS) localized to mitochondria (Bates et al. 1995; 
Tatoyan and Giulivi 1998; Kanai et al. 2001; Lacza et al. 2001; Elfering et al. 
2002; Riobo et al. 2002; Haynes et al. 2004). Evidence in rat liver mitochondria 
indicates that mtNOS exhibited Ca2+–dependent increase in activity, which was 
blocked by NOS inhibitors and might be involved in mitochondrial O2 
consumption and membrane potential (Ghafourifar and Richter 1997). It has 
been suggested that NOS present within the mitochondria could be the source of 
NO• observed (Giulivi et al. 1998). Various groups have clearly established that 
NO• inhibits cytochrome c oxidase in intact mitochondria reversibly by competing 
with oxygen (Radi et al. 2002; Persichini et al. 2005). In vitro studies indicated 
that peroxynitrite (ONOO-) is involved in release of Ca2+ thereby preserving 
membrane potential (Bringold et al. 2000).  
It was shown that uptake of Ca2+ by mitochondria stimulates mtNOS 
causing release of cytochrome c involving ONOO-, suggesting that Ca2+ –
induced apoptosis is partly mediated via mtNOS (Ghafourifar et al. 1999). There 
is ample evidence showing that NO• and its derivatives such as ONOO- are 
involved in inhibition of respiration at the level of ETC as well as alter other 
mitochondrial proteins (Brown and Borutaite 2002; Radi et al. 2002; Elfering et al. 
2004; Traaseth et al. 2004). Peroxynitrite (ONOO-) is also capable of causing 
lipid peroxidation (Violi et al. 1999) as well as DNA modification (Aust and 
Eveleigh 1999). On the other hand, the type of NOS  isoform in the mitochondria, 
the availability of substrates and cofactors for the enzyme, Ca2+ dependency and 
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it putative physiological function and pathological effects have been called into 
question (French et al. 2001; Lacza et al. 2003; Brookes 2004; Gao et al. 2004; 
Ghafourifar and Cadenas 2005; Lacza et al. 2006). 
Several lines of evidence suggest that perturbations in intracellular Ca2+ 
homeostasis are involved in mitochondrial mediated apoptotic pathway. 
However, the sequelae of events leading from mitochondrial Ca2+ overload to 
RNS mediated damage in the mitochondria are still unclear. It can be postulated 
that inactivation of key respiratory and anti-oxidant enzymes, lipid peroxidation 
and DNA modifications by NO• and ONOO- could cause increased oxidative 
stress, ATP depletion due to mitochondrial dysfunction and subsequent cell 
death. The sources of NO• and its derivatives responsible for the observed 
effects are not yet understood completely. In light of these findings and gaps 
therein, we measured the effects of calcium on mitochondrial respiration, free 
radical generation and oxidative damage markers, in addition to NOS activity and 
NOS protein in purified mitochondria.  
Our results confirm the presence of an active NOS enzyme inside the 
mitochondria that is not due to cytosolic contamination. We also show that 
calcium inhibits mitochondrial respiration in a dose- and time-dependent manner 
as well as increases ROS/RNS levels, although either of those two parameters 
was not reversed in presence of NOS inhibitors. There were detectable but not 
significant changes in levels of oxidative damage markers with exposure to 
patho-physiological doses of calcium. Taken together, our data suggests that 
although calcium induces mitochondrial dysfunction the mechanism may not 
entirely be via the mtNOS pathway.  
 
Materials & Methods  
 
Reagents: 
Mannitol, sucrose, bovine serum albumin (BSA), ethylene glycol-bis(2-
aminoethylether)-N,N,N',N'-tetraacetic acid (EGTA), hydroxyethyl piperazine-1- 
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ethanesulfonic acid potassium salt (HEPES), potassium phosphate monobasic 
anhydrous (KH2PO4), magnesium chloride (MgCl2), malate, pyruvate, adenosine 
5’-diphosphate (ADP), succinate, calcium chloride (CaCl2), L-Arginine (L-Arg), 
potassium chloride (KCl), proteinase-K and horseradish peroxidase (HRP) were 
purchased from Sigma-Aldrich (St. Louis, MO, USA). Dihydro dichlorofluorescin 
diacetate (H2DCF-DA), tetramethylrhodamine ethyl ester (TMRE) were 
purchased from Molecular Probes (Eugene, OR). Oligomycin A, rotenone and 
carbonyl cyanide 4-(trifluoromethoxy) phenylhydrazone (FCCP) were purchased 
from Biomol (Plymouth Meeting, PA). NG-Nitro-L-arginine (L-NNA) and NG-Nitro-
L-arginine methyl ester, hydrochloride (L-NAME) were purchased from 
Calbiochem (San Diego, CA). Bicinchoninic acid (BCA) protein assay kit was 
purchased from Pierce (Rockford, IL). 
 
Isolation and Purification of Brain Mitochondria:  
All experimental protocols involving animals were approved by the 
University of Kentucky Animal Use and Care Committee.  This protocol contains 
modifications of previously described procedures (Brown et al. 2004; Nukala et 
al. 2006).  All procedures were performed on ice throughout the protocol.  Male 
Sprague-Dawley rats (~250-300g) were decapitated and the brains were rapidly 
removed. The cortices were dissected out and placed in an all-glass dounce 
homogenizer containing five times the volume of isolation buffer with 1 mM 
EGTA (215 mM mannitol, 75 mM sucrose, 0.1 % BSA, 20 mM HEPES, 1 mM 
EGTA and pH is adjusted to 7.2 with KOH).  The tissue was homogenized and 
mitochondria were isolated by differential centrifugation.  Briefly, the homogenate 
was centrifuged at 1300 x g for 3 minutes twice in an eppendorf microcentrifuge 
at 4ºC and the supernatant was transferred to new tubes. The resulting 
supernatant was transferred to new microcentrifuge tubes and topped off with 
isolation buffer with EGTA and centrifuged at 13,000 x g for 10 minutes.  The 
supernatant was discarded and the pellet was resuspended in 500 µL of isolation 
buffer with EGTA. To obtain maximal yield of total (synaptic and non-synaptic) 
mitochondria, synaptosomal membranes were disrupted by nitrogen cell 
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disrupter incubated for 10 min at 1200psi. The sample was further purified by 
percoll density gradient centrifugation. Stocks of 40%, 24% and 30% percoll were 
prepared fresh in isolation buffer with EGTA. 3.5 ml of 24% stock was carefully 
layered over 3.5 ml of 40% in 13 ml ultraclear tubes. Equal volume of 30% 
percoll was added to the sample to get a 15% final concentration and loaded 
gently on top of the 24% layer. The sample was centrifuged in fixed angle type 
SE-12 rotor at 30,400 x g for 10 min at 4ºC in RC 5C Plus (Sorvall) high-speed 
centrifuge. Fraction 3 containing total mitochondria formed at the interphase of 
40% and 24% layers was carefully removed and placed in fresh ultraclear tubes. 
The tubes were topped off with isolation buffer without EGTA (215 mM mannitol, 
75 mM sucrose, 0.1 % BSA, 20 mM HEPES and pH is adjusted to 7.2 with KOH) 
and centrifuged in fixed angle SE-12 rotor at 16,700 x g for 15 min at 4ºC in RC 
5C Plus (Sorvall) high-speed centrifuge. The supernatants are carefully removed. 
The tubes were topped off with isolation buffer without EGTA and centrifuged in 
fixed angle SE-12 rotor at 13,000 x g for 10 min at 4ºC in RC 5C Plus (Sorvall) 
high-speed centrifuge. The supernatants were carefully removed and the loose 
pellets at the bottom were transferred to microcentrifuge tubes. The tubes were 
topped off with isolation buffer without EGTA and centrifuged at 13,000 x g for 10 
min at 4ºC. The supernatants were carefully removed and the pellets were 
resuspended in 500 µL of isolation buffer without EGTA.  The tubes were topped 
off with isolation buffer without EGTA and centrifuged at 10,000 x g for 5 min at 
4ºC to yield a tighter pellet. The final mitochondrial pellet was resuspended in 
isolation buffer without EGTA to yield a concentration of ~ 10mg/ml.  The protein 
concentration was determined using the BCA protein assay kit measuring 
absorbance at 562 nm with a BioTek Synergy HT plate reader (Winooski, 
Vermont). 
 
Electron Microscopy: 
After the last 10,000 × g centrifugation, the mitochondrial pellets were 
fixed in 4% glutaraldehyde overnight at 4ºC before being embedded for electron 
microscopy. Next, the pellets were washed overnight at 4ºC in 0.1M sodium 
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cacodylate buffer, followed by 1 hr secondary fixation at room temperature in 1% 
osmium tetroxide. Then, the mitochondrial pellets were rinsed with distilled water 
and dehydrated for 10 min each in 70%, 85%, 95%, twice in 100% ethanol and 
twice in propylene oxide. The pellets were placed in a 1:1 mixture of propylene 
oxide and Epon/Araldite resin and infiltrated overnight on a rotator. Next, 100% 
Epon/Araldite resin was added and rotated for 1hr at room temperature. Finally 
fresh resin was prepared and degassed using a vacuum chamber. The 
mitochondrial pellets were added to the flat molds, filled with fresh resin, and 
baked overnight at 60ºC. The 90 nm sections were cut using an RMC MT-7000 
ultramicrotome mounted on 150 mesh copper grids and stained with uranyl 
acetate and lead citrate. The sections were examined using a Zeiss 902 electron 
microscope. 
 
Respiration Studies:  
The respiratory activity of isolated mitochondria was measured using a 
Clark-type oxygen electrode (Hansatech Instruments, Norfolk, England) (Brown 
et al. 2004; Nukala et al. 2006).  120-160 ug/mL of isolated mitochondria were 
suspended in a sealed, constantly stirred, and thermostatically-controlled 
chamber at 37ºC in respiration buffer (125 mM KCl, 2 mM MgCl2, 2.5 mM 
KH2PO4, 0.1 % BSA, 20 mM HEPES at pH 7.2). The rate of oxygen consumption 
was calculated based on the slope of the response of isolated mitochondria to 
oxidative substrates in the order- 5 mM pyruvate and 2.5 mM malate; 150 µM 
ADP; 2 µM of oligomycin; 2 µM FCCP; 1µM Rotenone and 10mM succinate. 
 
Affinity Purification by 2’,5’-ADP-Sepharose Beads:  
NADPH immobilized to 2’,5’-ADP-Sepharose beads (50ug; Amersham 
Biosciences), with modifications (Lacza et al. 2003), were allowed to swell in 
dH2O at 4ºC. They were centrifuged at 10,000 x g for 10 min and resuspended in 
binding buffer consisting of 10mM phosphate (PO-4) buffer and 0.15M sodium 
chloride (NaCl) in 3:1 ratio. Mitochondria (1mg/ml; 50-100ug) were incubated 
with the beads in 1:1 ratio overnight with rocking at 4°C. The samples were 
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centrifuged at 1300 x g for 5min. The pelleted beads were washed 3 times with 
isolation buffer without EGTA and treated with sample buffer (containing SDS). 
The supernatants were centrifuged at 10,000 x g for 10min twice and the 
resulting pellet was processed for Western blots. 
 
Proteinase-K Treatment:  
Mitochondrial aliquots (100ug each at 1mg/ml concentration) were 
incubated with and without Proteinase-K (50-200ug/ml final; Sigma) for 30 
minutes at 4°C or 25°C (Gao et al. 2004) or alternately at 37°C.  
Phenylmethylsulfonyl fluoride (PMSF; 1-2mM final; Roche) was added to the 
aliquots to stop the reaction and incubated for 10 min at 4°C or 25°C or 
alternately at 37°C. The samples were centrifuged at 10,000 x g for 10 min. The 
pellets and supernatants were collected and processed for Western blots. 
 
Western Blotting:  
Western blots for nNOS, PSD-95 and VDAC were carried out as 
described previously (Brown et al. 2004; Nukala et al. 2006). Briefly, the percoll-
purified mitochondria were diluted to 1ug/ul in isolation buffer without EGTA and 
used for western blots.  Sample buffer was added to the samples based on 
relative protein concentrations and boiled for 10min. Samples (5-20ug each) 
were separated by SDS-PAGE 3-8% Tris-acetate gels (NuPage), along with 
molecular weight markers (Multi-Marker, Invitrogen).  Following SDS-PAGE, 
polypeptides were transferred electrophoretically onto 0.2 µm nitrocellulose 
membranes. Membranes were incubated at room temperature for 1-2 hour in 5% 
non-fat milk in 50 mM Tris-saline containing 0.05% Tween-20 at pH 7.5 (TTBS).  
The blots were incubated overnight in the primary antibody in TTBS at room 
temperature.  The primary antibodies used in study included polyclonal neuronal 
nitric oxide synthase (nNOS) at 1:250 donated by Dr.Tim Miller; monoclonal post-
synaptic density 95 (PSD-95) at 1:20,000 from BD-Transduction; monoclonal 
cytochrome c oxidase subunit IV (COX IV) at 1:20,000 from Molecular Probes 
(Eugene, OR, USA); polyclonal extracellular signal-regulated protein kinase 1/2 
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(Erk-1/2) at 1:1000 and polyclonal voltage-dependent anion channel (VDAC) at 
1:10,000 from Affinity Bioreagents. After overnight incubation in primary antibody, 
the membranes were rinsed three times in TTBS and incubated in secondary 
antibody for 1-2 hours in either HRP-conjugated goat anti-mouse IgG (1:6000) for 
PSD-95, or HRP-conjugated goat anti-rabbit IgG (1:3000) for nNOS and (1:6000) 
for VDAC. The blots were rinsed thoroughly in TTBS and were developed using 
Pierce SuperSignal West Pico chemi-luminescent substrate and analyzed using 
Kodak Image-Station. Alternately, the nNOS and VDAC blots were incubated 
with fluorescent secondary anti-body (Rockland) (goat-α-rabbit, 1:10,000 in 
TTBS) or (1:5000) for Erk1/2 for 2hrs, with agitation, at room temperature. Blots 
were rinsed with TTBS, dried, scanned and quantified using a Licor scanner and 
Odyssey software. 
 
NOS Activity (L-Arginine to L-Citrulline Conversion) Assay:  
Briefly, increasing amounts of percoll-purified intact mitochondria were 
added to each reaction (total volume of 500µl) in duplicates consisting of C14 
cocktail mix (50mM HEPES, 10mM L-Arg, 40mM CaCl2, 50µM CaM, C14 L-Arg) 
in presence of NADPH and BH4 (Bredt et al. 1990; Bredt and Snyder 1990; Miller 
2002). Purified NOS is used as a positive control. The tubes are vortexed and 
flash centrifuged and incubated at room temperature for 15min.The reaction is 
stopped by adding STOP buffer (100mM HEPES; 1mM L-Cit; 10mM EDTA; pH 
5.5) to each reaction. The tubes are vortexed and flash centrifuged and the 
contents are transferred to columns. The columns were washed with 1ml of 
distilled water twice. 10ul of cocktail mix is added to a BLANK vial. Approximately 
8mls of ScintiSafe (Fisher SX25.5) scintillation liquid is added to each vial. The 
vials are read using scintillation counter and activity calculated as percent of 
control (no mitochondria). 
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Fluorescent Spectrometry to Measure Mitochondrial ROS/RNS Generation 
and Membrane Potential:  
Mitochondrial ROS/RNS levels and membrane potential were measured 
using Shimadzu spectrofluorophotometer (RF-5301) as described previously 
(Brown et al. 2006). Mitochondria (100ug) were added to a thermostatically 
controlled (37ºC), constantly stirred cuvette in a total volume of 2mls of 125mM 
KCl buffer, containing 5mM pyruvate and 2.5mM malate, 150 µM ADP, 2 µM of 
oligomycin, 1mM L-Arg, 10µM H2DCF-DA (Ex: 485nm, Em: 530nm), 150nM 
TMRE (Ex: 550nm, Em: 575nm) and 25U/ml HRP. Each run was performed with 
a baseline reading of buffer. Mitochondria, calcium and the substrates/inhibitors 
were added as indicated. The slope of DCF fluorescence was quantified for the 
respective conditions including baseline and expressed in arbitrary units. 
Alternately, mitochondrial ROS production was measured using 10µM 
H2DCF-DA (Ex: 485nm, Em: 530nm) and 25U/ml HRP in the Biotek Synergy HT 
plate reader as previously described (Brown et al. 2006). Isolated mitochondria 
(100ug) were added to 100 µl of 125mM KCl respiration buffer with 5 mM 
pyruvate and 2.5 mM malate as oxidative substrates and incubated at 37ºC. ROS 
production was calculated as the rate of DCF fluorescence over 15-30min of 
incubation, expressed in arbitrary fluorescence units. 
 
Slot-blots for Oxidative Markers:  
Samples used for respiration were centrifuged for 5min @ 10,000g. Buffer 
containing 0.1M PBS and protease inhibitor cocktail (Roche) was added to 
samples, then diluted to 200ng/ml with the protease inhibitor cocktail in 0.1M 
PBS. For oxidative damage determination, the OxyBlot Protein Oxidation 
Detection Kit (Chemicon) was used according to manufacturer’s specifications.  
Samples were loaded at 1ug/well onto the slot blot apparatus and transferred 
onto 0.2µm thick nitrocellulose membrane under vacuum.  The membranes were 
blocked for 2hrs, with agitation, in 1% Casein/PBS at room temperature. Primary 
antibodies were diluted in 0.1% casein/PBST and used as follows - rabbit-α-DNP 
(Chemicon) at 1:1000, mouse-α-3NT (Upstate) at 1:2000, rabbit-α-HNE 
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(Calbiochem) at 1:10,000.  Blots were incubated in primary antibody overnight, 
with agitation, at 4ºC. Blots were rinsed with PBST and incubated Goat-α-Mouse 
(Jackson, for 3-NT) and Goat-α-Rabbit (Upstate; for HNE & DNP) for 2hrs, with 
agitation, at room temperature. Blots were rinsed with PBST, dried, scanned and 
quantified using a Bio-Rad scanner. 
 
Statistical Analysis:  
All results are expressed as means ± SD. For statistical evaluation, One-
way analysis of variance (ANOVA) was used to test for differences involving 
multiple experimental groups or Student’s t test was employed for data analysis 
involving only two groups. When required, Student-Newman-Keuls post-hoc test 
was used for pair-wise comparisons among multiple groups. Significance was set 
at p < 0.05 for all analyses. 
 
Results 
 
Characterization of Mitochondrial Preparations:  
 We initially characterized our mitochondrial isolation and purification 
methodologies by analyzing the ultra-structure of mitochondria and probing for 
mitochondrial markers. The electron-microscopy pictures indicate that the 
preparations predominantly contain mitochondria (Figure 4.1A). Mitochondria 
subjected to the rigorous percoll-purification maintained their structures, including 
intact outer and inner mitochondrial membranes as well as cristae (Figure 4.1B & 
4.1C). Mitochondrial marker proteins (VDAC and COX) were probed by western 
blots in the various fractions obtained during the sequential purification steps 
(Figure 4.2). We observed an enrichment of both outer (VDAC) and inner (COX) 
membrane markers in the percoll purified fraction whereas they are markedly 
lower in the synaptosomal fraction.  
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Calcium and Mitochondrial Respiration:  
To determine if calcium affects mitochondrial function, we measured 
mitochondrial oxygen consumption using a Clark-type electrode and observed a 
significant reduction of mitochondrial respiration (Figure 4.3). The reduction in 
respiratory control ratio (RCR; State III/State IV) was calcium dose-dependent 
(Figure 4.4). We then analyzed each of the substrate/inhibitor induced respiration 
states. We observed that Complex I (pyruvate/malate as substrates) mediated 
respiration was affected by calcium in a dose-dependent manner. We observed 
higher oxygen consumption upon addition of calcium accompanied by a 
reduction in State III respiration (in presence of ADP). However, State IV 
respiration (in presence of Oligomycin- Complex V inhibitor) was not affected. 
There was also a reduction in maximal oxygen consumption upon addition of the 
uncoupler FCCP. There were no changes observed in the presence of Rotenone 
(Complex I inhibitor) or Complex II mediated respiration (succinate as substrate) 
(Figure 4.5). Lastly, we observed an incubation time-dependent effect of calcium 
on the mitochondria in State III, State IV and State V respiration. Interestingly, we 
again did not observe changes in succinate-driven respiration (Figure 4.6). 
 
Mitochondria and NOS Protein:  
To determine whether a nitric oxide Synthase (NOS) isoform was present 
in the mitochondria, we probed for NOS using Western blots. We were able to 
detect NOS protein in percoll-purified intact mitochondrial fraction using an 
antibody directed against neuronal NOS (nNOS), while PSD-95 is present in the 
synaptosomal but absent in the mitochondrial fraction (Figure 4.7). We were able 
to detect increased intensity of NOS protein as a function of the antibody dilution 
(Figure 4.8A). To rule out contamination by cytosolic NOS, we incubated 
mitochondria with 2’,5’-ADP Sepharose beads, which binds to any extra-
mitochondrial NOS, and were able to detect  the protein in the mitochondrial 
fraction (Figure 4.8B). Further, this protein band was detectable even after the 
addition of Proteinase-K, which digests any protein bound to the outer 
mitochondrial membrane, indicating that NOS has an intra-mitochondrial 
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localization (Figure 4.9A). Lastly, Proteinase-K was able to digest Erk1/Erk2 
(cytosolic marker) completely in presence of Triton-X, a detergent used to 
permeabilize membranes (Figure 4.9B).  
 
Mitochondria and NOS Activity:  
Based on the data indicating the presence of NOS protein in the 
mitochondria and to test the involvement of nitric oxide synthase (NOS) in 
calcium-mediated inhibition of mitochondrial respiration, we conducted 
experiments to determine NOS activity in mitochondria. We were able to 
measure enzyme activity of NOS in percoll-purified intact mitochondria, as 
detected by radiolabeled L-Arg to L-Cit conversion assay and observed an 
increase in NOS activity dependent on the amount of mitochondrial protein 
(Figure 4.10). 
 
Calcium and Mitochondrial ROS/RNS Generation:  
 To determine if calcium could induce ROS/RNS generation in the 
mitochondria, we used dihydro-dichlorofluorescin diacetate (H2DCF-DA) to 
measure free radical generation. We observed a significant increase in the DCF 
fluorescence of mitochondria in presence of calcium (200nmol/mg) compared to 
those without calcium (Figure 4.11). To test if mitochondrial NOS might be 
involved in such ROS/RNS increases, in another experiment, we used a NOS 
inhibitor- NG-Nitro-L-arginine methyl ester, hydrochloride (L-NAME) and a 
peroxynitrite scavenger - Tempol in presence of calcium (Figure 4.12). However, 
neither L-NAME nor Tempol decreased the calcium induced ROS/RNS levels. 
 
Calcium and Mitochondrial Oxidative Damage Markers:   
Lastly, to assess the total extent of mitochondrial oxidative damage with 
calcium, we utilized slot-blots to measure changes in markers of protein 
oxidation, lipid peroxidation and protein nitration. We observed no differences 
with calcium in levels of protein carbonyls, 4-hydroxynonenal (HNE) or in the 
levels of 3-nitrotyrosine (3-NT). We observed slight increases in levels of protein 
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carbonyls (Figure 4.13) at lower concentrations compared to higher 
concentrations of calcium. However, with 4-HNE (Figure 4.14) and 3-NT (Figure 
4.15), no differences were observed at any concentrations of calcium used. 
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Figure 4.1: Ultra-structure of mitochondria is maintained after percoll-
purification. Percoll-purified mitochondria were used to analyze their purity and 
ultra-structure using electron microscopy (EM). The top panel (A) is a low-
magnification photograph of freshly isolated cortical mitochondria (Scale: 2cm = 
2µm). The bottom panels (B) and (C) are high-magnification photographs of 
individual mitochondria isolated from the same preparation. Intact outer and inner 
mitochondrial membranes along with maintained cristae can be observed (Scale: 
1cm = 0.1µm). 
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Figure 4.1: Ultra-structure of mitochondria is maintained after  
percoll-purification. 
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Figure 4.2: Outer and inner mitochondrial membrane marker protein levels 
are enriched with percoll-purification. Representative Western blots of 
mitochondrial markers in the various fractions collected during the isolation and 
purification procedure. The fractions were probed by a monoclonal antibody 
against cytochrome c oxidase subunit IV (COX IV or COX) at 1:20,000 and a 
polyclonal antibody against voltage dependent anion channel (VDAC) at 
1:10,000 dilutions. The percoll-purified mitochondrial fractions demonstrate an 
enrichment of VDAC (outer membrane marker) and COX (inner membrane 
marker) protein levels compared to the brain homogenate and the crude 
mitochondrial fractions.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 108
 
Figure 4.2: Outer and inner mitochondrial membrane marker protein levels 
are enriched with percoll-purification. 
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Figure 4.3:  Representative traces of mitochondrial oxygen consumption 
with calcium. Mitochondrial respiration was carried out at 37ºC by incubating 
mitochondria in respiration buffer and oxygen consumption of mitochondria was 
measured in response to addition of various substrates and inhibitors. Baseline 
respiration is termed as State I containing 125mM KCl respiration buffer and 
mitochondria (25-30ug). State II is initiated by addition of 5mM Pyruvate and 
2.5mM Malate as substrates for Complex I of the electron transport chain (ETC). 
Calcium was added to the mitochondria (0-1000nmol/mg) for 1min and State III is 
initiated by activation of ATP Synthase (Complex V) with addition of ADP 
(150µM). State IV occurs when ATP Synthase is inhibited by addition of 
Oligomycin (2µM). FCCP (2µM) induces State V by uncoupling electron transport 
from oxidative phosphorylation. Rotenone (1µM) is added followed by Succinate 
(10mM) to verify electron transport through Complex II. All respiration 
measurements were made in presence of 1mM L-Arg in KCl respiration buffer. 
Calcium inhibited respiration in a dose-dependent manner. 
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Figure 4.3:  Representative traces of mitochondrial oxygen consumption 
with calcium. 
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Figure 4.4:  Calcium decreases mitochondrial respiratory control ratio 
(RCR). Increasing concentrations of calcium were used at the doses indicated 
and the RCR, measured as State III (presence of ADP) over State IV (presence 
of Oligomycin), of mitochondria in presence of calcium was significantly lowered 
compared to the mitochondria with no calcium. No significant differences were 
seen between 100 and 200nmoles/mg. Data represent group means ± SD; n = 3 
per group. One-Way ANOVA; Student-Newman-Keuls post-hoc test; * p < 0.05 
compared to 0nmol/mg Calcium; # p < 0.05 compared to 100nmol/mg. 
 
Measurement DF F – value P – value Power 
RCR 3 19.926 0.0005 1.000 
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Figure 4.4:  Calcium decreases mitochondrial respiratory control ratio 
(RCR). 
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Figure 4.5:  Calcium decreases mitochondrial bioenergetics in a dose-
dependent manner. Increasing doses of calcium were added to the 
mitochondria after the addition of the complex I substrates Pyruvate & Malate.  
An increase in the nmol of oxygen consumed upon addition of calcium is 
observed, which reaches significance at 500nmol/mg. Decreases in 
bioenergetics was observed in State III (ADP) and State V (FCCP) as well. 
However, calcium did not affect the complex II (Succinate) driven respiration. 
Data represent group means ± SD; n = 3 per group. One-Way ANOVA; Student-
Newman-Keuls post-hoc test; * p < 0.05 compared to 0nmol/mg Calcium; # p < 
0.05 compared to 100nmol/mg Calcium; @ p < 0.05 compared to 200nmol/mg. 
 
Measurement DF F – value P – value Power 
Pyr/Mal 3 0.189 0.9009 0.072 
Calcium 3 28.811 0.0001 1.000 
ADP 1 3 8.318 0.0077 0.920 
ADP 2 3 4.148 0.0478 0.632 
Oligo 3 0.641 0.6100 0.131 
FCCP 3 1.523 0.2815 0.261 
Rot 3 0.647 0.6064 0.132 
Succ 3 0.253 0.8568 0.080 
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Figure 4.5:  Calcium decreases mitochondrial bioenergetics in a  
dose-dependent manner. 
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Figure 4.6:  Calcium decreases mitochondrial bioenergetics in a time-
dependent manner. Mitochondria were incubated with calcium after the addition 
of the complex I substrates (pyruvate & malate) for increasing amounts of time.  
An increase in the nmol of oxygen consumed upon addition of calcium was 
observed while State III (ADP) driven respiration was inhibited with longer 
incubations with calcium. When a higher concentration of calcium was added, the 
inhibitory effect was more pronounced. However, as seen previously in Figure 
4.3, calcium did not affect the complex II (Succinate) driven oxygen consumption. 
n = 2 per group. 
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Figure 4.6:  Calcium decreases mitochondrial bioenergetics in a 
time-dependent manner. 
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Figure 4.7: NOS protein detected in brain mitochondria. Representative 
Western blots indicating the purity of mitochondrial preparation. A polyclonal 
antibody (1:250) against neuronal NOS (nNOS) shows immunoreactivity in the 
percoll-purified mitochondrial fraction suggesting its presence in brain 
mitochondria. Post-snyaptic density 95 (PSD-95), probed by a monoclonal 
antibody (1:20,000), is present in the synaptosomal fraction but absent from the 
enriched mitochondrial fraction indicating that the mitochondrial preparation is 
relatively pure. 
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Figure 4.7: NOS protein detected in brain mitochondria. 
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Figure 4.8: NOS protein is not an extra-mitochondrial contamination.  
A) Representative Western blots showing that an intense ~155kD band was 
detected in percoll-purified mitochondria (5 or 10ug protein) with decreasing 
dilutions of a polyclonal antibody against neuronal NOS (nNOS). B) Percoll-
purified mitochondria (1mg/ml; 50-100ug) were subjected to affinity purification 
by incubating them without (Total) or with 2’,5’-ADP Sepharose beads (50ug) 
overnight with rocking at 4ºC to remove possible contamination by extra-
mitochondrial NOS. They were then probed with antibodies against neuronal 
NOS (nNOS; 1:250) and voltage-dependent anion channel (VDAC; 1:10,000) 
using Western blots. Representative blots indicate the presence of NOS in the 
mitochondria treated with beads suggesting that NOS detected in the 
mitochondrial fraction is not an extra-mitochondrial contamination. Enrichment of 
(VDAC) indicates that the effect of the beads is specific to proteins requiring 
NADPH as a cofactor. 
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Figure 4.8: NOS protein is not an extra-mitochondrial contamination. 
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Figure 4.9: NOS protein is present in an intra-mitochondrial location.  
A) Percoll-purified mitochondria (1mg/mg; 100ug) were incubated for 30min at 
4ºC or 25ºC in absence or presence of a protease- Proteinase-K (50ug/ml) that 
can digest proteins not protected by membranes. The reaction was stopped by 
phenylmethylsulfonyl fluoride (PMSF; 1-2mM final) incubated for 10 min at 4°C or 
25°C. The samples were centrifuged at 10,000 x g for 10 min and the pellets and 
supernatants were collected and processed for Western blots. Antibody against 
neuronal NOS (nNOS) at 1:250 shows that nNOS was retained in the 
mitochondrial pellet fraction upon treatment with Proteinase-K, suggesting that it 
is present inside the mitochondria. Antibody against voltage-dependent anion 
channel (VDAC) at 1:10,000 indicates that VDAC was unaffected showing that it 
is protected by mitochondrial membranes and therefore resistant to degradation. 
Finally the effect of Proteinase-K degradation was not affected by the 
temperature of incubation (4°C or 25°C). B) Brain homogenates were incubated 
with Proteinase-K and/or a detergent- Triton-X (0.1%) and the reactions were 
carried out for 30min at 37°C. The samples were then probed using Western 
blots for Erk1/Erk2 (a cytosolic marker protein) using a polyclonal antibody at 
1:1000. Representative blot shows that extracellular signal-regulated protein 
kinase 1/2 (Erk1/Erk2) was degraded partially in presence of Proteinase-K 
(200ug/ml) or Triton-X (0.1%) as it is not protected by membranes and 
completely degraded when both Proteinase-K and Triton-X (0.1%) were added.  
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Figure 4.9: NOS protein is present in an intra-mitochondrial location. 
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Figure 4.10: NOS activity detected in brain mitochondria. Varying amounts of 
percoll-purified mitochondria (0-200ug) were incubated for 15min at 25ºC in 
presence of NOS substrates (radio-labeled L-Arginine), cofactors (NADPH, CaM 
and BH4) and activator- calcium (100µM). The reaction was stopped by adding 
excess of L-Citrulline and NOS activity was measured by the increase in radio-
labeled Citrulline (dpm/min) produced compared to percent control (no 
mitochondria). Insert indicates a bar graph of NOS activity measured as 
nmol/min/mg of mitochondrial protein. Data represent group means ± SD; n = 4 
per group; Student’s t-test. 
 
Measurement DF t – value P – value 
NOS Activity 6 - 2.199 0.0702 
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Figure 4.10: NOS activity detected in brain mitochondria. 
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Figure 4.11: Calcium increased mitochondrial ROS/RNS levels. Mitochondria 
(1mg/ml; 100ug) were incubated in 125mM KCl respiration buffer for 15min at 
37ºC in presence of pyruvate and malate and 10µM H2DCF-DA (Ex: 485nm, Em: 
530nm). ROS production was calculated as the rate of DCF fluorescence 
expressed in arbitrary fluorescence units. A significant increase in the DCF 
fluorescence was observed in mitochondria treated with calcium (200nmol/mg) 
compared to those without calcium. Data represent group means ± SD; n = 4 per 
group; Student’s t-test; * p < 0.05 compared to 0nmol/mg Calcium at 15min. 
 
Measurement DF t – value P – value 
DCF Fluorescence 6 - 3.112 0.0208 
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Figure 4.11: Calcium increased mitochondrial ROS/RNS levels. 
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Figure 4.12: Tempol or L-NAME did not decrease calcium induced 
ROS/RNS levels. Mitochondria (1mg/ml; 100ug) were incubated in 125mM KCl 
respiration buffer for 30min at 37ºC in presence of pyruvate and malate and 
10µM H2DCF-DA (Ex: 485nm, Em: 530nm). ROS production was calculated as 
the percent increase in rate of DCF fluorescence compared to mitochondria with 
no calcium and expressed in arbitrary fluorescence units. Calcium (200nmol/mg) 
significantly increased ROS/RNS generation compared to mitochondria with no 
calcium. 100µM NG-Nitro-L-arginine methyl ester, hydrochloride (L-NAME), a 
NOS inhibitor or 5µM Tempol (a peroxynitrite scavenger) did not decrease 
ROS/RNS levels in mitochondria treated with calcium. Data represent group 
means ± SD; n = 5 per group; One-Way ANOVA; Student-Newman-Keuls post-
hoc test; * p < 0.05 compared to 0nmol/mg Calcium. 
 
Measurement DF F – value P – value Power 
DCF Fluorescence 3 8.606 0.0012 0.98 
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Figure 4.12: Tempol or L-NAME did not decrease calcium induced 
ROS/RNS levels. 
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Figure 4.13: Calcium did not alter levels of protein carbonyls. Aliquots of 
mitochondrial samples (200ng/ml) used for respiration studies were collected and 
assessed for protein oxidation with an OxyBlot Protein Oxidation Detection Kit 
using Slot-blots. Levels of protein carbonyls were measured by a polyclonal 
antibody against the DNP moieties (1:1000) of oxidized proteins and expressed 
as percent increase compared to their levels in mitochondria without calcium. 
Protein carbonyls increased at lower concentrations of calcium (100nmol/mg) 
than at higher concentrations (200 and 500nmol/mg). However, these changes 
were not statistically significant compared to control (no calcium). Data represent 
group means ± SD; n = 3 per group; One-Way ANOVA. 
 
Measurement DF F – value P – value Power 
Protein Carbonyls 3 1.610 0.2621 0.275 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 130
 
Figure 4.13: Calcium did not alter levels of protein carbonyls. 
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Figure 4.14: Calcium did not alter levels of 4-hydroxynonenal (4-HNE). 
Aliquots of mitochondrial samples (200ng/ml) used for respiration studies were 
collected and assessed for lipid peroxidation using Slot-blots. Levels of 4-
hydroxynonenal (4-HNE) were measured by a polyclonal antibody against 4-HNE 
(1:10,000) and expressed as percent increase compared to their levels in 
mitochondria without calcium. No changes in the levels of 4-HNE were observed 
with any of the calcium concentrations used. Data represent group means ± SD; 
n = 3 per group; One-Way ANOVA. 
 
Measurement DF F – value P – value Power 
4-Hydroxynonenal 3 2.048 0.1857 0.342 
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Figure 4.14: Calcium did not alter levels of 4-hydroxynonenal (4-HNE). 
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Figure 4.15: Calcium did not alter levels of 3-nitrotyrosine (3-NT). Aliquots of 
mitochondrial samples (200ng/ml) used for respiration studies were collected and 
assessed for protein nitration using Slot-blots. Levels of 3-nitrotyrosine (3-NT) 
were measured by a monoclonal antibody against 3-NT (1:2,000) and expressed 
as percent increase compared to their levels in mitochondria without calcium. 
Levels of 3-NT did not change at any concentrations of calcium. Data represent 
group means ± SD; n = 3 per group; One-Way ANOVA. 
 
Measurement DF F – value P – value Power 
3-Nitrotyrosine 3 0.051 0.9835 0.056 
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Figure 4.15: Calcium did not alter levels of 3-nitrotyrosine (3-NT). 
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Discussion 
  
Our studies demonstrate that calcium inhibits mitochondrial respiration, 
and increases free radical generation. We also confirm the presence of an active 
NOS enzyme in the mitochondria, raising the possibility of its involvement in 
mitochondrial dysfunction. However, we could not improve mitochondrial 
bioenergetics or decrease ROS/RNS levels with NOS inhibitors or peroxynitrite 
scavengers. Moreover, while we did observe increases in levels of protein 
carbonyls (indicator of protein oxidation) and 4-Hydroxynonenal (4-HNE; 
indicator of lipid peroxidation) we did not observe any changes in the levels of 3-
Nitrotyrosine (3-NT; indicator of protein nitration) in presence of calcium. All 
these results suggest that though there is an active NOS in the mitochondria, it 
may not be entirely responsible for the calcium induced mitochondrial 
dysfunction. 
Mitochondria isolated from the brain are most often contaminated by 
synaptosomes, formed by the pinched off pre- and post-synaptic ends of 
neurons, that can alter and complicate the interpretation of results obtained from 
such mitochondria (Anderson and Sims 2000). Therefore, we employed a 
method to release the synaptic mitochondria with nitrogen disruption which would 
increase the total yield of mitochondria (Brown et al. 2004), avoiding the adverse 
effects of digitonin (Brustovetsky et al. 2002). We further purified the total 
mitochondria (synaptic and non-synaptic) by percoll discontinuous gradient 
centrifugation. We checked for the purity of those mitochondrial preparations by 
electron microscopy and found them to have mostly mitochondria with preserved 
structures including intact cristae that lodge the ETC necessary for oxidative 
phosphorylation (Figure 4.1). Moreover, mitochondrial marker proteins such as 
VDAC for outer and COX for inner mitochondrial membranes are enriched in the 
mitochondrial fraction with the sequential purification steps (Figure 4.2) while 
minimizing contamination. Furthermore, we used only fresh mitochondria for the 
studies described in this chapter, as cryopreserved mitochondria exhibit 
decreases in mitochondrial bioenergetics (Nukala et al. 2006). 
 136
 
Calcium (Ca2+) is taken up by the mitochondria through a uniporter, when 
the cytoplasmic Ca2+ reaches around 1µM (Chalmers and Nicholls 2003; Nicholls 
2005). Calicum is shown to regulate the citric acid cycle (TCA or Kreb’s cycle) by 
activating pyruvate dehydrogenase (PDHC), NAD+-dependent isocitrate 
dehydrogenase and α-ketoglutarate dehydrogenase complex (KGDHC) resulting 
in increases of NADH levels (Denton et al. 1988; Wan et al. 1989) as well as ATP 
production by activating ATP synthase (Territo et al. 2000). These reactions 
occur in the 0.1 to 1µM concentration range with fast kinetics on the order of milli-
seconds and provide for a physiological relevance to calcium inside the 
mitochondria. At higher concentrations, calcium could inhibit respiration, cause 
mitochondria to undergo MPT and release cytochrome c ultimately leading to cell 
death (Gunter et al. 2004; Nicholls and Chalmers 2004; Jemmerson et al. 2005). 
In our studies, we added patho-physiological doses (100 - 500nmol/mg 
amounting to 10 - 50µM) of calcium to isolated mitochondria and examined its 
effects on Complex I driven mitochondrial respiration in presence of L-Arg. We 
observed that calcium induced mitochondrial dysfunction and the severity was 
dose-dependent (Figure 4.3), similar to previous reports (Brustovetsky et al. 
2003; Zhou et al. 2005). Of interest is the fact that mitochondria subjected to 
density gradient centrifugation are more sensitive to Ca2+ effects than unpurified 
CNS mitochondria (Brustovetsky and Dubinsky 2000). We observed significant 
decreases in RCR (Figure 4.4) as well as decreases in individual states, most 
noticeably in State III (coupled respiration in presence of ADP) and to a lesser 
extent in State V (maximal respiration in presence of FCCP) (Figure 4.5).  
Though the oxygen consumption increased initially upon addition of 
calcium and returned to State II respiration rates, the response to ADP was 
markedly affected, and this could be due to the transient depolarizing effect seen 
with calcium (Figure 4.5). In one study, mitochondria exposed to a low Ca2+ 
concentration (4µM) resulted in a VDAC-mediated reversible cytochrome c 
release, whereas at a higher Ca2+ concentration (100µM), there was 
mitochondrial inhibition due to MPT induced irreversible cytochrome c release 
(Schild et al. 2001). No changes could be observed in Complex II (succinate as 
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the substrate) driven oxygen consumption indicating that the inhibition of 
mitochondrial respiration might be occurring at Complex I or upstream in the 
Kreb’s cycle. Dubinsky’s group, upon addition of calcium, has shown that 
cytochrome c released was accompanied by MPT and rupture of outer 
mitochondrial membrane. However, the decline in mitochondrial respiration was 
attributed to inhibition of Complex I rather than loss of cytochrome c 
(Brustovetsky et al. 2002), supporting our data. Further, the inhibition of 
mitochondrial respiration was exacerbated with longer exposures to calcium 
(Figure 4.6), consistent with a previous study (Territo et al. 2000). This suggests 
that deleterious effects of calcium are induced immediately and sustained over 
time. However, it is not entirely clear how calcium inhibits mitochondrial 
respiration and causes release of cytochrome c leaving room for the possibility of 
a mitochondrial NOS-mediated pathway (Lores-Arnaiz et al. 2004; Boveris et al. 
2006). In fact, an involvement of NOS for the effects of calcium on mitochondrial 
respiration was shown in liver (Ghafourifar and Richter 1997; Giulivi 1998; 
Traaseth et al. 2004; Schild and Reiser 2005), heart (Jekabsone et al. 2003; 
Saavedra-Molina et al. 2003) and kidney (Boveris et al. 2006). 
Therefore, in subsequent experiments we used two different NOS 
inhibitors to assess if they can reverse the inhibition of mitochondrial respiration 
induced by calcium (not shown). NG-nitro-L-arginine (L-NNA) and its NG-Nitro-L-
arginine methyl ester, hydrochloride (L-NAME) are both L-Arginine analogues. L-
NNA potently inhibits nNOS by binding tightly but non-covalently while L-NAME 
is less specific being the precursor to L-NNA (Bryk and Wolff 1999). However, we 
did not observe increases in State III respiration of mitochondria pre-incubated 
(2-5min) with various concentrations of L-NNA or L-NAME with calcium (not 
shown), similar to other studies in liver (Tay et al. 2004), heart (French et al. 
2001) or brain (Schild et al. 2001) mitochondria. This could be due to the fact that 
L-Arg was present throughout the reaction and could possibly be competing with 
the inhibitor thereby rendering the inhibitors inefficient. We also omitted L-Arg 
when the inhibitors were added and it did not change the outcome, raising the 
possibility of the inhibitors not being sufficiently specific. Moreover, at higher 
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concentrations, each of the inhibitors had a toxic affect on mitochondrial 
bioenergetics. In another experiment, 5µM tempol, a scavenger of peroxynitrite 
decomposition products and acting in a catalytic manner (Carroll et al. 2000), 
was added to the mitochondria with calcium and tempol was unable to prevent 
the inhibition of mitochondrial respiration (not shown). These data suggest that 
the concentrations and kinetics of calcium may have an overwhelming effect on 
mitochondrial respiration and/or may not directly involve mtNOS. It could also be 
due to the differences in mitochondria from brain and other tissues from rat and 
other species, mitochondrial isolation and purification procedures, buffer systems 
and substrates and inhibitors used. Alternately, NO• or its derivatives observed 
might diffuse into the mitochondria and lastly, a NOS-independent pathway for 
generation of NO• (Zweier et al. 1999) might exist in the mitochondria. 
One of the first reports for the existence of mtNOS enzyme in liver and in 
brain non-synaptosomal mitochondria surfaced in 1995 and indicated that it is 
similar to the eNOS isoform present bound to the inner mitochondrial membrane 
facing the matrix (Bates et al. 1995). Since then, it was suggested the isoform in 
liver mitochondria being similar to iNOS (Tatoyan and Giulivi 1998) while other 
groups have followed up showing mitochondrial isoform to be iNOS in lung 
mitochondria (Escames et al. 2003), eNOS (Lacza et al. 2001) and a nNOS 
variant (Riobo et al. 2002; Lores-Arnaiz et al. 2004) in brain mitochondria. No 
specific gene for mtNOS has been reported thus far and the targeting of mtNOS 
could involve phosphorylation or a yet undiscovered mitochondrial localization 
signal (Brookes 2004). Based on substrate-, cofactor- and activator-requirements 
and availability, it is more plausible that the NOS isoform inside the mitochondria 
is constitutive similar to eNOS or nNOS rather than the inducible NOS. 
Therefore, to confirm the presence of NOS protein we used a polyclonal 
antibody against nNOS. PSD-95, a synaptosomal marker and present in the 
synaptosomal fraction, was absent in the mitochondrial fraction (Figure 4.7). We 
were able to detect NOS protein in the percoll-purified mitochondrial fraction and 
the intensity of the band was dependent on the antibody dilution (Figure 4.7 & 
4.8A). However, the possibility of contamination of mitochondria by cytosolic 
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NOS still exists (Brookes 2004). To check for such contamination, we obtained 
percoll-purified mitochondria and subjected them to further affinity purification 
(Lacza et al. 2003). We treated them with NADPH (NOS cofactor) immobilized to 
2’,5’-ADP Sepharose beads, that will bind to any NADPH requiring enzyme 
bound to the outer membrane, and were still able to detect NOS (Figure 4.8B). 
The NOS band intensity was lower compared to untreated mitochondria while 
VDAC showed a much intense band, leaving a possibility for contamination. 
Therefore, we treated percoll-purified mitochondria with a protease (Proteinase-
K), that will selectively digest proteins not protected by mitochondrial membranes 
(Gao et al. 2004). Indeed, we used Proteinase-K with Erk-1/Erk-2, a cytosolic 
marker, and it was degraded by Proteinase-K and completely digested in 
presence of Triton-X (Figure 4.9B). We noticed NOS protein in Proteinase-K 
treated mitochondria. VDAC, an outer mitochondrial membrane marker, 
remained intact (Figure 4.9A) indicating that the Proteinase-K did not affect 
mitochondrial integrity.  
Giulivi’s group published a contradictory report where they purified and 
characterized a protein from liver mitochondria and showed the isoform to be 
nNOSα-like with two post-translational modifications – acylation by myristic acid 
at the N-terminus and a phosphorylation site (Elfering et al. 2002) but do not see 
similar results in the heart mitochondria (French et al. 2001). Similarly, Busija’s 
group, in a comprehensive study, question the validity of their previous claim by 
showing that mtNOS is not eNOS, nNOS or iNOS in liver (Lacza et al. 2003) or 
heart mitochondria (Csordas et al. 2007). In lieu of the divergent and confounding 
reports and due to non-availability of antibodies specific against mtNOS (Brookes 
2004), although our data indicates a nNOS isoform present in the brain 
mitochondria, it does not rule out the presence of an eNOS or iNOS isoform in 
the mitochondria at this time. 
Various groups have shown an active NOS in liver (Ghafourifar and 
Richter 1997; Tatoyan and Giulivi 1998; Giulivi 2003), lung (Escames et al. 
2003), heart (Kanai et al. 2001), kidney (Boveris et al. 2003), muscle (Boveris et 
al. 2002) and brain mitochondria (Lacza et al. 2001; Riobo et al. 2002; Lores-
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Arnaiz et al. 2004) while it is disputed by other groups (French et al. 2001; Lacza 
et al. 2003; Csordas et al. 2007). We tested if the mitochondrial nNOS detected 
in our brain mitochondrial preparations is physiologically relevant by measuring 
its activity in percoll-purified mitochondria. All the studies reporting NOS activity 
indicate that it shows Ca2+-dependent activity and therefore we carried out all our 
NOS activity measurements in presence of 100µM calcium (Miller 2002). Our 
data shows that there is measurable nitric oxide (NO•) production (12.6 ± 0.67 
nmol/min/mg) that increased with varying amounts of mitochondrial protein 
(Figure 4.10), suggesting the presence of a physiologically relevant NOS enzyme 
in brain mitochondria. The levels we detected were much higher than other 
reports obtained from brain mitochondria (Lacza et al. 2001; Riobo et al. 2002; 
Lores-Arnaiz et al. 2004). One of the reasons for this difference could be the 
reaction incubation times, where a longer incubation could result in a feedback 
inhibition of the enzyme by the NO• produced (Alderton et al. 2001). Secondly, 
the concentrations of Ca2+ and L-Arg and cofactors could alter the amount of NO 
generated and could explain the lack of effect of a nNOS antibody we used in 
another experiment. We used varying dilutions of the antibody (Riobo et al. 
2002), which was used to probe for NOS protein, to inhibit the enzymatic activity 
but did not see any decreases in NO• production (not shown). 
Mitochondria are the major sources of free radicals inside the cell formed 
by the leakage of electrons from various sources of the ETC (Turrens 2003) and 
calcium is shown to influence ROS/RNS generation in mitochondria by 
processes not completely understood (Camello-Almaraz et al. 2006). This is 
evident by the divergent reports on calcium increasing (Brustovetsky et al. 2003; 
Sousa et al. 2003), decreasing (Starkov et al. 2002; Gyulkhandanyan and 
Pennefather 2004), or causing no changes (Votyakova and Reynolds 2001; 
Votyakova and Reynolds 2005; Tretter and Adam-Vizi 2006) in the ROS/RNS 
levels of brain mitochondria. In general, from the above reports, succinate usually 
in presence of ETC inhibitors tends to produce higher levels of ROS/RNS with 
calcium compared to pyruvate/malate/glutamate as substrates.   
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We examined if calcium (200nmol/mg) induces or increases ROS/RNS 
generation within mitochondria that might be responsible for the inhibition of 
mitochondrial respiration. We did observe a significant increase in ROS/RNS 
levels with calcium (Figure 4.11) in presence of pyruvate/malate as substrates. 
Furthermore, the ROS/RNS levels increased over time in both groups. In another 
experimental protocol, we observed decreases in ROS/RNS levels with calcium 
accompanied by partial loss of membrane potential (Appendix 1A and 1B), 
supporting previous reports (Vergun and Reynolds 2005). This data is similar to 
the transient depolarizing effect on mitochondria seen with higher doses of 
calcium in our respiration studies. Our lab has previously shown that non-
synaptic mitochondria are able to buffer more calcium than synaptic mitochondria 
before losing the membrane potential (∆ψ) and undergoing swelling but do not 
exhibit differences in ROS/RNS levels (Brown et al. 2006). Those mitochondria 
were able to sequester higher amounts of calcium compared to the doses we 
used in the current set of experiments. One important difference is the use of 
total mitochondria and the absence of ADP before the calcium challenge, 
especially since the presence of ADP retains mitochondrial membrane potential 
(∆ψ) and prevents MPT (Andreyev et al. 1998). Second, the continuous infusion 
method of calcium was used previously whereas bolus additions were used in all 
the experiments described in this chapter. Finally, we noticed that the opposite 
effects of calcium are in fact due to the ‘effective’ protein and calcium 
concentrations in the reaction buffers. To observe increases in ROS/RNS levels, 
the reactions should be carried out at higher concentrations of both the 
mitochondrial protein and calcium (Figure 4.11) while a reverse effect is seen 
with lower concentrations (Appendix 1.A & 1.B). The results from our 
experiments bring forth an important finding that could explain the discrepancies, 
about calcium effects on ROS/RNS levels, observed with the previously 
published literature. 
It is well established that NO• at nanomolar concentrations competes with 
oxygen and reversibly inhibits cytochrome c oxidase (COX), acting as a 
physiological regulator of mitochondrial respiration (Brown 2001; Brookes et al. 
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2002; Moncada and Erusalimsky 2002; Babior 2004). The source of NO• was 
shown to be endogenous to the mitochondria (Giulivi et al. 1998) leading to 
decreases in ATP generation (Giulivi 1998) and increases in ROS/RNS levels 
(Sarkela et al. 2001), possibly due to a physical interaction between 
mitochondrial NOS (mtNOS) and COX (Persichini et al. 2005). However, 
prolonged exposure of COX to higher levels of NO• results in its irreversible 
inhibition caused by peroxynitrite (ONOO-) (Brown and Borutaite 2002; Radi et al. 
2002). Although, NO• can directly react with superoxide (O2•-) to form ONOO-, 
NO• can react with ubiquinol (QH2), the reduced form of ubiquinone (Q), to yield 
NO- and ubisemiquinone (QH•) radical. NO- can then react with molecular 
oxygen (O2) to form ONOO- (Poderoso et al. 1999). Both NO• and ONOO- are 
capable of diffusing across membranes and therefore into mitochondria (Radi et 
al. 2002). One study showed the production of ONOO- following Ca2+ uptake and 
activation of mtNOS and resulted in efflux of calcium from the mitochondria 
(Bringold et al. 2000). Calcium is also shown to result in release of cytochrome c 
(Andreyev and Fiskum 1999; Petrosillo et al. 2004) mediated through 
peroxynitrite (Borutaite et al. 1999; Ghafourifar et al. 1999) but independent of 
membrane permeability transition in brain mitochondria (Andreyev et al. 1998). 
Based on those observations and our own data showing the presence of 
an active NOS enzyme in brain mitochondria, it raises the possibility of the 
involvement of ONOO- in calcium-induced free radical generation. Therefore we 
used L-NAME and tempol to test if they would decrease the higher ROS/RNS 
levels observed with calcium. We observed significant increases in ROS/RNS as 
seen previously in all the groups tested compared to mitochondria without 
calcium (Figure 4.12). Although tempol slightly decreased ROS/RNS levels 
compared to mitochondria treated with calcium it was not significant, similar to a 
previous study (Lacza et al. 2006). This is in contrast a previous report, where 
calcium increased ROS/RNS levels and decreased in presence of tempol (Schild 
and Reiser 2005). However, it was not verified if the high dose of tempol (10mM) 
rescued mitochondrial respiration and the effect of tempol could have been due 
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to its toxic effects on the mitochondria. This brings into question the role of nitric 
oxide (NO•) and peroxynitrite in calcium induced free radical generation in the 
mitochondria. Another plausible reason is that dichloro fluorescein (DCF) 
measures a range of ROS/RNS including H2O2 and ONOO- which makes it 
difficult to interpret the results. Moreover it is also susceptible to photo auto-
oxidation (Possel et al. 1997; Ischiropoulos et al. 1999; Radi et al. 2001; Thomas 
et al. 2002). 
Finally, we tested if the increases in ROS/RNS levels observed with 
calcium translates into oxidative damage in the mitochondria. We therefore 
measured the levels of protein carbonyls (an indicator of protein oxidation), 4-
hydroxynonenal (4-HNE; indicator of lipid peroxidation). We observed differences 
in protein carbonyls (Figure 4.13) and 4-HNE (Figure 4.14) at lower 
concentrations of calcium but they were not significant. Moreover, a wide variety 
of nitrated proteins have been found in the mitochondria indicating involvement of 
peroxynitrite (Riobo et al. 2001; Elfering et al. 2004) and we therefore measured 
the levels of 3-nitrotyrosine (3-NT; indicator for protein nitration). However, we 
did not observe any changes in levels of 3-NT at any of the calcium doses tested 
(Figure 4.15). An absence of measurable or significant changes in oxidative 
damage markers does not necessarily mean the lack of RNS involvement. The 
methodology used measures the extent of total oxidative damage and not the 
individual modified proteins (Kohen and Nyska 2002; Tarpey et al. 2004). In fact, 
oxidative damage to certain key mitochondrial proteins including those involved 
in Kreb’s cycle or Electron Transport Chain (ETC) has been observed. While 
Complexes I and II of ETC, creatine kinase are oxidatively inactivated by 
peroxynitrite, ATP synthase, aconitase, VDAC and Mn-SOD are inactivated by 
nitration of tyrosine residues through the peroxynitrite decomposition products 
(Radi et al. 2002). The inactivation or inhibition of these proteins might be 
sufficient to inhibit mitochondrial respiration (ex: ATP Synthase) or amplify the 
free radical generation (ex: Mn-SOD) and thereby contribute to mitochondrial 
dysfunction ultimately resulting in cell death. 
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Based on the collective evidence, although the brain mitochondria contain 
a nNOS-like functional enzyme it may not play a major role in calcium mediated 
dysfunction in brain mitochondria. This is based on the lack of effect of NOS 
inhibitors and/or peroxynitrite scavengers on calcium induced a) inhibition of 
mitochondrial respiration and b) increases in ROS/RNS levels. Moreover, no 
alterations were detected in levels of markers for oxidative damage. The short 
exposure time (less than 30min) of mitochondria to calcium might be insufficient 
to elicit detectable changes in ROS/RNS levels and/or oxidative damage 
markers.  
Mitochondrial dysfunction, as measured by mitochondrial respiration, 
ROS/RNS levels and oxidative damage markers, is more prominent in 
pathologies following traumatic injuries, stroke and neurodegenerative conditions 
such as Alzheimer’s disease (AD). This implies that calcium induced 
mitochondrial dysfunction may be only one of the many mechanisms responsible 
for the global cellular oxidative stress. One such mechanism is the cytosolic 
calcium induced activation of phospholipase A2 (PLA2) that mediates the rapid 
release of arachidonic acid (AA) and lysophospholipids.  Some of the AA is 
converted to pro-inflammatory mediators such as prostaglandins, leukotrienes 
and thromboxanes, collectively known as eicosanoids. Arachidonic acid (AA) 
cascade can lead to generation of free radicals resulting in lipid peroxidation 
thereby altering plasma membrane as well as mitochondrial membrane 
composition, fluidity and permeability. The mitochondrial proteins can be oxidized 
from such cytosolic sources of free radicals and nitrated by cytosolic NOS 
mediated NO• and ONOO- generation. Lastly, calcium activated cytosolic 
calpains can also degrade mitochondrial proteins thereby causing mitochondrial 
dysfunction. 
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Chapter Five 
 
Summary and Future Directions 
 
Nature has equipped its various life forms with programmed development 
filled with redundancies to ensure survival and growth. There are however other 
stochastic events occurring in nature that modulate an organism’s adaptability 
and thereby determine its lifespan. Free radicals are one such entity that when 
left unchecked can cause oxidative stress and reversible or irreversible damage 
to the organism. Oxidative stress at the cellular level has been implicated to have 
a causal role in the gradual deterioration of tissue and organ function observed 
with aging and age-related neurodegeneration (reviewed in Chapter One). 
Typically, freshly isolated mitochondria are preferred for the study of their 
structure and function because such mitochondria are structurally intact as well 
as tightly coupled that is necessary for their respiratory function. However, in 
cases of a large sample size or valuable post-mortem samples or those requiring 
transport of samples, mitochondria isolated out of their cellular milieu undergo 
significant deterioration in their structure and function. This prevents conducting 
studies on mitochondrial bioenergetics thus limiting their usage. To overcome 
this obstacle, we optimized a method utilizing a well-characterized cryoprotectant 
such as dimethyl sulfoxide (DMSO).  
Freshly isolated mitochondria were cryopreserved in the presence of 
DMSO and stored for the intended duration (upto 6 months). Such cryopreserved 
mitochondria show similar structure and function compared to freshly isolated 
mitochondria as observed by the ultra-structure, mitochondrial marker (COX and 
VDAC) levels and mitochondrial respiration. There was a partial decrease in 
mitochondrial bioenergetics that could be attributed to the loss of cytochrome c 
from cryopreserved mitochondria. They however were functionally viable 
compared to mitochondria frozen in the absence of DMSO. We also observed 
that mitochondria can be cryopreserved in their crude or purified form. This 
makes it feasible to considerably expand the time-frame and the range of 
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biochemical, molecular and metabolic studies that can performed without the 
constraints of mitochondrial longevity ex vivo (Contents of Chapter 2). 
Alzheimer’s disease (AD) is one of the most prevalent neurodegenerative 
conditions in aged people resulting in a progressive deterioration of cognition and 
memory. While anatomic and metabolic deficiencies were observed with AD, the 
underlying mechanisms are yet unclear. Oxidative stress at the level of 
mitochondria and their dysfunction is one of the mechanisms gaining credibility. 
However, such studies are limited by the availability of suitable post-mortem 
brain tissues. We established a collaborative study with the Alzheimer’s Disease 
Research Center (ADRC) Rapid Autopsy Unit of the Sander’s Brown Center on 
Aging at University of Kentucky (Contents of Chapter 3). 
We successfully employed the cryopreservation method to store 
mitochondria from post-mortem brains of AD and control subjects that were 
longitudinally assessed for neuropsychological symptoms. Synaptic and non-
synaptic mitochondria were isolated from the middle-temporal (MT), frontal (F) 
and sensory (S) regions. The synaptic mitochondria from AD patients showed 
decreased respiration measured by their respiratory control ratio (RCR) and 
maximal complex I-driven respiration compared to control mitochondria in all the 
regions measured. We did not observe any changes in ROS/RNS levels. 
However, we observed higher oxidative damage (measured by protein carbonyls) 
in all the regions of AD compared to control subjects. Moreover, non-synaptic 
mitochondria had higher protein carbonyl content compared to synaptic 
mitochondria in each of the regions assessed. These data do indicate a role for 
mitochondrial oxidative stress and dysfunction. 
Mitochondria, owing to their origin, structure and function, occupy a unique 
and intriguing position in the cell. They primarily provide the energy critical for 
metabolism, apart from calcium buffering and other vital functions. The price 
mitochondria pay for their semi-autonomous existence is oxidative stress. This 
led to a newer and significant role being ascribed to mitochondria- their 
involvement in cell death. Though mitochondria are established as a major 
source of oxidative stress inside the cell, the underlying mechanisms require 
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further elucidation. This dissertation attempts to offer a mechanistic explanation 
to the sources and the interplay of free radicals and calcium in mitochondrial 
dysfunction (Contents of Chapter Four). 
One of the mechanisms postulated is the presence of a new isoform of 
nitric oxide synthase (mtNOS) that has been isolated and localized to 
mitochondria; though its existence and physiological role is debated. NOS, when 
activated by calcium, produces nitric oxide (NO•) which normally acts as a 
second messenger molecule in diverse cellular processes such as vasodilation 
and neurotransmission. NO• can also interact with ROS producing various 
reactive nitrogen species (RNS) such as nitrite, nitrogen dioxide radicals and 
peroxynitrite (ONOO-). These highly reactive radical species can damage DNA, 
proteins and lipids. This ultimately results in cell death via apoptosis or necrosis.  
We investigated if a) calcium causes oxidative damage and mitochondrial 
dysfunction and b) if mitochondrial function can be rescued. We generated dose- 
and time-response curves for the effect of calcium on mitochondrial 
bioenergetics. We observed a significant reduction in mitochondrial respiratory 
control ratio (RCR) and rate of oxygen consumption of brain mitochondria in a 
dose- and time-dependent manner. This was accompanied by a transient 
‘depolarizing’ effect on oxygen consumption with addition of calcium. This 
calcium effect was primarily Complex I (pyruvate and malate) driven respiration 
that was not observed with succinate (Complex II) driven respiration. 
We then tested NOS (L-NNA & L-NAME) inhibitors in presence of calcium 
and measured the rescue/recovery of mitochondrial bioenergetics. We observed 
no recovery of State III (in presence of ADP) respiration with any of the inhibitors. 
At higher concentrations, each of the inhibitors had a toxic affect on 
mitochondrial bioenergetics. We also tested tempol, a free-radical scavenger, 
and observed no recovery of mitochondrial function. From these data, we 
conclude that calcium alters mitochondrial bioenergetics significantly and 
irreversibly as shown by the lack of effect of NOS inhibitors and free-radical 
scavengers. This could be due to lack of specificity of NOS inhibitors or more 
plausibly an overwhelming effect of calcium. 
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Furthermore, we conducted experiments to a) measure NOS activity and 
b) detect NOS protein in purified brain mitochondria. NOS protein could be 
detected in the percoll-purified mitochondria while PSD-95 was enriched in the 
synaptosomal fraction but visibly absent in the mitochondrial fraction. To remove 
possible contamination of cytosolic NOS protein in brain mitochondria, we treated 
purified mitochondria with cytosolic protein removal or digestion treatments. The 
data indicates that NOS is present inside the mitochondria though the precise 
intra-mitochondrial location is yet to be determined. However, it must be noted 
that our studies do not completely rule out contamination of mitochondrial 
preparations. 
We measured NOS activity in isolated ultra-pure brain mitochondria and 
observed a mitochondrial protein-dependent increase in nitric oxide production in 
intact mitochondria. This suggests the presence of a NOS isoform localized to 
mitochondria, the exact nature of which is yet to be determined. This enzyme 
might be in part responsible for regulation of mitochondrial bioenergetics. 
However, the gene transcription, type of isoform, its transport, physiological 
function and regulation of protein levels and enzyme activity are all questions that 
need further investigation. 
Experiments were then conducted to study if calcium altered ROS/RNS 
levels and we did observe significant increases in ROS/RNS levels over time in 
presence of calcium. We then tested if L-NAME or tempol would alter the 
ROS/RNS levels. We observed no changes in the ROS/RNS levels with either of 
the treatments. In a slightly different experimental paradigm, we measured 
ROS/RNS levels in parallel with changes in membrane potential. We did not 
observe any increases in ROS/RNS levels with calcium. On the contrary, 
ROS/RNS levels decreased significantly in presence of higher concentrations of 
calcium. This was accompanied by a detectable loss of membrane potential with 
the addition of calcium.  These data suggest that the loss in membrane potential 
in presence of calcium might be responsible for the decrease in the observed 
free-radical generation. One plausible explanation could be that loss of 
mitochondrial membrane potential might lead to inhibition of the electron 
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transport chain. Studies remain to be performed if loss of membrane potential 
leads to membrane permeability transition (MPT) and possibly release of 
cytochrome c. The differences in ROS/RNS levels with calcium under various 
experimental paradigms could be attributed to the effective concentration of 
calcium and mitochondrial protein in the respiration medium. This could explain 
the contradictory results of various groups reporting that calcium increased or 
decreased or caused no change in ROS/RNS levels. 
We addressed the question if changes in ROS/RNS levels with calcium 
led to changes in mitochondrial membrane and protein components. We tested 
this by measuring levels of protein carbonyls, 3-nitrotyrosine (3-NT) and 4-
hydroxynonenal (4-HNE), as markers for protein oxidation, protein nitration and 
lipid peroxidation respectively, in presence of calcium. We observed differences 
in the levels of protein carbonyls with calcium but were not significant. We did not 
observe any changes in the levels of and 4-HNE and 3-NT, raising the question 
of the consequences of changes in ROS/RNS levels, the time-frame required to 
alter mitochondrial components and their role in mitochondrial dysfunction 
through oxidative damage per se.  
During the course of this dissertation, one of the recurring and 
confounding reasons is the experimental conditions used by the various groups 
to determine the effects of calcium on mitochondrial respiration, presence of 
mtNOS and its regulation and consequences of calcium induced free radical 
generation. More careful studies are required to address plausible alternate 
mechanisms, other than acute effects of mtNOS mediated oxidative stress, 
underlying mitochondrial dysfunction observed with calcium.  
One such mechanism is a role for nitric oxide (NO•) in mitochondrial 
biogenesis (Nisoli and Carruba 2006). NO• through the cyclic GMP (cGMP) 
pathway causes increased mitochondrial proliferation resulting in mitochondria 
that are functionally active. It is also shown to upregulate Hsp70, a mitochondrial 
chaperone involved in protein import and folding. NO• is upregulated with caloric 
restriction that also activates mitochondrial biogenesis implicating its role in 
extending lifespan. Therefore, the role of mtNOS in aging requires further 
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investigation. It should be kept in mind that nitric oxide (NO•) can also act as an 
anti-oxidant based on its local concentrations and the surrounding environment. 
Lastly, NO• is also involved in upregulation of uncoupling proteins (UCPs) 
possibly due to cross-talk between mtNOS and UCPs at the level of 
mitochondria. 
The presence of UCPs in mitochondria adds another dimension in the 
regulation of mitochondrial bioenergetics (Mattiasson and Sullivan 2006). They 
are present in the mitochondrial inner membrane and help in translocation of 
protons from the inter-membrane space back into the matrix. This results in 
uncoupling of electron transport and oxidation from ADP phosphorylation of the 
ETC leading to lowering of membrane potential (∆ψ) and instead of ATP 
generation the energy is dissipated in the form of heat. Apart from their classic 
role in thermogenesis, UCPs are also shown to be involved in mitochondrial 
proliferation and thereby increase ATP levels. Because UCPs lower the 
membrane potential, they could alter mitochondrial calcium uptake and/or 
overload thereby preventing induction of cell death through membrane 
permeability transition. In addition, ketone bodies are shown to provide more 
NADH, substrate for Complex I driven respiration, and also lower ROS by 
altering the redox state of ubiquinone. Therefore, mild uncoupling through UCPs, 
whereby ROS generation is lowered while preserving mitochondrial function, 
presents a novel therapeutic opportunity in a variety of disease settings and such 
mechanisms are currently being investigated in the laboratory. 
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Appendix A 
 
Figure A.1: Calcium decreases mitochondrial ROS/RNS levels. Mitochondria 
(100ug) were added to a constantly stirred cuvette in a total volume of 2mls of 
125mM KCl buffer at 37ºC containing 1mM L-Arg, 10µM H2DCF-DA (Ex: 485nm, 
Em: 530nm). Each run was performed with a baseline reading of buffer. 
Mitochondria, calcium and the substrates/inhibitors were added as indicated. The 
slope of DCF fluorescence was quantified for the respective conditions including 
baseline and expressed in arbitrary units. A significant decrease in DCF 
fluorescence, as a measure of free radical generation was observed in 
mitochondria treated with calcium compared to those without calcium. The 
decrease was calcium dose-dependent and was observed with additions of 
calcium, ADP, Oligomycin, FCCP and Rotenone but not Succinate. Data 
represent group means ± SD; n = 3 per group. One-Way ANOVA; Student-
Newman-Keuls post-hoc test; * p < 0.05 compared to 0nmol/mg Calcium; @ p < 
0.05 compared to 200nmol/mg. 
 
Measurement DF F – value P – value Power 
Mito 2 0.000 - 0.05 
Pyr/Mal 2 0.574 0.5964 0.102 
Calcium 2 20.738 0.0038 0.987 
ADP 2 11.936 0.0125 0.889 
Oligo 2 5.773 0.0502 0.594 
FCCP 2 5.815 0.0496 0.597 
Rot 2 3.851 0.0972 0.429 
Succ 2 0.080 0.9241 0.057 
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Figure A.1: Calcium decreases mitochondrial ROS/RNS levels. 
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Figure A.2: Calcium decreases mitochondrial membrane potential. 
Mitochondria (100ug) were added to a constantly stirred cuvette in a total volume 
of 2mls of 125mM KCl buffer at 37ºC containing 1mM L-Arg, 150nM TMRE (Ex: 
550nm, Em: 575nm). Each run was performed with a baseline reading of buffer. 
Mitochondria, calcium and the substrates/inhibitors were added as indicated. An 
increase in TMRE fluorescence, as a measure of loss of mitochondrial 
membrane potential (∆ψ), was observed in mitochondria treated with calcium 
compared to those with no calcium. This increase was calcium dose-dependent 
and was sustained in presence of ADP (see calcium 200-500nmol/mg). n = 3 per 
group. 
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Figure A.2: Calcium decreases mitochondrial membrane potential. 
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Appendix B 
 
adenosine triphosphate (ATP), electron transport chain (ETC), calcium (Ca2+), 
reactive oxygen species (ROS), de-oxy ribo nucleic acid (DNA), mitofusins (Mfn), 
dynamin-related proteins (Drp), peroxisome proliferator-activated receptor-γ 
coactivator (PGC), nuclear respiratory factor (NRF), outer mitochondrial 
membrane (OMM), inner mitochondrial membrane (IMM), inter-membrane space 
(IMS), mitochondrial DNA (mtDNA), ribonucleic acid (RNA), ribosomal RNA 
(rRNA), transfer RNA (tRNA), translocase of the outer membrane (TOM), sorting 
and assembly machinery (SAM), translocase of the inner membrane (TIM), 
nicotanamide adenine dinucleotide (NADH), flavin adenine dinucleotides 
(FADH2), adenosine diphosphate (ADP), inorganic phosphate (Pi), NADH-
ubiquinone oxidoreductase (Complex I), coenzyme Q (ubiquinone), succinate-
ubiquinone oxidoreductase (Complex II), nitroproprionic acid (3-NP), Ubiquinone-
cytochrome c oxidoreductase (Complex III), cytochrome c oxidase (COX or 
Complex IV), water (H2O), F0-F1-ATPase or ATP synthase (Complex V), adenine 
nucleotide translocase (ANT), magnesium (Mg2+), voltage-operated channels 
(VOC), receptor-operated channels (ROC), N-methyl-D-aspartate (NMDA), store-
operated channels (SOC), receptor tyrosine kinases (TyrK), Phospholipase C 
(PLC), endoplasmic reticulum (ER), inositol 1,4,5-trisphosphate receptors 
(InsP3R), ryanodine receptors (RyR), protein kinase C (PKC), protein kinase A 
(PKA), protein phophatases 1 and 2a (PP1 and PP2a), calmodulin (CaM), 
troponin C (TnC), nuclear factor-kappa B (NF-κB), nuclear factor of activated T 
cells (NF-AT), cyclic adenosine monophosphate (cAMP), cyclic-AMP response 
element binding protein (CREB), NF-kappaB inhibitory protein (IκB), calmodulin 
kinase II (CaMKII), sarco(endo)plasmic reticulum Ca2+-ATPases (SERCA), 
secretory-pathway Ca2+-ATPases (SPCA), mitochondrial calcium uniporter 
(MCU), sodium (Na+), Na+/ Ca2+ exchangers (NCX), plasma membrane (PM), 
plasma membrane Ca2+-ATPases (PMCA), proton (H+), permeability transition 
pore (PTP), nitric oxide  or nitrogen monoxide (NO•), endothelium-dependent 
relaxation factor (EDRF), superoxide (O2•-), cyclic guanosine monophosphate 
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(cGMP), nitric oxide synthase (NOS), neuronal NOS (nNOS or NOS-1), inducible 
NOS (iNOS or NOS-2), endothelial NOS (eNOS or NOS3), calmodulin (CaM), 
(6R)-5,6,7,8-tetrahydro-L-biopterin (BH4), nicotinamide adenine dinucleotide 
phosphate (NADPH), flavin adenine dinucleotide (Fadeel and Orrenius 2005), 
flavin mononucleotide (FMN), PSD-95 discs large/ZO-1 homology (PDZ), post-
synaptic density protein 95 (PSD-95), heat-shock protein 90 (Hsp90), protein 
inhibitor of NOS (PIN), inositol 1,4,5-trisphosphate (IP3), diacylglycerol (Arrigoni, 
Benzi et al. 1984), phosphatidylinositol 4,5-bisphosphate (PIP2), protein kinase B 
(Akt), eNOS-interacting protein (NOSIP), eNOS traffic inducer  protein 
(NOSTRIN), interferon-γ (IFN-γ), janus kinase (JAK),  signal transducers and 
activators of transcription (STAT), IFN-γ regulatory factor 1 (IRF-1), NOS-
associated protein 110 (NAP-110), iron-sulphur (Fe-S), heme-oxygenase 1 (HO-
1), cytochrome c oxidase (COX-IV), soluble guanylyl cyclase (sGC), hypoxia-
inducible factor 1 (HIF-1), iron-regulatory protein (IRP), iron-responsive elements 
(IREs), aryl-hydrocarbon receptor nuclear translocator (ARNT), vascular 
endothelial growth factor (VEGF), insulin-like growth factor II (IGF-II), cGMP-
dependent protein kinase (PKG), cyclic nucleotide-gated channels (CNG), central 
nervous system (CNS), peripheral nervous system (PNS), long-term potentiation 
(LTP), lipopolysaccharide (LPS), reactive nitrogen species (RNS), nitroxyl 
radicals (NO-), peroxynitrite (ONOO-), hydroxyl radical (•OH), hydrogen peroxide 
(H2O2), copper,zinc-associated superoxide dismutase (Cu,Zn-SOD), free radical 
theory of aging (FRTA), mitochondrial theory of aging (MTA), ozone (O3), ultra-
violet radiation (UV), peroxyl radicals (ROO•), alkoxyl radicals (RO•), 
hypochlorous acid (HOCl), manganese-superoxide dismutase (Mn-SOD), 
glutathione peroxidase (GPx), nitrosoperoxo carbonate (ONOOCO2-), nitrogen 
dioxide (•NO2), carbonate (CO3•-), peroxynitrous acid (ONOOH), interleukin-8 
(IL-8), interleukin-1β (IL-1β), epidermal growth factor (EGF), insulin receptor 
kinase (IRK), mitogen-activated protein kinases (MAPK), extracellular signal-
regulated protein kinase (ERK), c-Jun NH2-terminal kinase (JNK), activator 
protein 1 (AP-1), low-molecular-weight antioxidants (LMWA), ascorbate (Vitamin 
C), tocopherols (Vitamin E), glutathione (GSH), lipid radical (L•), lipid peroxyl 
 157
 
radical (LOO•), malonyldialdehyde (MDA), 4-hydroxynonenal (4-HNE), cysteine 
(Cys), methionine (Met), iron (Fe2+), copper (Cu+), lysine (Lys), histidine (His), 3-
nitro tyrosine (3-NT), arginine (Arg), proline (Pro), threonine (Thr), tryptophan 
(Trp), 8-hydroxy-2-deoxyguanosine (8-OHdG), manganese (Mn2+), phosphatidyl 
serine (PS), caspase recruitment domain (CARD), death effector domain (DED), 
Fas ligand (FasL), tumor necrosis factor-α (TNFα), tumor necrosis factor-α 
receptor 1 (TNFR1), death-inducing signaling complex (DISC), mitochondrial 
membrane permeability transition pore (MPTP), benzodiazepine receptor (PBR), 
hexokinase (HK), creatine kinase (CK), second mitocondria-derived activator of 
caspases/ direct IAP-binding protein with low pI (Smac/Diablo), apoptotic 
protease-activating factor 1 (Apaf-1), apoptosis-inducing factor  (AIF), 
Endonuclease G (Endo G), high temperature requirement protein A2 
(HtrA2/Omi), inhibitors of apoptosis proteins (IAP), voltage-dependent anion 
channel (VDAC), cyclophilin D (CypD), µ-calpain (calpain I), m-calpain (calpain 
II), Alzheimer’s disease (AD), Parkinson’s disease (PD), average life expectancy 
(ALE), maximum lifespan (MLS), mild cognitive impairment (MCI), respiratory 
control ratio (RCR), cryoprotective additives (CPA), dimethyl sulfoxide (DMSO), 
bovine serum albumin (BSA), potassium phosphate monobasic anhydrous 
(KH2PO4), ethylene glycol-bis(2-aminoethylether)-N,N,N',N'-tetraacetic acid 
(EGTA), hydroxyethyl piperazine-1-ethanesulfonic acid potassium salt (HEPES), 
magnesium chloride (MgCl2), carbonyl cyanide 4-(trifluoromethoxy) 
phenylhydrazone (FCCP), bicinchoninic acid (BCA), potassium chloride (KCl), 
enzyme-linked immunosorbent Assay (ELISA), tris-buffered saline (TBS), 
horseradish peroxidase (HRP), analysis of variance (ANOVA), standard 
deviations (SD), β-Amyloid (Aβ), positron emission tomography (PET), functional 
magnetic resonance imaging (fMRI), ayloid precursor protein (APP), post-mortem 
interval (PMI), potassium hydroxide (KOH), dihydro dichlorofluorescin diacetate 
(H2DCF-DA), Alzheimer’s disease research center (ADRC), frontal (F), middle-
temporal (MT), sensory (S), dichloro fluorescein (DCF), arbitrary units (AU), 2,4-
dinitrophenyl hydrazone (DNP), nuclear DNA (nDNA), pyruvate dehydrogenase 
complex (PDHC), α-ketoglutarate dehydrogenase complex (KGDHC), 
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mitochondrial NOS (mtNOS), calcium chloride (CaCl2), L-arginine (L-Arg), L-
citrulline (L-Cit), tetramethylrhodamine ethyl ester (TMRE), NG-Nitro-L-arginine 
(L-NNA) and NG-Nitro-L-arginine methyl ester, hydrochloride (L-NAME), sodium 
chloride (NaCl), phosphate (PO-4), phenylmethylsulfonyl fluoride (PMSF), 
phosphate buffer saline (PBS), ubiquinol (QH2), ubiquinone (Q), ubisemiquinone 
(QH•), phospholipase A2 (PLA2), arachidonic acid (AA) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 159
 
References 
 
 
Alderton, W. K., et al. (2001). "Nitric oxide synthases: structure, function and 
inhibition." Biochem J 357(Pt 3): 593-615. 
Ameisen, J. C. (2002). "On the origin, evolution, and nature of programmed cell 
death: a timeline of four billion years." Cell Death Differ 9(4): 367-93. 
Anderson, M. F. and N. R. Sims (2000). "Improved recovery of highly enriched 
mitochondrial fractions from small brain tissue samples." Brain Res Brain 
Res Protoc 5(1): 95-101. 
Andreyev, A. and G. Fiskum (1999). "Calcium induced release of mitochondrial 
cytochrome c by different mechanisms selective for brain versus liver." 
Cell Death Differ 6(9): 825-32. 
Andreyev, A. Y., et al. (1998). "Cytochrome c release from brain mitochondria is 
independent of the mitochondrial permeability transition." FEBS Lett 
439(3): 373-6. 
Andreyev, A. Y., et al. (2005). "Mitochondrial metabolism of reactive oxygen 
species." Biochemistry (Mosc) 70(2): 200-14. 
Araki, T. (1977). "Freezing injury in mitochondrial membrances. I. Susceptible 
components in the oxidation systems of frozen and thawed rabbit liver 
mitochondria." Cryobiology 14(2): 144-50. 
Araki, T. (1977). "Freezing injury in mitochondrial membranes. II. Degradation of 
phospholipid in rabbit liver mitochondria during freezing and storage at low 
temperatures." Cryobiology 14(2): 151-9. 
Armstrong, J. S. (2006). "Mitochondrial membrane permeabilization: the sine qua 
non for cell death." Bioessays 28(3): 253-60. 
Artal-Sanz, M. and N. Tavernarakis (2005). "Proteolytic mechanisms in necrotic 
cell death and neurodegeneration." FEBS Lett 579(15): 3287-96. 
Aust, A. E. and J. F. Eveleigh (1999). "Mechanisms of DNA oxidation." Proc Soc 
Exp Biol Med 222(3): 246-52. 
Babior, B. M. (2004). "NADPH oxidase." Curr Opin Immunol 16(1): 42-7. 
 160
 
Bates, T. E., et al. (1995). "Immunocytochemical evidence for a mitochondrially 
located nitric oxide synthase in brain and liver." Biochem Biophys Res 
Commun 213(3): 896-900. 
Beal, M. F. (2005). "Mitochondria take center stage in aging and 
neurodegeneration." Ann Neurol 58(4): 495-505. 
Beckman, J. S. and W. H. Koppenol (1996). "Nitric oxide, superoxide, and 
peroxynitrite: the good, the bad, and ugly." Am J Physiol 271(5 Pt 1): 
C1424-37. 
Beckman, K. B. and B. N. Ames (1998). "The free radical theory of aging 
matures." Physiol Rev 78(2): 547-81. 
Begley, J. G., et al. (1998). "Cryopreservation of rat cortical synaptosomes and 
analysis of glucose and glutamate transporter activities, and mitochondrial 
function." Brain Res Brain Res Protoc 3(1): 76-82. 
Bergendi, L., et al. (1999). "Chemistry, physiology and pathology of free 
radicals." Life Sci 65(18-19): 1865-74. 
Bernardi, P., et al. (2006). "The mitochondrial permeability transition from in vitro 
artifact to disease target." Febs J 273(10): 2077-99. 
Berridge, M. J., et al. (2000). "The versatility and universality of calcium 
signalling." Nat Rev Mol Cell Biol 1(1): 11-21. 
Berridge, M. J., et al. (2003). "Calcium signalling: dynamics, homeostasis and 
remodelling." Nat Rev Mol Cell Biol 4(7): 517-29. 
Blass, J. P. (2000). "The mitochondrial spiral. An adequate cause of dementia in 
the Alzheimer's syndrome." Ann N Y Acad Sci 924: 170-83. 
Blass, J. P. (2001). "Brain metabolism and brain disease: is metabolic deficiency 
the proximate cause of Alzheimer dementia?" J Neurosci Res 66(5): 851-
6. 
Bolanos, J. P., et al. (1997). "Nitric oxide-mediated mitochondrial damage in the 
brain: mechanisms and implications for neurodegenerative diseases." J 
Neurochem 68(6): 2227-40. 
Borutaite, V., et al. (1999). "Release of cytochrome c from heart mitochondria is 
induced by high Ca2+ and peroxynitrite and is responsible for Ca(2+)-
 161
 
induced inhibition of substrate oxidation." Biochim Biophys Acta 1453(1): 
41-8. 
Boveris, A., et al. (2002). "The role of mitochondrial nitric oxide synthase in 
inflammation and septic shock." Free Radic Biol Med 33(9): 1186-93. 
Boveris, A., et al. (2003). "Kidney mitochondrial nitric oxide synthase." Antioxid 
Redox Signal 5(3): 265-71. 
Boveris, A., et al. (2006). "Mitochondrial metabolic states regulate nitric oxide and 
hydrogen peroxide diffusion to the cytosol." Biochim Biophys Acta 1757(5-
6): 535-42. 
Bredt, D. S. and S. H. Snyder (1990). "Isolation of nitric oxide synthetase, a 
calmodulin-requiring enzyme." Proc Natl Acad Sci U S A 87(2): 682-5. 
Bredt, D. S., et al. (1990). "Localization of nitric oxide synthase indicating a 
neural role for nitric oxide." Nature 347(6295): 768-70. 
Bringold, U., et al. (2000). "Peroxynitrite formed by mitochondrial NO synthase 
promotes mitochondrial Ca2+ release." Free Radic Biol Med 29(3-4): 343-
8. 
Brookes, P. S. (2004). "Mitochondrial nitric oxide synthase." Mitochondrion 3(4): 
187-204. 
Brookes, P. S., et al. (2002). "Mitochondria: regulators of signal transduction by 
reactive oxygen and nitrogen species." Free Radic Biol Med 33(6): 755-
64. 
Brown, G. C. (2001). "Regulation of mitochondrial respiration by nitric oxide 
inhibition of cytochrome c oxidase." Biochim Biophys Acta 1504(1): 46-57. 
Brown, G. C. and V. Borutaite (2002). "Nitric oxide inhibition of mitochondrial 
respiration and its role in cell death." Free Radic Biol Med 33(11): 1440-
50. 
Brown, G. C., et al. (1999). Mitochondria and cell death. Princeton, N.J., 
Princeton University Press. 
Brown, M. R., et al. (2004). "Brain region-specific, age-related, alterations in 
mitochondrial responses to elevated calcium." J Bioenerg Biomembr 
36(4): 401-6. 
 162
 
Brown, M. R., et al. (2004). "Nitrogen disruption of synaptoneurosomes: an 
alternative method to isolate brain mitochondria." J Neurosci Methods 
137(2): 299-303. 
Brown, M. R., et al. (2006). "Synaptic mitochondria are more susceptible to Ca2+ 
overload than non-synaptic mitochondria." J Biol Chem 281(17): 11658-
68. 
Brustovetsky, N. and J. M. Dubinsky (2000). "Dual responses of CNS 
mitochondria to elevated calcium." J Neurosci 20(1): 103-13. 
Brustovetsky, N., et al. (2002). "Calcium-induced Cytochrome c release from rat 
brain mitochondria is altered by digitonin." Neurosci Lett 332(2): 91-4. 
Brustovetsky, N., et al. (2002). "Calcium-induced cytochrome c release from CNS 
mitochondria is associated with the permeability transition and rupture of 
the outer membrane." J Neurochem 80(2): 207-18. 
Brustovetsky, N., et al. (2003). "Increased susceptibility of striatal mitochondria to 
calcium-induced permeability transition." J Neurosci 23(12): 4858-67. 
Brustovetsky, N., et al. (2003). "Two pathways for tBID-induced cytochrome c 
release from rat brain mitochondria: BAK- versus BAX-dependence." J 
Neurochem 84(1): 196-207. 
Bryk, R. and D. J. Wolff (1999). "Pharmacological modulation of nitric oxide 
synthesis by mechanism-based inactivators and related inhibitors." 
Pharmacol Ther 84(2): 157-78. 
Butterfield, D. A., et al. (2006). "Oxidative stress in Alzheimer's disease brain: 
new insights from redox proteomics." Eur J Pharmacol 545(1): 39-50. 
Calabrese, V., et al. (2006). "Redox regulation of heat shock protein expression 
by signaling involving nitric oxide and carbon monoxide: relevance to brain 
aging, neurodegenerative disorders, and longevity." Antioxid Redox Signal 
8(3-4): 444-77. 
Camello-Almaraz, C., et al. (2006). "Mitochondrial reactive oxygen species and 
Ca2+ signaling." Am J Physiol Cell Physiol 291(5): C1082-8. 
Canevari, L., et al. (2004). "Toxicity of amyloid beta peptide: tales of calcium, 
mitochondria, and oxidative stress." Neurochem Res 29(3): 637-50. 
 163
 
Carafoli, E. (2002). "Calcium signaling: a tale for all seasons." Proc Natl Acad Sci 
U S A 99(3): 1115-22. 
Carafoli, E., et al. (2001). "Generation, control, and processing of cellular calcium 
signals." Crit Rev Biochem Mol Biol 36(2): 107-260. 
Carroll, R. T., et al. (2000). "4-Hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl 
(Tempol) inhibits peroxynitrite-mediated phenol nitration." Chem Res 
Toxicol 13(4): 294-300. 
Caspersen, C., et al. (2005). "Mitochondrial Abeta: a potential focal point for 
neuronal metabolic dysfunction in Alzheimer's disease." Faseb J 19(14): 
2040-1. 
Chalmers, S. and D. G. Nicholls (2003). "The relationship between free and total 
calcium concentrations in the matrix of liver and brain mitochondria." J Biol 
Chem 278(21): 19062-70. 
Chang, D. T. and I. J. Reynolds (2006). "Mitochondrial trafficking and morphology 
in healthy and injured neurons." Prog Neurobiol 80(5): 241-68. 
Chiarugi, A. (2005). ""Simple but not simpler": toward a unified picture of energy 
requirements in cell death." Faseb J 19(13): 1783-8. 
Ciechanover, A. (2006). "The ubiquitin proteolytic system: from an idea to the 
patient bed." Proc Am Thorac Soc 3(1): 21-31. 
Clayton, R., et al. (2005). "Cytochrome c release from rat brain mitochondria is 
proportional to the mitochondrial functional deficit: implications for 
apoptosis and neurodegenerative disease." J Neurochem 92(4): 840-9. 
Clementi, E. (2003). "The contribution of Salvador Moncada to our understanding 
of the biology of nitric oxide." IUBMB Life 55(10-11): 563-5. 
Cooper, C. E. and C. Giulivi (2007). "Nitric oxide regulation of mitochondrial 
oxygen consumption II: molecular mechanism and tissue physiology." Am 
J Physiol Cell Physiol. 
Crompton, M. (2003). "On the involvement of mitochondrial intermembrane 
junctional complexes in apoptosis." Curr Med Chem 10(16): 1473-84. 
Csordas, A., et al. (2007). "Human heart mitochondria do not produce 
physiologically relevant quantities of nitric oxide." Life Sci 80(7): 633-7. 
 164
 
Davies, K. J. (2000). "Oxidative stress, antioxidant defenses, and damage 
removal, repair, and replacement systems." IUBMB Life 50(4-5): 279-89. 
De Loecker, P., et al. (1991). "The effects of cryopreservation on protein 
synthesis and membrane transport in isolated rat liver mitochondria." 
Cryobiology 28(5): 445-53. 
Denton, R. M., et al. (1988). "Effects of Ca2+ on the activities of the calcium-
sensitive dehydrogenases within the mitochondria of mammalian tissues." 
J Cardiovasc Pharmacol 12 Suppl 5: S69-72. 
Dickinson, D. B., et al. (1967). "Dimethyl sulfoxide protects tightly coupled 
mitochondria from freezing damage." Science 156(783): 1738-9. 
Drew, B. and C. Leeuwenburgh (2002). "Aging and the role of reactive nitrogen 
species." Ann N Y Acad Sci 959: 66-81. 
Droge, W. (2002). "Free radicals in the physiological control of cell function." 
Physiol Rev 82(1): 47-95. 
Duchen, M. R. (2000). "Mitochondria and Ca(2+)in cell physiology and 
pathophysiology." Cell Calcium 28(5-6): 339-48. 
Dufour, E. and N. G. Larsson (2004). "Understanding aging: revealing order out 
of chaos." Biochim Biophys Acta 1658(1-2): 122-32. 
Dyall, S. D., et al. (2004). "Ancient invasions: from endosymbionts to organelles." 
Science 304(5668): 253-7. 
Dykens, J. A. (1994). "Isolated cerebral and cerebellar mitochondria produce free 
radicals when exposed to elevated CA2+ and Na+: implications for 
neurodegeneration." J Neurochem 63(2): 584-91. 
Elfering, S. L., et al. (2002). "Biochemistry of mitochondrial nitric-oxide synthase." 
J Biol Chem 277(41): 38079-86. 
Elfering, S. L., et al. (2004). "Aspects, mechanism, and biological relevance of 
mitochondrial protein nitration sustained by mitochondrial nitric oxide 
synthase." Am J Physiol Heart Circ Physiol 286(1): H22-9. 
Escames, G., et al. (2003). "Melatonin counteracts lipopolysaccharide-induced 
expression and activity of mitochondrial nitric oxide synthase in rats." 
Faseb J 17(8): 932-4. 
 165
 
Fadeel, B. and S. Orrenius (2005). "Apoptosis: a basic biological phenomenon 
with wide-ranging implications in human disease." J Intern Med 258(6): 
479-517. 
Farkas, E. and P. G. Luiten (2001). "Cerebral microvascular pathology in aging 
and Alzheimer's disease." Prog Neurobiol 64(6): 575-611. 
Fishbein, W. N. and J. L. Griffin (1976). "Studies on the mechanism of freezing 
damage to mouse liver. IV. Effects of ultrarapid freezing on structure and 
function of isolated mitochondria." Cryobiology 13(5): 542-56. 
Fleischer, S. (1979). "Long-term storage of mitochondria to preserve energy-
linked functions." Methods Enzymol 55: 28-32. 
Floyd, R. A. and K. Hensley (2002). "Oxidative stress in brain aging:  Implications 
for therapeutics of neurodegenerative diseases." Neurobiology of Aging 
23(5): 795-807. 
Forstermann, U., et al. (1995). "Isoforms of nitric oxide synthase. Properties, 
cellular distribution and expressional control." Biochem Pharmacol 50(9): 
1321-32. 
Freeman, B. A. (2000). "Oxygen: the air-borne nutrient that both sustains and 
threatens life." Nutrition 16(7-8): 478-80. 
French, S., et al. (2001). "Nitric oxide synthase in porcine heart mitochondria: 
evidence for low physiological activity." Am J Physiol Heart Circ Physiol 
280(6): H2863-7. 
Fridovich, I. (1998). "Oxygen toxicity: a radical explanation." J Exp Biol 201(Pt 8): 
1203-9. 
Fridovich, I. (1998). "The trail to superoxide dismutase." Protein Sci 7(12): 2688-
90. 
Friguet, B. (2006). "Oxidized protein degradation and repair in ageing and 
oxidative stress." FEBS Lett 580(12): 2910-6. 
Fuller, B. J., et al. (1989). "The bioenergetics of mitochondria after 
cryopreservation." Cryobiology 26(4): 333-40. 
Gao, S., et al. (2004). "Docking of endothelial nitric oxide synthase (eNOS) to the 
mitochondrial outer membrane: a pentabasic amino acid sequence in the 
 166
 
autoinhibitory domain of eNOS targets a proteinase K-cleavable peptide 
on the cytoplasmic face of mitochondria." J Biol Chem 279(16): 15968-74. 
Geller, D. A. and T. R. Billiar (1998). "Molecular biology of nitric oxide 
synthases." Cancer Metastasis Rev 17(1): 7-23. 
Ghafourifar, P. and C. Richter (1997). "Nitric oxide synthase activity in 
mitochondria." FEBS Lett 418(3): 291-6. 
Ghafourifar, P. and E. Cadenas (2005). "Mitochondrial nitric oxide synthase." 
Trends Pharmacol Sci 26(4): 190-5. 
Ghafourifar, P., et al. (1999). "Mitochondrial nitric-oxide synthase stimulation 
causes cytochrome c release from isolated mitochondria. Evidence for 
intramitochondrial peroxynitrite formation." J Biol Chem 274(44): 31185-8. 
Gibson, G. E., et al. (1998). "Abnormalities of mitochondrial enzymes in 
Alzheimer disease." J Neural Transm 105(8-9): 855-70. 
Giulivi, C. (1998). "Functional implications of nitric oxide produced by 
mitochondria in mitochondrial metabolism." Biochem J 332 ( Pt 3): 673-9. 
Giulivi, C. (2003). "Characterization and function of mitochondrial nitric-oxide 
synthase." Free Radic Biol Med 34(4): 397-408. 
Giulivi, C., et al. (1998). "Production of nitric oxide by mitochondria." J Biol Chem 
273(18): 11038-43. 
Giulivi, C., et al. (2006). "Nitric oxide regulation of mitochondrial oxygen 
consumption I: cellular physiology." Am J Physiol Cell Physiol 291(6): 
C1225-31. 
Golstein, P. and G. Kroemer (2005). "Redundant cell death mechanisms as relics 
and backups." Cell Death Differ 12 Suppl 2: 1490-6. 
Gray, M. W., et al. (1999). "Mitochondrial evolution." Science 283(5407): 1476-
81. 
Gray, M. W., et al. (2001). "The origin and early evolution of mitochondria." 
Genome Biol 2(6): REVIEWS1018. 
Greiff, D. and M. Myers (1961). "Effect of dimethyl sulphoxide on the cryo-
tolerance of mitochondria." Nature 190: 1202-4. 
 167
 
Greiff, D., et al. (1961). "The effects of glycerol, freezing and storage at low 
temperatures, and drying by vacuum sublimation on oxidative 
phosphorvlation by mitochondrial suspensions." Biochim Biophys Acta 50: 
233-42. 
Groves, J. T. and C. C. Wang (2000). "Nitric oxide synthase: models and 
mechanisms." Curr Opin Chem Biol 4(6): 687-95. 
Grune, T., et al. (2003). "Selective degradation of oxidatively modified protein 
substrates by the proteasome." Biochem Biophys Res Commun 305(3): 
709-18. 
Grune, T., et al. (2004). "Decreased proteolysis caused by protein aggregates, 
inclusion bodies, plaques, lipofuscin, ceroid, and 'aggresomes' during 
oxidative stress, aging, and disease." Int J Biochem Cell Biol 36(12): 
2519-30. 
Guix, F. X., et al. (2005). "The physiology and pathophysiology of nitric oxide in 
the brain." Prog Neurobiol 76(2): 126-52. 
Gunter, T. E., et al. (2004). "Calcium and mitochondria." FEBS Lett 567(1): 96-
102. 
Gutteridge, J. M. and B. Halliwell (2000). "Free radicals and antioxidants in the 
year 2000. A historical look to the future." Ann N Y Acad Sci 899: 136-47. 
Gyulkhandanyan, A. V. and P. S. Pennefather (2004). "Shift in the localization of 
sites of hydrogen peroxide production in brain mitochondria by 
mitochondrial stress." J Neurochem 90(2): 405-21. 
Hajnoczky, G., et al. (2003). "Calcium signaling and apoptosis." Biochem 
Biophys Res Commun 304(3): 445-54. 
Hanafy, K. A., et al. (2001). "NO, nitrotyrosine, and cyclic GMP in signal 
transduction." Med Sci Monit 7(4): 801-19. 
Harman, D. (2003). "The free radical theory of aging." Antioxid Redox Signal 
5(5): 557-61. 
Harman, D. (2006). "Alzheimer's disease pathogenesis: role of aging." Ann N Y 
Acad Sci 1067: 454-60. 
 168
 
Harman, D. and H. Harman (2003). ""I thought, thought, thought for four months 
in vain and suddenly the idea came"--an interview with Denham and Helen 
Harman. Interview by K. Kitani and G.O. Ivy." Biogerontology 4(6): 401-12. 
Haynes, V., et al. (2004). "Mitochondrial nitric-oxide synthase: enzyme 
expression, characterization, and regulation." J Bioenerg Biomembr 36(4): 
341-6. 
Hensley, K. and R. A. Floyd (2002). "Reactive oxygen species and protein 
oxidation in aging: a look back, a look ahead." Arch Biochem Biophys 
397(2): 377-83. 
Hirai, K., et al. (2001). "Mitochondrial abnormalities in Alzheimer's disease." J 
Neurosci 21(9): 3017-23. 
Hobbs, A. J., et al. (1999). "Inhibition of nitric oxide synthase as a potential 
therapeutic target." Annu Rev Pharmacol Toxicol 39: 191-220. 
Holliday, R. (2006). "Aging is no longer an unsolved problem in biology." Ann N Y 
Acad Sci 1067: 1-9. 
Hubalek, Z. (2003). "Protectants used in the cryopreservation of 
microorganisms." Cryobiology 46(3): 205-29. 
Hynd, M. R., et al. (2003). "Biochemical and molecular studies using human 
autopsy brain tissue." J Neurochem 85(3): 543-62. 
Ischiropoulos, H., et al. (1999). "Detection of reactive nitrogen species using 2,7-
dichlorodihydrofluorescein and dihydrorhodamine 123." Methods Enzymol 
301: 367-73. 
Jekabsone, A., et al. (2003). "Nitric oxide and calcium together inactivate 
mitochondrial complex I and induce cytochrome c release." J Mol Cell 
Cardiol 35(7): 803-9. 
Jemmerson, R., et al. (2005). "Cytochrome C release from CNS mitochondria 
and potential for clinical intervention in apoptosis-mediated CNS 
diseases." Antioxid Redox Signal 7(9-10): 1158-72. 
Kanai, A. J., et al. (2001). "Identification of a neuronal nitric oxide synthase in 
isolated cardiac mitochondria using electrochemical detection." Proc Natl 
Acad Sci U S A 98(24): 14126-31. 
 169
 
Keller, J. N., et al. (2000). "Impaired proteasome function in Alzheimer's 
disease." J Neurochem 75(1): 436-9. 
Kelly, K. M., et al. (2006). "The neurobiology of aging." Epilepsy Res 68 Suppl 1: 
S5-20. 
Kerr, J. F. (2002). "History of the events leading to the formulation of the 
apoptosis concept." Toxicology 181-182: 471-4. 
Kerr, J. F., et al. (1972). "Apoptosis: a basic biological phenomenon with wide-
ranging implications in tissue kinetics." Br J Cancer 26(4): 239-57. 
Kim, J. S., et al. (2003). "Mitochondrial permeability transition: a common 
pathway to necrosis and apoptosis." Biochem Biophys Res Commun 
304(3): 463-70. 
Kirkwood, T. B. (2005). "Understanding the odd science of aging." Cell 120(4): 
437-47. 
Kirkwood, T. B. and S. N. Austad (2000). "Why do we age?" Nature 408(6809): 
233-8. 
Klionsky, D. J. and S. D. Emr (2000). "Autophagy as a regulated pathway of 
cellular degradation." Science 290(5497): 1717-21. 
Koehler, C. M. (2004). "New developments in mitochondrial assembly." Annu 
Rev Cell Dev Biol 20: 309-35. 
Kohen, R. and A. Nyska (2002). "Oxidation of biological systems: oxidative stress 
phenomena, antioxidants, redox reactions, and methods for their 
quantification." Toxicol Pathol 30(6): 620-50. 
Kone, B. C., et al. (2003). "Protein interactions with nitric oxide synthases: 
controlling the right time, the right place, and the right amount of nitric 
oxide." Am J Physiol Renal Physiol 285(2): F178-90. 
Kroemer, G. and J. C. Reed (2000). "Mitochondrial control of cell death." Nat 
Med 6(5): 513-9. 
Kroemer, G. and M. Jaattela (2005). "Lysosomes and autophagy in cell death 
control." Nat Rev Cancer 5(11): 886-97. 
Kundu, M. and C. B. Thompson (2005). "Macroautophagy versus mitochondrial 
autophagy: a question of fate?" Cell Death Differ 12 Suppl 2: 1484-9. 
 170
 
Kuznetsov, A. V., et al. (2003). "Cryopreservation of mitochondria and 
mitochondrial function in cardiac and skeletal muscle fibers." Anal 
Biochem 319(2): 296-303. 
Lacza, Z., et al. (2001). "Mitochondrial nitric oxide synthase is constitutively 
active and is functionally upregulated in hypoxia." Free Radic Biol Med 
31(12): 1609-15. 
Lacza, Z., et al. (2003). "Mitochondrial nitric oxide synthase is not eNOS, nNOS 
or iNOS." Free Radic Biol Med 35(10): 1217-28. 
Lacza, Z., et al. (2006). "Mitochondrial NO and reactive nitrogen species 
production: does mtNOS exist?" Nitric Oxide 14(2): 162-8. 
LaFerla, F. M. (2002). "Calcium dyshomeostasis and intracellular signalling in 
Alzheimer's disease." Nat Rev Neurosci 3(11): 862-72. 
Lang, B. F., et al. (1999). "Mitochondrial genome evolution and the origin of 
eukaryotes." Annu Rev Genet 33: 351-97. 
Lee, C. P. (1995). "Biochemical studies of isolated mitochondria from normal and 
diseased tissues." Biochim Biophys Acta 1271(1): 21-8. 
Leist, M., et al. (1999). "Inhibition of mitochondrial ATP generation by nitric oxide 
switches apoptosis to necrosis." Exp Cell Res 249(2): 396-403. 
Lemasters, J. J. (2005). "Dying a thousand deaths: redundant pathways from 
different organelles to apoptosis and necrosis." Gastroenterology 129(1): 
351-60. 
Lemasters, J. J., et al. (1999). "Mitochondrial dysfunction in the pathogenesis of 
necrotic and apoptotic cell death." J Bioenerg Biomembr 31(4): 305-19. 
Lenaz, G., et al. (2006). "New insights into structure and function of mitochondria 
and their role in aging and disease." Antioxid Redox Signal 8(3-4): 417-37. 
Levine, R. L. and E. R. Stadtman (2001). "Oxidative modification of proteins 
during aging." Exp Gerontol 36(9): 1495-502. 
Lin, M. T., et al. (2002). "High aggregate burden of somatic mtDNA point 
mutations in aging and Alzheimer's disease brain." Hum Mol Genet 11(2): 
133-45. 
 171
 
Liu, J. and B. N. Ames (2005). "Reducing mitochondrial decay with mitochondrial 
nutrients to delay and treat cognitive dysfunction, Alzheimer's disease, 
and Parkinson's disease." Nutr Neurosci 8(2): 67-89. 
Lores-Arnaiz, S., et al. (2004). "Brain mitochondrial nitric oxide synthase: in vitro 
and in vivo inhibition by chlorpromazine." Arch Biochem Biophys 430(2): 
170-7. 
Lovelock, J. E. and M. W. Bishop (1959). "Prevention of freezing damage to 
living cells by dimethyl sulphoxide." Nature 183(4672): 1394-5. 
Lusena, C. V. (1965). "Release of enzymes from rat liver mitochondria by 
freezing." Can J Biochem 43(11): 1787-98. 
Lusena, C. V. and C. M. Dass (1966). "Structural changes associated with the 
release of enzymes from rat-liver mitochondria by freezing." Can J 
Biochem 44(6): 775-81. 
Manczak, M., et al. (2004). "Differential expression of oxidative phosphorylation 
genes in patients with Alzheimer's disease: implications for early 
mitochondrial dysfunction and oxidative damage." Neuromolecular Med 
5(2): 147-62. 
Markesbery, W. R. (1997). "Oxidative stress hypothesis in Alzheimer's disease." 
Free Radic Biol Med 23(1): 134-47. 
Mashimo, H. and R. K. Goyal (1999). "Lessons from genetically engineered 
animal models. IV. Nitric oxide synthase gene knockout mice." Am J 
Physiol 277(4 Pt 1): G745-50. 
Mattiasson, G. and P. G. Sullivan (2006). "The emerging functions of UCP2 in 
health, disease, and therapeutics." Antioxid Redox Signal 8(1-2): 1-38. 
Mattson, M. P. (2004). "Pathways towards and away from Alzheimer's disease." 
Nature 430(7000): 631-9. 
Mattson, M. P. (2004). "Pathways towards and away from Alzheimer's disease." 
Nature 430(7000): 631-9. 
Mattson, M. P. (2006). "Neuronal life-and-death signaling, apoptosis, and 
neurodegenerative disorders." Antioxid Redox Signal 8(11-12): 1997-
2006. 
 172
 
Mattson, M. P. and S. B. Kater (1988). "Isolated hippocampal neurons in 
cryopreserved long-term cultures: development of neuroarchitecture and 
sensitivity to NMDA." Int J Dev Neurosci 6(5): 439-52. 
McCord, J. M. (2000). "The evolution of free radicals and oxidative stress." Am J 
Med 108(8): 652-9. 
McHugh, P. and M. Turina (2006). "Apoptosis and necrosis: a review for 
surgeons." Surg Infect (Larchmt) 7(1): 53-68. 
Michelangeli, F., et al. (2005). "A plethora of interacting organellar Ca2+ stores." 
Curr Opin Cell Biol 17(2): 135-40. 
Miller, R. T. (2002). "Dinitrobenzene-mediated production of peroxynitrite by 
neuronal nitric oxide synthase." Chem Res Toxicol 15(7): 927-34. 
Miquel, J. (2002). "Can antioxidant diet supplementation protect against age-
related mitochondrial damage?" Ann N Y Acad Sci 959: 508-16. 
Moncada, S. and J. D. Erusalimsky (2002). "Does nitric oxide modulate 
mitochondrial energy generation and apoptosis?" Nat Rev Mol Cell Biol 
3(3): 214-20. 
Moncada, S. and J. P. Bolanos (2006). "Nitric oxide, cell bioenergetics and 
neurodegeneration." J Neurochem 97(6): 1676-89. 
Moreira, P. I., et al. (2006). "Brain and brawn: parallels in oxidative strength." 
Neurology 66(2 Suppl 1): S97-101. 
Mungrue, I. N., et al. (2003). "From molecules to mammals: what's NOS got to do 
with it?" Acta Physiol Scand 179(2): 123-35. 
Newmeyer, D. D. and S. Ferguson-Miller (2003). "Mitochondria: releasing power 
for life and unleashing the machineries of death." Cell 112(4): 481-90. 
Nicholls, D. G. (2005). "Mitochondria and calcium signaling." Cell Calcium 38(3-
4): 311-7. 
Nicholls, D. G. and M. W. Ward (2000). "Mitochondrial membrane potential and 
neuronal glutamate excitotoxicity: mortality and millivolts." Trends 
Neurosci 23(4): 166-74. 
Nicholls, D. G. and S. Chalmers (2004). "The integration of mitochondrial calcium 
transport and storage." J Bioenerg Biomembr 36(4): 277-81. 
 173
 
Nicholls, D. G. and S. J. Ferguson (2002). Bioenergetics 3. San Diego, Calif., 
Academic Press. 
Nicotera, P. and G. Melino (2004). "Regulation of the apoptosis-necrosis switch." 
Oncogene 23(16): 2757-65. 
Nisoli, E. and M. O. Carruba (2006). "Nitric oxide and mitochondrial biogenesis." 
J Cell Sci 119(Pt 14): 2855-62. 
Nisoli, E., et al. (2004). "Mitochondrial biogenesis as a cellular signaling 
framework." Biochem Pharmacol 67(1): 1-15. 
Nisoli, E., et al. (2005). "Calorie restriction promotes mitochondrial biogenesis by 
inducing the expression of eNOS." Science 310(5746): 314-7. 
Nukala, V. N., et al. (2006). "Cryopreservation of brain mitochondria: A novel 
methodology for functional studies." J Neurosci Methods 152(1-2): 48-54. 
Orrenius, S., et al. (2003). "Regulation of cell death: the calcium-apoptosis link." 
Nat Rev Mol Cell Biol 4(7): 552-65. 
Osawa, Y., et al. (2003). "Proteolytic degradation of nitric oxide synthase: effect 
of inhibitors and role of hsp90-based chaperones." J Pharmacol Exp Ther 
304(2): 493-7. 
Parihar, M. S. and G. J. Brewer (2007). "Mitoenergetic failure in Alzheimer 
disease." Am J Physiol Cell Physiol 292(1): C8-23. 
Park, M. K., et al. (2001). "Perinuclear, perigranular and sub-plasmalemmal 
mitochondria have distinct functions in the regulation of cellular calcium 
transport." Embo J 20(8): 1863-74. 
Parone, P. A., et al. (2002). "Mitochondria: regulating the inevitable." Biochimie 
84(2-3): 105-11. 
Pedersen, P. L. (1999). "Mitochondrial events in the life and death of animal 
cells: a brief overview." J Bioenerg Biomembr 31(4): 291-304. 
Perry, G., et al. (2002). "Is oxidative damage the fundamental pathogenic 
mechanism of Alzheimer's and other neurodegenerative diseases?" Free 
Radic Biol Med 33(11): 1475-9. 
Persichini, T., et al. (2005). "Mitochondrial type I nitric oxide synthase physically 
interacts with cytochrome c oxidase." Neurosci Lett 384(3): 254-9. 
 174
 
Petrosillo, G., et al. (2004). "Ca2+-induced reactive oxygen species production 
promotes cytochrome c release from rat liver mitochondria via 
mitochondrial permeability transition (MPT)-dependent and MPT-
independent mechanisms: role of cardiolipin." J Biol Chem 279(51): 
53103-8. 
Poderoso, J. J., et al. (1999). "The reaction of nitric oxide with ubiquinol: kinetic 
properties and biological significance." Free Radic Biol Med 26(7-8): 925-
35. 
Pollack, M., et al. (2002). "The role of apoptosis in the normal aging brain, 
skeletal muscle, and heart." Ann N Y Acad Sci 959: 93-107. 
Poon, H. F., et al. (2004). "Free radicals and brain aging." Clin Geriatr Med 20(2): 
329-59. 
Possel, H., et al. (1997). "2,7-Dihydrodichlorofluorescein diacetate as a 
fluorescent marker for peroxynitrite formation." FEBS Letters 416(2): 175-
178. 
Radi, R., et al. (2001). "Unraveling peroxynitrite formation in biological systems." 
Free Radical Biology and Medicine 30(5): 463-488. 
Radi, R., et al. (2002). "Nitric oxide and peroxynitrite interactions with 
mitochondria." Biol Chem 383(3-4): 401-9. 
Radi, R., et al. (2002). "Peroxynitrite reactions and formation in mitochondria." 
Free Radic Biol Med 33(11): 1451-64. 
Ranger, A. M., et al. (2001). "Mouse models of cell death." Nat Genet 28(2): 113-
8. 
Reddy, P. H. (2006). "Amyloid precursor protein-mediated free radicals and 
oxidative damage: implications for the development and progression of 
Alzheimer's disease." J Neurochem 96(1): 1-13. 
Reddy, P. H. and M. F. Beal (2005). "Are mitochondria critical in the 
pathogenesis of Alzheimer's disease?" Brain Res Brain Res Rev 49(3): 
618-32. 
 175
 
Ridnour, L. A., et al. (2004). "The chemistry of nitrosative stress induced by nitric 
oxide and reactive nitrogen oxide species. Putting perspective on stressful 
biological situations." Biol Chem 385(1): 1-10. 
Riobo, N. A., et al. (2001). "Nitric oxide inhibits mitochondrial NADH:ubiquinone 
reductase activity through peroxynitrite formation." Biochem J 359(Pt 1): 
139-45. 
Riobo, N. A., et al. (2002). "The modulation of mitochondrial nitric-oxide synthase 
activity in rat brain development." J Biol Chem 277(45): 42447-55. 
Rodriguez-Enriquez, S., et al. (2004). "Role of mitochondrial permeability 
transition pores in mitochondrial autophagy." Int J Biochem Cell Biol 
36(12): 2463-72. 
Saavedra-Molina, A., et al. (2003). "Mitochondrial nitric oxide inhibits ATP 
synthesis. Effect of free calcium in rat heart." Amino Acids 24(1-2): 95-
102. 
Santos, N. C., et al. (2003). "Multidisciplinary utilization of dimethyl sulfoxide: 
pharmacological, cellular, and molecular aspects." Biochem Pharmacol 
65(7): 1035-41. 
Saris, N. E. and E. Carafoli (2005). "A historical review of cellular calcium 
handling, with emphasis on mitochondria." Biochemistry (Mosc) 70(2): 
187-94. 
Sarkela, T. M., et al. (2001). "The modulation of oxygen radical production by 
nitric oxide in mitochondria." J Biol Chem 276(10): 6945-9. 
Sastre, J., et al. (2003). "The role of mitochondrial oxidative stress in aging." Free 
Radic Biol Med 35(1): 1-8. 
Scandalios, J. G. (2005). "Oxidative stress: molecular perception and 
transduction of signals triggering antioxidant gene defenses." Braz J Med 
Biol Res 38(7): 995-1014. 
Schild, L. and G. Reiser (2005). "Oxidative stress is involved in the 
permeabilization of the inner membrane of brain mitochondria exposed to 
hypoxia/reoxygenation and low micromolar Ca2+." Febs J 272(14): 3593-
601. 
 176
 
Schild, L., et al. (2001). "Distinct Ca2+ thresholds determine cytochrome c 
release or permeability transition pore opening in brain mitochondria." 
Faseb J 15(3): 565-7. 
Searcy, D. G. (2003). "Metabolic integration during the evolutionary origin of 
mitochondria." Cell Res 13(4): 229-38. 
Shacter, E. (2000). "Quantification and significance of protein oxidation in 
biological samples." Drug Metab Rev 32(3-4): 307-26. 
Sims, N. R. (1996). "Energy metabolism, oxidative stress and neuronal 
degeneration in Alzheimer's disease." Neurodegeneration 5(4): 435-40. 
Sims, N. R., et al. (1987). "Mitochondrial function in brain tissue in primary 
degenerative dementia." Brain Res 436(1): 30-8. 
Smaili, S. S., et al. (2003). "Mitochondria, calcium and pro-apoptotic proteins as 
mediators in cell death signaling." Braz J Med Biol Res 36(2): 183-90. 
Sorrentino, V. and R. Rizzuto (2001). "Molecular genetics of Ca(2+) stores and 
intracellular Ca(2+) signalling." Trends Pharmacol Sci 22(9): 459-64. 
Sousa, S. C., et al. (2003). "Ca2+-induced oxidative stress in brain mitochondria 
treated with the respiratory chain inhibitor rotenone." FEBS Lett 543(1-3): 
179-83. 
Stadtman, E. R. (2006). "Protein oxidation and aging." Free Radic Res 40(12): 
1250-8. 
Stadtman, E. R. and R. L. Levine (2003). "Free radical-mediated oxidation of free 
amino acids and amino acid residues in proteins." Amino Acids 25(3-4): 
207-18. 
Starkov, A. A., et al. (2002). "Regulation of hydrogen peroxide production by 
brain mitochondria by calcium and Bax." J Neurochem 83(1): 220-8. 
Starkov, A. A., et al. (2004). "Mitochondrial alpha-ketoglutarate dehydrogenase 
complex generates reactive oxygen species." J Neurosci 24(36): 7779-88. 
Stuart-Smith, K. (2002). "Demystified. Nitric oxide." Mol Pathol 55(6): 360-6. 
Sullivan, P. G. (2005). "Interventions with neuroprotective agents: novel targets 
and opportunities." Epilepsy Behav 7 Suppl 3: S12-7. 
 177
 
Sullivan, P. G. and M. R. Brown (2005). "Mitochondrial aging and dysfunction in 
Alzheimer's disease." Prog Neuropsychopharmacol Biol Psychiatry 29(3): 
407-10. 
Sullivan, P. G., et al. (2004). "Intrinsic differences in brain and spinal cord 
mitochondria: Implication for therapeutic interventions." J Comp Neurol 
474(4): 524-34. 
Sullivan, P. G., et al. (2004). "Proteasome inhibition alters neural mitochondrial 
homeostasis and mitochondria turnover." J Biol Chem. 
Sultana, R., et al. (2006). "Identification of nitrated proteins in Alzheimer's 
disease brain using a redox proteomics approach." Neurobiol Dis 22(1): 
76-87. 
Sultana, R., et al. (2006). "Protein oxidation and lipid peroxidation in brain of 
subjects with Alzheimer's disease: insights into mechanism of 
neurodegeneration from redox proteomics." Antioxid Redox Signal 8(11-
12): 2021-37. 
Sultana, R., et al. (2006). "Redox proteomics identification of oxidized proteins in 
Alzheimer's disease hippocampus and cerebellum: an approach to 
understand pathological and biochemical alterations in AD." Neurobiol 
Aging 27(11): 1564-76. 
Szabo, C. (2003). "Multiple pathways of peroxynitrite cytotoxicity." Toxicol Lett 
140-141: 105-12. 
Szewczyk, A. and L. Wojtczak (2002). "Mitochondria as a pharmacological 
target." Pharmacol Rev 54(1): 101-27. 
Taanman, J. W. (1999). "The mitochondrial genome: structure, transcription, 
translation and replication." Biochim Biophys Acta 1410(2): 103-23. 
Tarpey, M. M., et al. (2004). "Methods for detection of reactive metabolites of 
oxygen and nitrogen: in vitro and in vivo considerations." Am J Physiol 
Regul Integr Comp Physiol 286(3): R431-44. 
Tatoyan, A. and C. Giulivi (1998). "Purification and characterization of a nitric-
oxide synthase from rat liver mitochondria." J Biol Chem 273(18): 11044-
8. 
 178
 
Tay, Y. M., et al. (2004). "Do mitochondria make nitric oxide? no?" Free Radic 
Res 38(6): 591-9. 
Territo, P. R., et al. (2000). "Ca(2+) activation of heart mitochondrial oxidative 
phosphorylation: role of the F(0)/F(1)-ATPase." Am J Physiol Cell Physiol 
278(2): C423-35. 
Thomas, D. D., et al. (2002). "Guide for the use of nitric oxide (NO) donors as 
probes of the chemistry of NO and related redox species in biological 
systems." Methods Enzymol 359: 84-105. 
Toescu, E. C. and A. Verkhratsky (2004). "Ca2+ and mitochondria as substrates 
for deficits in synaptic plasticity in normal brain ageing." J Cell Mol Med 
8(2): 181-90. 
Toescu, E. C., et al. (2000). "Age-related structural and functional changes of 
brain mitochondria." Cell Calcium 28(5-6): 329-38. 
Toescu, E. C., et al. (2004). "Ca2+ regulation and gene expression in normal 
brain aging." Trends Neurosci 27(10): 614-20. 
Tolkovsky, A. M., et al. (2002). "Mitochondrial disappearance from cells: a clue to 
the role of autophagy in programmed cell death and disease?" Biochimie 
84(2-3): 233-40. 
Traaseth, N., et al. (2004). "Role of calcium signaling in the activation of 
mitochondrial nitric oxide synthase and citric acid cycle." Biochim Biophys 
Acta 1658(1-2): 64-71. 
Tretter, L. and V. Adam-Vizi (2006). "Moderate Dependence of ROS Formation 
on DeltaPsim in Isolated Brain Mitochondria Supported by NADH-linked 
Substrates." Neurochem Res. 
Troen, B. R. (2003). "The biology of aging." Mt Sinai J Med 70(1): 3-22. 
Tsvetkov, T., et al. (1985). "Functional changes in mitochondrial properties as a 
result of their membrane cryodestruction. II. Influence of freezing and 
thawing on ATP complex activity of intact liver mitochondria." Cryobiology 
22(2): 111-8. 
 179
 
Tsvetkov, T., et al. (1985). "Preservation of integrity of the inner mitochondrial 
membrane after freeze-thawing and freeze-drying." Cryobiology 22(3): 
301-6. 
Turrens, J. F. (2003). "Mitochondrial formation of reactive oxygen species." J 
Physiol 552(Pt 2): 335-44. 
Uylings, H. B. and J. M. de Brabander (2002). "Neuronal changes in normal 
human aging and Alzheimer's disease." Brain Cogn 49(3): 268-76. 
Vallance, P. (2001). "Nitric oxide." Biologist (London) 48(4): 153-8. 
Vergun, O. and I. J. Reynolds (2005). "Distinct characteristics of Ca(2+)-induced 
depolarization of isolated brain and liver mitochondria." Biochim Biophys 
Acta 1709(2): 127-37. 
Violi, F., et al. (1999). "Nitric oxide and its role in lipid peroxidation." Diabetes 
Metab Res Rev 15(4): 283-8. 
Votyakova, T. V. and I. J. Reynolds (2001). "DeltaPsi(m)-Dependent and -
independent production of reactive oxygen species by rat brain 
mitochondria." J Neurochem 79(2): 266-77. 
Votyakova, T. V. and I. J. Reynolds (2005). "Ca2+-induced permeabilization 
promotes free radical release from rat brain mitochondria with partially 
inhibited complex I." J Neurochem 93(3): 526-37. 
Wallace, D. C. (2005). "A mitochondrial paradigm of metabolic and degenerative 
diseases, aging, and cancer: a dawn for evolutionary medicine." Annu Rev 
Genet 39: 359-407. 
Wan, B., et al. (1989). "Regulation of citric acid cycle by calcium." J Biol Chem 
264(23): 13430-9. 
Wang, J., et al. (2005). "Increased oxidative damage in nuclear and 
mitochondrial DNA in Alzheimer's disease." J Neurochem 93(4): 953-62. 
Watts, J. A. and J. A. Kline (2003). "Bench to bedside: the role of mitochondrial 
medicine in the pathogenesis and treatment of cellular injury." Acad 
Emerg Med 10(9): 985-97. 
 180
 
Wei, Y. H. and H. C. Lee (2002). "Oxidative stress, mitochondrial DNA mutation, 
and impairment of antioxidant enzymes in aging." Exp Biol Med 
(Maywood) 227(9): 671-82. 
Yu, S. P., et al. (2001). "Ion homeostasis and apoptosis." Curr Opin Cell Biol 
13(4): 405-11. 
Zhou, P., et al. (2005). "Mitochondria are involved in the neurogenic 
neuroprotection conferred by stimulation of cerebellar fastigial nucleus." J 
Neurochem 95(1): 221-9. 
Ziegler, U. and P. Groscurth (2004). "Morphological features of cell death." News 
Physiol Sci 19: 124-8. 
Zong, W. X. and C. B. Thompson (2006). "Necrotic death as a cell fate." Genes 
Dev 20(1): 1-15. 
Zweier, J. L., et al. (1999). "Non-enzymatic nitric oxide synthesis in biological 
systems." Biochim Biophys Acta 1411(2-3): 250-62. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 181
 
VITA 
 
 
 
Name:    Vidya Nag Nukala 
 
Date of Birth:  01/03/1979 
 
Birthplace:    Machilipatnam, AP, INDIA 
 
Education: 
 
2001 - 2007:  Doctoral Degree Candidate 
   Department of Anatomy and Neurobiology 
   The Graduate School at the University of Kentucky 
   Lexington, KY, USA 
 
1999: Bachelor of Sciences (BS) 
Genetics, Microbiology and Chemistry,  
Osmania University,  
Hyderabad, INDIA 
 
Research Experience: 
 
2002 – 2007: Graduate Research Assistant, University of Kentucky, 
Department of Anatomy and Neurobiology, Spinal Cord and 
Brain Injury Research Center (SCoBIRC), Patrick Sullivan, 
Ph.D., Supervisor 
 
2002: Student researcher, University of Kentucky, Department of 
Anatomy and Neurobiology, Jeff Keller, Ph.D., Supervisor 
 182
 
2001: Student researcher, University of Kentucky, Department of 
Microbiology, Immunology and Molecular Genetics, Avi Nath 
Ph.D., Supervisor 
 
2001: Student researcher, University of Kentucky, Department of 
Physiology, Eric Smart Ph.D., Supervisor 
 
2001: Student researcher, University of Kentucky, Department of 
Molecular and Cellular Biochemistry, Kevin Sarge Ph.D., 
Supervisor 
 
Awards and Professional Honors: 
 
November 2006: Invited Speaker 
National Institute on Aging (NIA),  
National Institutes of Health (NIH), Baltimore, MD 
 
July 2006: Invited Speaker 
The Sam and Ann Barshop Institute for Longevity and Aging 
Studies,  
The University of Texas Health Science Center at San 
Antonio (UTHSCSA), San Antonio, TX 
 
June 2006: Invited Speaker 
Institute of Brain Aging and Dementia,  
University of California Irvine, Irvine, CA 
 
October 2005: Student Chairperson - Organizing Committee, 
Annual Fall Aging Symposium ‘Life and Death: The 
Mitochondrial Perspective’, 
  
 183
 
Department of Anatomy and Neurobiology,  
University of Kentucky 
 
January 2005: Member - Graduate Student Committee,  
Course curriculum for ‘Seminar in Anatomy’ (ANA 600), 
Department of Anatomy and Neurobiology, 
University of Kentucky 
 
10/2004 – 02/2005: Organizer, SCoBIRC Student/Post-doc Journal Club, 
University of Kentucky 
 
October 2004:        Member - Organizing Committee, 
Annual Fall Aging Symposium 'Frontiers in Neuroscience', 
Department of Anatomy and Neurobiology, 
University of Kentucky 
 
August 2004: Ellison Medical Foundation Award, Training Course in 
‘Molecular Biology of Aging’, 
Marine Biological Laboratory (MBL),  
Woods Hole, MA 
 
07/2003 – 10/2004: Kentucky Spinal Cord and Head Injury Research Trust 
(KSCHIRT) Fellowship, Louisville, KY 
 
07/2001 – 06/2002: Member - Student Advisory Committee,  
Integrated Biomedical Sciences (IBS),  
University of Kentucky 
 
08/2001 – 06/2002: Integrated Biomedical Sciences (IBS) Fellowship,  
University of Kentucky 
 
 184
 
Publications:  
 
Wycliffe O. Opii, Vidya N. Nukala, Rukhsana Sultana, Kristen M. Day, Michael. 
L. Merchant, Jon B. Klein, Patrick. G. Sullivan and D. Allan Butterfield. Proteomic 
Identification of Oxidized Mitochondrial Proteins Following Experimental 
Traumatic Brain Injury, J Neurotrauma. 2007 May;24(5):772-89. 
 
Pandya, J.D., Pauly, J.R., Nukala, V.N., Sebastian, Day, K.M., A.H., Korde, 
A.M., Springer, J.E., Maragos, W.F., Hall, E.D., Sullivan, P.G. Mitochondrial 
Uncouplers as Possible Therapeutic Interventions following Traumatic Brain 
Injury, J Neurotrauma. 2007 May;24(5):798-811. 
 
Erica Rockabrand, Natalia Slepko, Antonello Pantalone, Vidya N. Nukala, 
Aleksey Kazantsev, J. Lawrence Marsh, Patrick G. Sullivan, Joan S. Steffan, 
Stefano L. Sensi, and Leslie Michels Thompson. The first 17 amino acids of 
Huntingtin modulate its sub-cellular localization, aggregation and effects on 
calcium homeostasis, Hum Mol Genet. 2007 Jan 1;16(1):61-77. 
 
Vidya N. Nukala, Indrapal N. Singh, Laurie M. Davis, Patrick G. Sullivan. 
Cryopreservation of Brain Mitochondria Using Dimethyl Sulfoxide: A Novel 
Methodology for Functional Studies, J Neurosci Methods. 152 (2006) 48-54. 
 
Qunxing Ding, Kristi Reinacker, Edgardo Dimayuga, Vidya Nukala,  Jennifer 
Drake,  D. Allan Butterfield, Jay C. Dunn, Sarah Martin,  Annadora J. Bruce-
Keller, and Jeffrey N. Keller.  Role of the Proteasome in Protein Oxidation and 
Neural Viability Following Low-level Oxidative Stress, FEBS Lett. 2003 Jul 
10;546(2-3):228-32.
 
Qunxing Ding, Edgardo Dimayuga, Sarah Martin,  Annadora J. Bruce-Keller, 
Vidya Nukala, Ana Maria Cuervo and Jeffrey N. Keller.  Characterization of 
 185
 
Chronic Low-Level Proteasome Inhibition on Neural Homeostasis, J Neurochem. 
2003 Jul;86(2):489-97. 
 
Manuscripts in Preparation: 
 
Vidya N. Nukala, Jignesh D. Pandya, Kristen M. Day, Richard T. Miller and 
Patrick G. Sullivan. Nitric Oxide Synthase May Be Involved in Calcium 
Mediated Oxidative Stress and Brain Mitochondrial Dysfunction [In 
Preparation]. 
 
V. N. Nukala, E. Head, B. A. Muggenburg, C. W. Cotman and P. G. Sullivan. 
Effects of Age, Dietary and Behavioral Enrichments on Brain Mitochondria in a 
Canine Model of Human Aging [In Preparation]. 
 
Abstracts/Posters: 
 
V.N. Nukala, J.D. Pandya, R.T. Miller, P.G. Sullivan. Role of Nitric Oxide 
Synthase in Brain Mitochondrial Dysfunction. 23rd Annual National Neurotrauma 
Society Symposium, Washington DC, November 7-9, 2005. 
 
Vidya N. Nukala, Indrapal N. Singh, Laurie M. Davis, Melanie L. McEwen, Doug 
A. Price, Steve S. Scheff and Patrick G. Sullivan. Cryopreservation of Brain 
Mitochondria Using Dimethyl Sulfoxide: A Practical Method for Functional 
Recovery, Society for Neuroscience Bluegrass Chapter, Lexington, KY, March 
15, 2005. 
 
V.N. Nukala, K. Dorenbos, B. Muggenberg, E. Head, C.W. Cotman, P.G. 
Sullivan. Mitochondrial Aging in the Canine Brain: Implications for Mitochondrial 
Bioenergetics and Homeostasis, Mitochondria & Neuroprotection Symposium, 
Ft.Lauderdale, FL, April 16-19, 2004. 
 
 186
 
Nukala V.N., Dragicevic N.B., Springer J.E., Sullivan P.G. Role of Mitochondrial 
Nitric Oxide Synthase in Aging and Traumatic Brain Injury. 33rd Annual meeting 
of the Society for Neuroscience, New Orleans, LA, November 8-12, 2003. 
 
V.N. Nukala, N.B. Dragicevic, P.G. Sullivan. Role of Mitochondrial Nitric Oxide 
Synthase in Neuronal Injury. 21st Annual National Neurotrauma Society 
Symposium, Biloxi, MS, November 6-7, 2003. 
 
N.B. Dragicevic, V.N. Nukala, S.G. Rabchevsky, P.G. Sullivan Characterization 
of Mitochondria from Different Regions of the Spinal Cord. 21st Annual National 
Neurotrauma Society Symposium, Biloxi, MS, November 6-7, 2003. 
 
Gee, J.R., Bruce-Keller, A.J., Nukala, V.N., Kindy, M.S., Keller, J.N., Traurig H.A.  
Role Of Astrocytes And Apolipoprotein E In The Regulation Of Striatal Neuron 
Homeostasis And Motor Function. 32nd Annual Meeting of the Society for 
Neuroscience, Orlando, FL, November 1-7, 2002. 
 
Dunn, J.C., Ding, Q., Nukala, V.N., Dimayuga, E., Dimayuga, F., Bruce-Keller, 
A.-J., Keller, J.-N.  Implications For P53, Cell Cycle Disruption, And MDM2 In 
Polyglutamine Disorders. 32nd Annual Meeting of the Society for Neuroscience, 
Orlando, FL, November 1-7, 2002. 
 
Nukala V, Jones M, Nath A. Matrix Metalloproteinase-2 (MMP-2) Is Expressed In 
The Brains Of Patients With HIV-1 Encephalitis. 21st Annual Meeting of the 
American Society for Virology. Lexington, KY, July 20-24, 2002. 
 
 
Signed: VIDYA NAG NUKALA 
 187
